Sentence,class,file
"2005;90(11):6263-7, http://dx.doi.org/10.1210/jc.2004-2322.25.",Non-OADS,/arxiv_data1/oa_pdf/7f/81/cln-68-s1-075.PMC3583162.pdf
"2004;19(6):1431-7, http://dx.doi.org/10.1093/humrep/deh255.",Non-OADS,/arxiv_data1/oa_pdf/7f/81/cln-68-s1-075.PMC3583162.pdf
"2004;82(1):218-9, http://dx.doi.org/10.1016/j.fertnstert.2003.11.055.",OADS,/arxiv_data1/oa_pdf/7f/81/cln-68-s1-075.PMC3583162.pdf
"2012;27(2):331- 9, http://dx.doi.org/10.1093/humrep/der404.",Non-OADS,/arxiv_data1/oa_pdf/7f/81/cln-68-s1-075.PMC3583162.pdf
"2006;86(2):466-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7f/81/cln-68-s1-075.PMC3583162.pdf
"1996;11(1):231-2, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"1995;10(1):148-52, http://dx.doi.org/10.1093/humrep/10.1.148.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"1997;68(2):376-9, http://dx.doi.org/10.1016/S0015-0282(97)81534-8.11.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"1984;70(1):219-28, http://dx.doi.org/10.1530/jrf.0.0700219.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"1997;3(3):195-203, http://dx.doi.org/ 10.1093/humupd/3.3.195.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"2005;84:S373-S4, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"2000;73(5):955-60, http://dx.doi.org/10.1016/S0015-0282(00)00416-7.",OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
Available from: http://ivfconundrums.com/node/137.,Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"2003;79(1):30-8, http://dx.doi.org/10.1016/ S0015-0282(02)04407-2.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"2007;14(6):746-57, http://dx.doi.org/10.1016/S1472-6483(10)60678-5.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"2009;92(5):1638-45, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"1999;71(2):240-3, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
Available from: http://www.maleinfertility.org/new-retrieval2.html.Lab Processing & ICSI with OA and NOA Males Popal W and Nagy ZPCLINICS 2013;68(S1):125-130 130,Non-OADS,/arxiv_data1/oa_pdf/13/53/cln-68-s1-125.PMC3583163.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/licenses/by-nc-sa/3.0/ ..",Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
Working Paper 9941. http://www.nber.org/ papers/w9941 8.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
http://dx.doi.org/ 10.2139/ssrn.1130315 11.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
http://www.cepal.org/publicaciones/xml/9/32669/DP_CostHunger.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
http://www.who.int/healthinfo/ statistics/bodprojectionspaper.pdf 29. WHO (2010) Global status report on noncommunicable diseases.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
http://www.who.int/chp/chronic_disease_ report/media/searo.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
http://www.weforum.org/reports/ global-economic-burden-non-communicable-diseases 32.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/S0007114512005107a.PMC3583164.pdf
Available at: http://www.eurocontrol.int/articles/forecasts.Accessed on June 2012.,Non-OADS,/arxiv_data1/oa_pdf/e6/4f/srep01344.PMC3583169.pdf
Available at: http://www.complexworld.eu/sesar-and-wp-e/.,Non-OADS,/arxiv_data1/oa_pdf/e6/4f/srep01344.PMC3583169.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Cardillo, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/4f/srep01344.PMC3583169.pdf
"2005;83(4):920-2, http://dx.doi.org/10.1016/j.fertnstert.2004.09.028.",OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2006;86(3):516-23, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2004;19(11):2502-8, http://dx.doi.org/10.1093/humrep/deh462.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2004;364(9430):273-83, http://dx.doi.org/10.1016/ S0140-6736(04)16678-6.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1998;83(9):3110-4, http://dx.doi.org/10.1210/jc.83.9.3110.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2009;144 Suppl 1:S192-8, http://dx.doi.org/10.1016/j.ejogrb.2009.02.034.",OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1998;13(11):3090-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1997;12(10):2186-91, http://dx.doi.org/10.1093/humrep/12.10.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1997;7(7):1079-85, http://dx.doi.org/10.1007/s003300050258.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2012;79(3):684-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2011;25(2):239-50, http://dx.doi.org/10.1016/j.beem.",OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1992;267(13):1794-7, http://dx.doi.org/10.1001/ jama.1992.03480130110034.37.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2001;16(3):529-33, http://dx.doi.org/10.1093/humrep/16.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1976;34(2):119-24, http://dx.doi.org/10.1007/BF0027 8879.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"1996;5(7):933- 43, http://dx.doi.org/10.1093/hmg/5.7.933.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2003;4(8):598-612, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2000;15(7):1431-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
"2001;7(10):987-94, http://dx.doi.org/10.1093/molehr/7.10.987.The Azoospermic Male Gudeloglu A and Parekattil SJCLINICS 2013;68(S1):27-34 34",Non-OADS,/arxiv_data1/oa_pdf/ac/83/cln-68-s1-027.PMC3583174.pdf
Available from: http://www.cdc.gov.,OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2011;66(4):691-700, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2011;66(8):1463-78, http://dx.doi.org/10.1590/S1807-59322011000800026.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2011;95(7):2209-U121, http://dx.doi.org/ 10.1016/j.fertnstert.2011.03.058.",OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2006;85(6):1586-622, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2009;7:111, http://dx.doi.org/10.1186/1477-7827-7-111.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"Cambridge: Cambridge University Press; 2011.pp.41-53, http://dx.doi.org/10.1017/ CBO9780511734755.006.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2000;73(6):1155-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2011;3:138-53, http://dx.doi.org/10.2174/1874255601103010138.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"1997;68(1):108-11, http://dx.doi.org/10.1016/S0015-0282(97)81484- 7.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"1998;13(2):348-52, http://dx.doi.org/10.1093/humrep/13.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"1999;14(11):2796-800, http://dx.doi.org/10.1093/humrep/ 14.11.2796.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"1999;14(3):741-8, http://dx.doi.org/10.1093/humrep/14.3.741.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2000;15(6):1383-8, http://dx.doi.org/10.1093/humrep/15.6.1383.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2001;94(2):250-5, http://dx.doi.org/ 10.1016/S0301-2115(00)00347-X.",OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2003;35(4):220-6, http://dx.doi.org/10.1046/j.1439-0272.2003.00563.x.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2010;13(1):44-50, http://dx.doi.org/10.3109/13685530903342203.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2003;18(10):2093-7, http://dx.doi.org/10.1093/humrep/ deg403.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2007;22(4):1080-5, http://dx.doi.org/10.1093/humrep/del488.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2011;26(7):1752-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2002;17(10):2600-14, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2004;82(3):628-33, http://dx.doi.org/10.1016/j.fertnstert.",OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2002;5(2):171-8, http://dx.doi.org/10.1016/S1472-6483(10) 61621-5.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2002;17(3):671-94, http://dx.doi.org/10.1093/humrep/17.3.671.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2005;73(3):162-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2000;15(5):1189-94, http://dx.doi.org/10.1093/humrep/15.5.1189.",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
"2002;17(9):2249-57, http://dx.doi.org/10.1093/humrep/17.9.2249.CLINICS 2013;68(S1):141-149 Reproductive potential of azoospermic males in ART Esteves SC and Agarwal A 149",Non-OADS,/arxiv_data1/oa_pdf/96/bf/cln-68-s1-141.PMC3583175.pdf
Available from: http://www.ki.se/org/nafa/manual/ Manual2002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/11/cln-68-s1-035.PMC3583176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits unrestricted, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/cvs346.PMC3583257.pdf
"In addition, there is a GO consortium speciﬁcally focused on annotating genes relevant tocardiovascular disease (http://www.geneontology.org/GO.cardio.",Non-OADS,/arxiv_data1/oa_pdf/e1/4c/cvs346.PMC3583257.pdf
69Our aim was to contribute to a better understanding of enzymatic and metabolite changes associated............................................................................................................................... .......................................................Table 3 Functional annotation databases Abbreviation Name Website BBID Biological Biochemical Image Database http://bbid.grc.nia.nih.gov/ BioCarta BioCarta Pathways http://www.biocarta.com/genes/index.asp GO Gene Ontology http://www.geneontology.org/KEGG Kyoto Encyclopedia of Genes and Genomes http://www.genome.jp/kegg/ NCBI BioSystems NCBI BioSystems Database http://www.ncbi.nlm.nih.gov/biosystems OMIM Online Mendelian Inheritance in Man http://omim.org/PANTHER Protein ANalysis THrough Evolutionary Relationships http://www.pantherdb.org/ PID NCI-Pathway Interaction Database http://pid.nci.nih.gov/ Reactome Reactome http://www.reactome.org/WikiPathways WikiPathways http://www.wikipathways.org/index.php/WikiPathwaysProteomics and systems biology 619,OADS,/arxiv_data1/oa_pdf/e1/4c/cvs346.PMC3583257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Soc iety and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/8c/ef/cvt003.PMC3583260.pdf
"Data were collected by using an online survey package (http://www.surveymonkey.com; SurveyMonkey, Portland, Oregon).",OADS,/arxiv_data1/oa_pdf/8e/a2/i1936-900X-14-1-1.PMC3583278.pdf
"Additional data on the EDs were obtained to assess for nonresponse bias, including Level I trauma designation (http://www.amtrauma.org), PA region (http://www.phc4.org)—including Southeastern PA, Central PA, and Western PA—andthe presence of an emergency medicine residency training program (http://www.saem.org/saemdnn/).",Non-OADS,/arxiv_data1/oa_pdf/8e/a2/i1936-900X-14-1-1.PMC3583278.pdf
Centers for Medicare and Medicaid Services Web site.Available at: http://www.cms.gov/HospitalOutpatientPPS/HORD/ itemdetail.asp?itemID ¼CMS1240960&.,OADS,/arxiv_data1/oa_pdf/8e/a2/i1936-900X-14-1-1.PMC3583278.pdf
"PLoS Genet 2012; 8:e1002471; PMID:22253611; http://dx.doi.org/10.1371/journal.pgen.1002471http://dx.doi.org/10.4161/worm.20465MINI-REVIEW Worm 1:3, 141 –150; July/August/September 2012; G2012 Landes Bioscience www.landesbioscience.com Worm 141",Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
J Biomed Biotechnol 2010; 2010: 864749; PMID:20414365; http://dx.doi.org/10.1155/ 2010/8647494.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Adv Exp Med Biol 2008; 642:192-206; PMID:19181102; http://dx.doi.org/10.1007/978-0-387-84847-1_14 5.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
PLoS Genet 2012; 8: e1002471; PMID:22253611; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
J Am Soc Nephrol 2006; 17:1807- 19; PMID:16738015; http://dx.doi.org/10.1681/ASN.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
"eLS: John Wiley & Sons, Ltd., 2007. http://www.els.net [doi:10.1002/9780470015902.a0000646.pub2] 9.",Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Annu Rev Biochem 2011; 80:1055-87; PMID:21456965; http://dx.doi.org/10.1146/annurev- biochem-061809-121639 11.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Int J Biochem Cell Biol 2005; 37:1997-2011; PMID: 16125109; http://dx.doi.org/10.1016/j.biocel.2005.02.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Genome Biol 2000; 1:REVIEWS1013; PMID:11178235; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Annu Rev Biochem 2005; 74:739-89; PMID:15952902; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Biochem Biophys Res Commun 2003; 312:173-7; PMID:14630038; http://dx.doi.org/10.1016/j.bbrc.2003.09.248 19.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Mol Cell Biol 2002; 22: 4181-8; PMID:12024031; http://dx.doi.org/10.1128/ MCB.22.12.4181-4188.2002 20.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Genes Dev 2006; 20:2279-92; PMID:16912277; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
EMBO J 2003; 22:5058-67; PMID:14517244; http://dx.doi.org/10.1093/emboj/ cdg472 22.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
EMBO J 2007; 26:935-43; PMID:17290229; http://dx.doi.org/10.1038/sj.emboj.7601540 23.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
PLoS One 2011; 6:e24686; PMID:21980350; http://dx.doi.org/ 10.1371/journal.pone.002468624.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
EMBO J 2011; 30:2990-3003; PMID:21673654; http://dx.doi.org/10.1038/emboj.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Nat Methods 2010; 7:473-8; PMID: 20453865; http://dx.doi.org/10.1038/nmeth.1460 26.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Science 2003; 301:1387-91; PMID:12958363; http://dx.doi.org/10.1126/science.1087782 27.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Autophagy 2010; 6:622-33; PMID:20523114; http://dx.doi.org/10.4161/auto.6.5.12252 28.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Neuron 2004; 42:367- 74; PMID:15134634; http://dx.doi.org/10.1016/ S0896-6273(04)00246-6 29.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Dev Cell 2012; 22:348-62; PMID:22264801; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Development 2009; 136:911-22; PMID:19211675; http://dx.doi.org/10.1242/dev.030759 33.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Cell 2008; 132:149-60; PMID:18191228; http://dx.doi.org/10.1016/j.cell.2007.10.058 35.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Curr Opin Cell Biol 2010; 22:575-82; PMID:20822890; http://dx.doi.org/10.1016/j.ceb.2010.08.011 38.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Neurotoxicology 2012; In press; http://dx.doi.org/10.1016/j.neuro.2012.04.01939.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
J Neurosci 2006; 26:1711-20; PMID:16467519; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
"Genes Dev 2007; 21:3006-16; PMID: 18006691; http://dx.doi.org/10.1101/gad.1575307 44. van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, Nollen EA.",OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
PLoS Genet 2008; 4:e1000027; PMID:18369446; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Nature 2011; 477:107-10; PMID: 21841800; http://dx.doi.org/10.1038/nature10324 49.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
J Mol Biol 2001; 307:1061- 73; PMID:11286556; http://dx.doi.org/10.1006/jmbi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Proc Natl Acad Sci U S A 2011; 108:17797-802; PMID:22006323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Protein Sci 2000; 9:2489-96; PMID:11206070; http://dx.doi.org/10.1110/ps.9.12.2489 52.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Mol Neurodegener 2009; 4:38-51; PMID:19785750; http://dx.doi.org/10.1186/1750-1326-4-38 www.landesbioscience.com Worm 149,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Science 2008; 320:811-4; PMID:18467592; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Nature 2003; 421:231-7; PMID:12529635; http://dx.doi.org/ 10.1038/nature01278 57.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Gene 2001; 263:103-12; PMID:11223248; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
J Biol Chem 2006; 281:1808-16; PMID:16239215; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Hum Mol Genet 2009; 18:2739-47; PMID: 19414486; http://dx.doi.org/10.1093/hmg/ddp209 61.,OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Aging Cell 2012; 11:82-92; PMID:22051349; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/12/a7/worm-1-141.PMC3583358.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/08/68/535.PMC3583658.pdf
"•	 Although far from perfect, there are many clear examples of site  preferences, and there are good computational tools for examin - ing consensus sites (e.g., http://elm.eu.org/, http://netphorest   .info/, http://scansite.mit.edu/; Songyang et al., 1994; Yaffe  et al., 2001; Obenauer et al., 2003; Miller et al., 2008; Dinkel  et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/08/68/535.PMC3583658.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/49/0d/543.PMC3583659.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/b6/555.PMC3583660.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4e/bf/566.PMC3583661.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/80/7f/578.PMC3583662.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f2/45/588.PMC3583663.pdf
"Presumably,  during the transformation experiment that produced this mutant, a Marker Location (base pairs)aMapped distance (cM)b RDG 7,400,000 14.7 (34) TUB2 7,700,000 15.6 (45) 8820 8,820,000 6.8 (47) 14-3-3 9,000,000 4.3 (46) 9280 9,280,000 0 (79) 6330 6,330,000 0 (96) 6170 6,170,000 0 (124) ODA9 6,070,000 0 (43) 6000 6,000,000 0 (123) 5750 5,750,000 3.3 (92) aApproximate position of markers is given according to the Joint Genome  Institute (JGI) database for Chlre4 (http://genome.jgi-psf.org/Chlre4/Chlre4   .info.html).",Non-OADS,/arxiv_data1/oa_pdf/f2/45/588.PMC3583663.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1d/71/601.PMC3583664.pdf
"The Pfam web - site (http://pfam.sanger.ac.uk/), as of April 2011, notes 200 se - quences from diverse organisms that have a copine domain plus  two C2 domains, 25 with copine domains plus a single C2 domain,  and 168 containing only a copine domain.",OADS,/arxiv_data1/oa_pdf/1d/71/601.PMC3583664.pdf
"To predict possible transmembrane heli - ces in the copine family, we used the following programs: TMHMM  Server v. 2.0 (www.cbs.dtu.dk/services/TMHMM-2.0), PRED-TMR  (http://athina.biol.uoa.gr/PRED-TMR/input.html), and HMMtop  (www.enzim.hu/hmmtop/server/hmmtop.cgi).",OADS,/arxiv_data1/oa_pdf/1d/71/601.PMC3583664.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/87/f0/617.PMC3583665.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/00/5f/633.PMC3583666.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/31/7c/643.PMC3583667.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ee/58/659.PMC3583668.pdf
"RNA Biology 9:10, 1266–1274; October 2012; © 2012 Landes Bioscience ReseAR ch p ApeR 1266 RNA Biology Volume 9 Issue 10*Correspondence to: Dmitrij Frishman and Alexander Shneider; Email: d.frishman@wzw.tum.de and ashneider@curelab.com Submitted: 07/17/12; Revised: 08/29/12; Accepted: 09/04/12http://dx.doi.org/10.4161/rna.22081Introduction Influenza vaccines have been a great public health priority1 and  their future is man-made constructs created using molecular  biology tools.",Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nat Rev Microbiol 2006; 4:565-6; PMID:16888876;  http://dx.doi.org/10.1038/nrmicro1482.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nat Rev Drug Discov 2006; 5:183- 4; PMID:16557657; http://dx.doi.org/10.1038/ nrd1988.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Int Rev Immunol  2008; 27:392-426; PMID:19065349; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Virol 2007; 81:9238-48; PMID:17596317; http://dx.doi.org/10.1128/JVI.00893-07.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Virol 2004; 78:995- 8; PMID:14694130; http://dx.doi.org/10.1128/ JVI.78.2.995-998.2004.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Gen Virol  2007; 88:2724-9; PMID:17872525; http://dx.doi.org/10.1099/vir.0.83014-0.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Virology 2008; 380:304- 11; PMID:18768193; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Virol J 2006; 3:58;  PMID:16934156; http://dx.doi.org/10.1186/1743- 422X-3-58.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nature 2006; 440:556- 60; PMID:16554823; http://dx.doi.org/10.1038/ nature04518.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Vector Borne Zoonotic Dis 2011; 11:649-58; PMID:21254926; http://dx.doi.org/10.1089/ vbz.2010.0105.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
OMICS 2009; 13:421- 30; PMID:19594376; http://dx.doi.org/10.1089/ omi.2009.0036.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
RNA 2011; 17:991- 1011; PMID:21536710; http://dx.doi.org/10.1261/ rna.2619511.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Int Rev Immunol 2010; 29:533-56; PMID:20923332;  http://dx.doi.org/10.3109/08830185.2010.507828.Table 7.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Virology 2000; 269:284-93; PMID:10753707;  http://dx.doi.org/10.1006/viro.2000.0244.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Vaccine 1994; 12:675- 81; PMID:8091843; http://dx.doi.org/10.1016/0264- 410X(94)90215-1.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Cell Mol Life Sci 2011; 68:3019-31; PMID:21626408;  http://dx.doi.org/10.1007/s00018-011-0734-2.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Proc Am Thorac Soc 2005; 2:166- 73; PMID:16113487; http://dx.doi.org/10.1513/pats.200501-011AW.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
BMC Bioinformatics 2010; 11:129; PMID:20230624; http://dx.doi.org/10.1186/1471-2105-11-129.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nucleic Acids Res 2003; 31:3423-8; PMID:12824339; http://dx.doi.org/10.1093/nar/gkg614.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
BMC Bioinformatics 2008; 9:474; PMID:19014431; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nature 2010; 467:103- 7; PMID:20811459; http://dx.doi.org/10.1038/ nature09322.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nature  2009; 460:711-6; PMID:19661910; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nat Rev Genet 2007; 8:196-205;  PMID:17262054; http://dx.doi.org/10.1038/nrg2053.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Virol  2009; 83:8021-31; PMID:19494001; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nucleic Acids Res 1981; 9:133- 48; PMID:6163133; http://dx.doi.org/10.1093/ nar/9.1.133.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Monatsh Chem 1994;  125:167-88; http://dx.doi.org/10.1007/BF00818163.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery 2011; 1:231-40;  http://dx.doi.org/10.1002/widm.30.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Virology 2010; 396:1- 9; PMID:19906393; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Virol  2008; 82:9236-44; PMID:18596091; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Virus Genes 2008; 36:531-8; PMID:18401695;  http://dx.doi.org/10.1007/s11262-008-0229-x.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Virol 2008; 82:5999-6008; PMID:18385240; http://dx.doi.org/10.1128/JVI.00203-08.18.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
PLoS ONE 2012; 7:e35989;  PMID:22558296; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
PLoS ONE 2011; 6:e27327;  PMID:22110627; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Lect Notes Comput Sci 2004;  3142:919-31; http://dx.doi.org/10.1007/978-3-540- 27836-8_77.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Proc Natl Acad Sci USA  1975; 72:2017-21; PMID:1056009; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Biopolymers 1990; 29:1105-19; PMID:1695107;  http://dx.doi.org/10.1002/bip.360290621.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
RNA  2004; 10:1178-90; PMID:15272118; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nucleic Acids Res 2001; 29:5079-89;  PMID:11812840; http://dx.doi.org/10.1093/ nar/29.24.5079.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
J Gen Virol 2004; 85:1113- 24; PMID:15105528; http://dx.doi.org/10.1099/vir.0.19462-0.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nucleic Acids Res 2012; 40:956-62; PMID:21954438; http://dx.doi.org/10.1093/nar/ gkr790.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Nucleic Acids Res 2005; 33(Database  issue):D29-33; PMID:15608199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
Virology  1992; 186:795-7; PMID:1733114; http://dx.doi.org/10.1016/0042-6822(92)90050-Y.,Non-OADS,/arxiv_data1/oa_pdf/28/98/rna-9-1266.PMC3583857.pdf
"Do not distribute.RNA Biology 9:10, 1288–1301; October 2012; © 2012 Landes Bioscience Rese ARch  p A pe R 1288  RNA Biology  V olume 9 Issue 10*Correspondence to: Hans-Joachim Wieden; Email: hj.wieden@uleth.ca Submitted: 07/27/12; Revised: 09/05/12; Accepted: 09/08/12http://dx.doi.org/10.4161/rna.22131Introduction Protein expression is a central process in all cellular life, and the  majority of ubiquitous genes code for components of the transla - tion system like ribosomal proteins, aa-tRNA synthetases, transla - tion factors, proteins involved in polypeptide secretion and RNA and protein modification enzymes.",Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Nat Rev  Microbiol 2003; 1:127-36; PMID:15035042; http://dx.doi.org/10.1038/nrmicro751.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Annu Rev Biochem 2011; 80:943-71; PMID:21675921; http://dx.doi.org/10.1146/annurev-biochem-062708-134043.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Curr Opin Microbiol 2003; 6:135-9; PMID:12732302; http://dx.doi.org/10.1016/S1369-5274(03)00037-7.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Nucleic Acids Res 2004; 32:5452-63; PMID:15479782; http://dx.doi.org/10.1093/nar/gkh885.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Int  J Parasitol 2009; 39:49-58; PMID:18713637; http://dx.doi.org/10.1016/j.ijpara.2008.05.019.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Biochem Biophys Res Commun 2011; 408:459-64; PMID:21527254; http://dx.doi.org/10.1016/j.bbrc.2011.04.052.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Mol Cell Proteomics 2010; 9:1594-615; PMID:20423899; http://dx.doi.org/10.1074/mcp.M000038-MCP201.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Mol Microbiol 2001; 41:289-97; PMID:11489118; http://dx.doi.org/10.1046/j.1365-2958.2001.02536.x.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Mol Biol 2002; 317:41-72; PMID:11916378; http://dx.doi.org/10.1006/jmbi.2001.5378.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Biol Chem 2000; 381:377-87; PMID:10937868; http://dx.doi.org/10.1515/BC.2000.050.13.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Biochimie 1999; 81:889-95; PMID:10572302; http://dx.doi.org/10.1016/S0300-9084(99)00207-2.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Bacteriol 2000; 182:6819-23; PMID:11073929; http://dx.doi.org/10.1128/JB.182.23.6819-6823.2000.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Protein Expr Purif 2003; 30:203-9; PMID:12880769; http://dx.doi.org/10.1016/S1046-5928(03)00107-4.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Microbiology 2008; 154:3537-46; PMID:18957606; http://dx.doi.org/10.1099/mic.0.2008/022137-0.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Biochimie 2012; 94:1647-59; PMID:22554723; http://dx.doi.org/10.1016/j.biochi.2012.04.016.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
PLoS One 2011; 6:e14792; PMID:21483493; http://dx.doi.org/10.1371/journal.pone.0014792.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Bacteriol 2003; 185:4031-7; PMID:12837776; http://dx.doi.org/10.1128/JB.185.14.4031-4037.2003.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Infect  Immun 2004; 72:5783-90; PMID:15385478; http://dx.doi.org/10.1128/IAI.72.10.5783-5790.2004.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Int J Med Microbiol 2011; 301:469-74; PMID:21570909; http://dx.doi.org/10.1016/j.ijmm.2011.02.002.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Mol Cell Proteomics 2006; 5:366-78; PMID:16284124; http://dx.doi.org/10.1074/mcp.M500303-MCP200.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Biol Chem 2010; 285:37359-69; PMID:20876569; http://dx.doi.org/10.1074/jbc.M110.172080.24.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Biol Chem 1998; 273:22480-9; PMID:9712873; http://dx.doi.org/10.1074/jbc.273.35.22480.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Zhejiang Univ Sci B 2009; 10:796-804; PMID:19882753; http://dx.doi.org/10.1631/jzus.B0910009.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Mol Cancer Res 2010; 8:57-66; PMID:20053727; http://dx.doi.org/10.1158/1541-7786.MCR-09-0278.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Biol Chem 2007; 282:19928-37; PMID:17430889; http://dx.doi.org/10.1074/jbc.M700541200.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Proteins 2005; 59:332-8; PMID:15726588; http://dx.doi.org/10.1002/prot.20413.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
EMBO J 2006; 25:2940-51; PMID:16763562; http://dx.doi.org/10.1038/sj.emboj.7601171.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
"Ash MR, Guilfoyle A, Clarke RJ, Guss JM, Maher MJ, Jormakka  M. Potassium-activated GTPase reaction in  the G Protein-coupled ferrous iron transporter B. J Biol Chem 2010; 285:14594-602; PMID:20220129; http://dx.doi.org/10.1074/jbc.M110.111914.",OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
New Phytol 2008; 179:530-45; PMID:19086295; http://dx.doi.org/10.1111/j.1469-8137.2008.02473.x.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Mol Biol 2009; 392:910-22; PMID:19591841; http://dx.doi.org/10.1016/j.jmb.2009.07.004.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Mol Biol 2011; 409:399-414; PMID:21501623; http://dx.doi.org/10.1016/j.jmb.2011.04.004.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Nucleic Acids Res 2003; 31:3784-8; PMID:12824418; http://dx.doi.org/10.1093/nar/gkg563.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Methods Enzymol 2007; 430:1-30; PMID:17913632; http://dx.doi.org/10.1016/S0076-6879(07)30001-3.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Bioinformatics 2006; 22:195-201; PMID:16301204; http://dx.doi.org/10.1093/bioinformatics/bti770.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Nucleic Acids Res 2009; 37(Database issue):D387-92; PMID:18931379; http://dx.doi.org/10.1093/nar/gkn750.44.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
BMC Genomics 2008; 9:102; PMID:18304323; http://dx.doi.org/10.1186/1471-2164-9-102.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Science 2007; 316:593-7; PMID:17379776; http://dx.doi.org/10.1126/science.1132067.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Cell 1988; 54:1013-8; PMID:3046750; http://dx.doi.org/10.1016/0092-8674(88)90116-X.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
EMBO J 1998; 17:7490-7; PMID:9857203; http://dx.doi.org/10.1093/emboj/17.24.7490.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Nature 1997; 385:37-41; PMID:8985244; http://dx.doi.org/10.1038/385037a0.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Acta Crystallogr D Biol Crystallogr 2011; 67:973-80; PMID:22101824; http://dx.doi.org/10.1107/S0907444911039461.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Biol Chem 2003; 278:28378-87; PMID:12730230; http://dx.doi.org/10.1074/jbc.M301381200.36.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
DNA Res 2005; 12:291-9; PMID:16769691; http://dx.doi.org/10.1093/dnares/dsi012.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
RNA 2008; 14:381-9; PMID:18083833; http://dx.doi.org/10.1261/rna.800308.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
Annu Rev Biochem 2011; 80:501-26; PMID:21529161; http://dx.doi.org/10.1146/annurev-biochem-062608-160432.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Bacteriol 2008; 190:718-26; PMID:17965154; http://dx.doi.org/10.1128/JB.01020-07.,Non-OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
J Mol Biol 2003; 326:585-92; PMID:12559924; http://dx.doi.org/10.1016/S0022-2836(02)01427-4.,OADS,/arxiv_data1/oa_pdf/3b/8f/rna-9-1288.PMC3583859.pdf
"Jörg Reichrath describes Challenge and promise Human skin aging Evgenia Makrantonaki1,2 1Department of Dermatology, Venereology, al lergology and im munology; Dessau Medical ce nter; Dessau, Germany; 2in stitute of cl inical Pharmacology and to xicology;  ch arité University Medicine Berlin; Berlin, Germany *Correspondence to: Evgenia Makrantonaki; Email: emakrantonaki@yahoo.com Submitted: 11/13/12; Accepted: 11/13/12http://dx.doi.org/10.4161/derm.23097the protective role of Vitamin D and its compounds against hazard - ous effects of skin-aging agents, such as UV and ionising radiation,  and presents recent data showing the detoxifying effects and regula-tion of genes involved in cellular aging by vitamin D. Melatonin, the hormone that has been postulated to be one of  the most important endocrine regulators and antioxidants, is the topic of the review by Konrad Kleszczynski and Tobias Fischer.",Non-OADS,/arxiv_data1/oa_pdf/eb/8d/de-4-225.PMC3583880.pdf
The skin appears dry and pale with fine wrinkles displaying a certain degree of laxity and a  *Correspondence to: Andrea Vierkötter;   Email: Andrea.Vierkoetter@uni-duesseldorf.de Submitted: 12/30/11; Accepted: 02/28/12http://dx.doi.org/10.4161/de.19858Skin aging does not only occur by passing time alone but also  by the exposure to different environmental factors.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
"Dermatol Clin 2003; 21:725-32, x; PMID:14717413; http://dx.doi.org/10.1016/S0733-8635(03)00085-8 3.",Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2010; 130:2719-26; PMID:20664556; http://dx.doi.org/10.1038/jid.2010.204 7.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
JAMA 1969; 210:2377-80; PMID:5395389; http://dx.doi.org/10.1001/jama.1969.03160390039008 8.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 1979; 73:59-66; PMID:448178; http://dx.doi.org/10.1111/1523-1747.ep12532763 9.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Am Acad Dermatol 1989; 21:623-31; PMID:2778126; http://dx.doi.org/10.1016/S0190-9622(89)70229-2 11.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Arch Dermatol Res 1982; 272:229-38; PMID:7165330; http://dx.doi.org/10.1007/BF0050905012.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Photodermatol Photoimmunol Photomed 2003; 19:228-34; PMID:14535893; http://dx.doi.org/10.1034/j.1600-0781.2003.00054.x 13.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Exp Gerontol 2008; 43:629-32; PMID:18534799; http://dx.doi.org/10.1016/j.exger.2008.04.010 14.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Skin Pharmacol Physiol 2010; 23:15-7; PMID:20090404; http://dx.doi.org/10.1159/000257259 15.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Br J Dermatol 2007; 157:874-87; PMID:17711532; http://dx.doi.org/10.1111/j.1365-2133.2007.08108.x 16.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2012; 132:976-84; PMID:22170486; http://dx.doi.org/10.1038/jid.2011.394 17.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Nature 1996; 379:335-9; PMID:8552187; http://dx.doi.org/10.1038/379335a0 19.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Clin Invest 2000; 106:663-70; PMID:10974019; http://dx.doi.org/10.1172/JCI936220.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2001; 117:219-26; PMID:11511297; http://dx.doi.org/10.1046/j.0022-202x.2001.01432.x 21.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Photochem Photobiol 1997; 66:271-5; PMID:9277148; http://dx.doi.org/10.1111/j.1751-1097.1997.tb08654.x 22.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 1998; 111:709-10; PMID:9764861; http://dx.doi.org/10.1046/j.1523-1747.1998.00337.x 23.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2004; 122:1277-83; PMID:15140232; http://dx.doi.org/10.1111/j.0022-202X.2004.22502.x 24.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Photodermatol Photoimmunol Photomed 2000; 16:239-44; PMID:11132125; http://dx.doi.org/10.1034/j.1600-0781.2000.160601.x 25.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Curr Opin Genet Dev 2001; 11:667-72; PMID:11682311; http://dx.doi.org/10.1016/S0959-437X(00)00251-3 26.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Free Radic Biol Med 2002; 32:1157-70; PMID:12031900; http://dx.doi.org/10.1016/S0891-5849(02)00816-X 27.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Methods Enzymol  2000; 319:428-36; PMID:10907531; http://dx.doi.org/10.1016/S0076-6879(00)19040-8 28.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Free Radic Res 2006; 40:1259-68; PMID:17090415; http://dx.doi.org/10.1080/10715760600911154,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Part Fibre Toxicol 2005; 2:10; PMID:16242040; http://dx.doi.org/10.1186/1743-8977-2-10 52.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Environ Health Perspect 2003; 111:455-60; PMID:12676598; http://dx.doi.org/10.1289/ehp.6000 53.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Sci Total Environ 1992; 116:109-35; PMID:1411492; http://dx.doi.org/10.1016/0048-9697(92)90368-3 54.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Dermatol Sci 2005; 40:187-93; PMID:16154324; http://dx.doi.org/10.1016/j.jdermsci.2005.06.006 55.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Pigment Cell Res 2001; 14:337-47; PMID:11601655; http://dx.doi.org/10.1034/j.1600-0749.2001.140505.x 56.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2004; 122:1448-55; PMID:15175036; http://dx.doi.org/10.1111/j.0022-202X.2004.22609.x 57.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Dermatol Sci 2011; 62:138-40; PMID:21458244; http://dx.doi.org/10.1016/j.jdermsci.2011.02.010 59.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2012; 132:733-6; PMID:22071478; http://dx.doi.org/10.1038/jid.2011.35041.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Am J Public Health 1995; 85:78-82; PMID:7832266; http://dx.doi.org/10.2105/AJPH.85.1.78 42.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Int J Dermatol 2001; 40:431-3; PMID:11678995; http://dx.doi.org/10.1046/j.1365-4362.2001.01238.x 43.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Photodermatol Photoimmunol Photomed 2001; 17:178-83; PMID:11499540; http://dx.doi.org/10.1034/j.1600-0781.2001.170407.x 44.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Arch Dermatol Res 2000; 292:188-94; PMID:10836612; http://dx.doi.org/10.1007/s004030050476 45.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2003; 120:548-54; PMID:12648216; http://dx.doi.org/10.1046/j.1523-1747.2003.12092.x 46.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Investig Dermatol Symp Proc 2009; 14:53-5; PMID:19675554; http://dx.doi.org/10.1038/jidsymp.2009.13 47.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Occup Environ Med 2008; 65:56-60; PMID:17634245; http://dx.doi.org/10.1136/oem.2007.034348 48.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Epidemiology 2008; 19:702-10; PMID:18633326; http://dx.doi.org/10.1097/EDE.0b013e318181b3ca 49.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 1997; 108:753-7; PMID:9129228; http://dx.doi.org/10.1111/1523-1747.ep12292144 50.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Biochem Biophys Res Commun 2003; 305:741-6; PMID:12763055; http://dx.doi.org/10.1016/S0006-291X(03)00812-X29.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Gerontol A Biol Sci Med Sci 2007; 62:490-9; PMID:17522352; http://dx.doi.org/10.1093/gerona/62.5.490 30.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Exp Cell Res 1965; 37:614-36; PMID:14315085; http://dx.doi.org/10.1016/0014-4827(65)90211-9 31.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Micron 2004; 35:155-9; PMID:15036269; http://dx.doi.org/10.1016/j.micron.2003.11.002 32.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2002; 119:1323-9; PMID:12485435; http://dx.doi.org/10.1046/j.1523-1747.2002.19630.x 33.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Br J Dermatol 2006; 155:1131-8; PMID:17107379; http://dx.doi.org/10.1111/j.1365-2133.2006.07510.x 34.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Free Radic Biol Med 2007; 43:128-35; PMID:17561101; http://dx.doi.org/10.1016/j.freeradbiomed.2007.04.002 35.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
Skin Pharmacol Physiol 2010; 23:40-6; PMID:20090407; http://dx.doi.org/10.1159/000257262 36.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Investig Dermatol Symp Proc 2009; 14:44-9; PMID:19675552; http://dx.doi.org/10.1038/jidsymp.2009.1 37.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Invest Dermatol 2010; 130:1524-36; PMID:20130591; http://dx.doi.org/10.1038/jid.2010.9 38.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
J Dermatol 2007; 34:593-600; PMID:17727362; http://dx.doi.org/10.1111/j.1346-8138.2007.00341.x 39.,Non-OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
N  Engl J Med 1969; 280:53; PMID:5761724; http://dx.doi.org/10.1056/NEJM196901022800129 40.,OADS,/arxiv_data1/oa_pdf/59/13/de-4-227.PMC3583881.pdf
"7 Superoxide anions are  short lived, known to induce macromolecular damage—such as damage to DNA, proteins and lipids—and to react with other reactive oxygen/nitrogen species like nitric oxide to form highly  *Correspondence to: Karin Scharffetter-Kochanek;   Email: karin.scharffetter- kochanek@uniklinik-ulm.deSubmitted: 03/26/12; Revised: 07/27/12; Accepted: 08/13/12http://dx.doi.org/10.4161/derm.21819The free radical theory of aging postulates that the production  of mitochondrial reactive oxygen species is the major determinant of aging and lifespan.",Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Cell 2005; 120:483-95; PMID:15734681; http://dx.doi.org/10.1016/j.cell.2005.02.001 3.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Cell Biol 2011; 194:7-15; PMID:21746850; http://dx.doi.org/10.1083/jcb.201102095 5.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Angew  Chem Int Ed Engl 1986; 25:1058-71; http://dx.doi.org/10.1002/anie.198610581 6.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Free Radic Biol Med 2009; 47:344-56; PMID:19477268; http://dx.doi.org/10.1016/j.freeradbiomed.2009.05.018 8.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Mol Cell 2007; 26:1-14; PMID:17434122; http://dx.doi.org/10.1016/j.mol-cel.2007.03.016 9.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Cell Biol 2002; 158:357-68; PMID:12119354; http://dx.doi.org/10.1083/jcb.200111028 10.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Science 2005; 308:1909-11; PMID:15879174; http://dx.doi.org/10.1126/science.110665311.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Nature 2002; 419:316-21; PMID:12239572; http://dx.doi.org/10.1038/nature01036 12.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Mech Ageing Dev 2005; 126:333-9; PMID:15621215; http://dx.doi.org/10.1016/j.mad.2004.08.025 13.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Med Genet 2004; 41:946-50; PMID:15591282; http://dx.doi.org/10.1136/jmg.2004.019588,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Nat Genet 1995; 11:376-81; PMID:7493016; http://dx.doi.org/10.1038/ng1295-376 44.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Aging Cell 2009; 8:311-23; PMID:19627270; http://dx.doi.org/10.1111/j.1474-9726.2009.00481.x 46.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Physiol Genomics 2003; 16:29-37; PMID:14679299; http://dx.doi.org/10.1152/physiolgenomics.00122.2003 47.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Free Radic Biol Med 2005; 38:1458-70; PMID:15890620; http://dx.doi.org/10.1016/j.freerad-biomed.2005.02.009 48.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Cardiovasc Res 2008; 80:280-9; PMID:18596060; http://dx.doi.org/10.1093/cvr/cvn182 49.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Aging Cell 2011; 10:239-54; PMID:21108731; http://dx.doi.org/10.1111/j.1474-9726.2010.00658.x 51.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Aging Cell 2006; 5:379-89; PMID:16911562; http://dx.doi.org/10.1111/j.1474-9726.2006.00231.x 52.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Nature 2011; 479:232-6; PMID:22048312; http://dx.doi.org/10.1038/nature10600 54.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Exp Gerontol 2007; 42:911-23; PMID:17574363; http://dx.doi.org/10.1016/j.exger.2007.04.009 31.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Mutat Res 1999; 423:11-21; PMID:10029667; http://dx.doi.org/10.1016/S0027-5107(98)00220-6 32.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Free Radic Biol Med 2001; 30:238-47; PMID:11165870; http://dx.doi.org/10.1016/S0891-5849(00)00463-9 33.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Invest Dermatol 1999; 112:13-8; PMID:9886257; http://dx.doi.org/10.1046/j.1523-1747.1999.00465.x 34.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Arch Dermatol 2002; 138:1473-9; PMID:12437453; http://dx.doi.org/10.1001/archderm.138.11.1473 35.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Nat Rev Drug Discov 2007; 6:480-98; PMID:17541420; http://dx.doi.org/10.1038/nrd2308 36.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Investig Dermatol Symp Proc 2009; 14:20-4; PMID:19675548; http://dx.doi.org/10.1038/jidsymp.2009.8 37.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Am J Pathol 2009; 174:101-14; PMID:19116368; http://dx.doi.org/10.2353/ajpath.2009.080599 38.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Free Radic Biol Med 2000; 28:397-402; PMID:10699751; http://dx.doi.org/10.1016/S0891-5849(99)00253-1 39.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Neurobiol Learn Mem 2007; 87:372-84; PMID:17129739; http://dx.doi.org/10.1016/j.nlm.2006.10.003 40.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Gerontol A Biol Sci Med Sci 2009; 64:1114-25; PMID:19633237; http://dx.doi.org/10.1093/gerona/glp100 41.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Cell Metab 2010; 12:662-7; PMID:21109198; http://dx.doi.org/10.1016/j.cmet.2010.11.01514.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Arch Dermatol 2008; 144:666-72; PMID:18490597; http://dx.doi.org/10.1001/archderm.144.5.666 15.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Invest Dermatol 2010; 130:415-24; PMID:19641518; http://dx.doi.org/10.1038/jid.2009.224 16.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Dtsch Dermatol Ges 2003; 1:223-32; PMID:16285500; http://dx.doi.org/10.1046/j.1610-0387.2003.03515.x 17.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Exp Gerontol 2003; 38:1265-70; PMID:14698806; http://dx.doi.org/10.1016/j.exger.2003.09.006 18.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Cell 2005; 120:513-22; PMID:15734683; http://dx.doi.org/10.1016/j.cell.2005.02.003 20.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Int J Biochem Cell Biol 2002; 34:1401-14; PMID:12200035; http://dx.doi.org/10.1016/S1357-2725(02)00053-5 21.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Adv Cancer Res 2007; 98:221-59; PMID:17433912; http://dx.doi.org/10.1016/S0065-230X(06)98007-5 22.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Arch Dermatol Res 2009; 301:273-87; PMID:19306099; http://dx.doi.org/10.1007/s00403-009-0935-9 23.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Biol Chem 1999; 274:25869-76; PMID:10464329; http://dx.doi.org/10.1074/jbc.274.36.25869 24.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Biol Chem 2004; 279:45634-42; PMID:15308634; http://dx.doi.org/10.1074/jbc.M408893200 25.,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
J Cell Physiol 1999; 180:114-22; PMID:10362024; http://dx.doi.org/10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP133.0.CO;2-0 27.,Non-OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
Exp Gerontol 2002; 37:1165-74; PMID:12470828; http://dx.doi.org/10.1016/S0531-5565(02)00136-5,OADS,/arxiv_data1/oa_pdf/7e/a0/de-4-232.PMC3583882.pdf
"Naturally, intrinsic and extrinsic aging of the  *Correspondence to: Florence Debacq-Chainiaux;  Email: florence.chainiaux@fundp.ac.beSubmitted: 08/15/12; Revised: 01/11/13; Accepted: 01/17/13http://dx.doi.org/10.4161/derm.23652Skin is a model of choice in studies on aging.",Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Arch Dermatol 2002; 138:1462-70; PMID:12437452; http://dx.doi.org/10.1001/arch - derm.138.11.1462 2.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Photochem Photobiol B 2001; 63:41-51; PMID:11684450; http://dx.doi.org/10.1016/S1011-1344(01)00201-9 3.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Eur Acad Dermatol Venereol 2011; 25:873-84; PMID:21261751; http://dx.doi.org/10.1111/j.1468-3083.2010.03963.x 4.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Clin Exp Dermatol 2001; 26:592-9; PMID:11696063; http://dx.doi.org/10.1046/j.1365-2230.2001.00905.x 5.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Aging Cell 2013; PMID:23286790; http://dx.doi.org/10.1111/acel.12039 6.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
PLoS One 2012; 7:e34746; PMID:22506048; http://dx.doi.org/10.1371/journal.pone.0034746 7.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
PLoS One 2010; 5:e12432; PMID:20824210; http://dx.doi.org/10.1371/journal.pone.0012432 8.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Gerontol 2010; 45:801-13; PMID:20719245; http://dx.doi.org/10.1016/j.exger.2010.08.005 9.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
PLoS One 2009; 4:e8021; PMID:19956599; http://dx.doi.org/10.1371/journal.pone.0008021 10.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Arch Dermatol 2009; 145:1375-9; PMID:20026845; http://dx.doi.org/10.1001/archder-matol.2009.303 11.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Arch Dermatol 2007; 143:1543-6; PMID:18087005; http://dx.doi.org/10.1001/archderm.143.12.154312.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Ageing Res Rev 2002; 1:705-20; PMID:12208239; http://dx.doi.org/10.1016/S1568-1637(02)00024-7 13.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Invest Dermatol 2000; 115:177-82; PMID:10951233; http://dx.doi.org/10.1046/j.1523-1747.2000.00009.x 15.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Science 1996; 274:1194-7; PMID:8895468; http://dx.doi.org/10.1126/science.274.5290.1194 16.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Photochem Photobiol 2007; 83:205-12; PMID:16965181; http://dx.doi.org/10.1562/2006-03-09-IR-840 17.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Toxicology 2003; 189:21-39; PMID:12821280; http://dx.doi.org/10.1016/S0300-483X(03)00150-1 18.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Cell Res 1999; 248:194-202; PMID:10094826; http://dx.doi.org/10.1006/excr.1999.4393 19.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Oncogene 2003; 22:2422-31; PMID:12717419; http://dx.doi.org/10.1038/sj.onc.1206301 20.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Semin Cutan Med Surg 2011; 30:190-8; PMID:22123416; http://dx.doi.org/10.1016/j.sder.2011.08.004 21.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Cell Res 1961; 25:585-621; PMID:13905658; http://dx.doi.org/10.1016/0014-4827(61)90192-6 22.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http://dx.doi.org/10.1038/nrm2233 23.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Nature 1990; 345:458-60; PMID:2342578; http://dx.doi.org/10.1038/345458a0 24.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Gerontol 2004; 39:1713-21; PMID:15582287; http://dx.doi.org/10.1016/j.exger.2004.05.010 26.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/nature02118 28.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Curr Biol 2003; 13:1549-56; PMID:12956959; http://dx.doi.org/10.1016/S0960-9822(03)00542-6 29.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Curr Biol 1999; 9:939-45; PMID:10508581; http://dx.doi.org/10.1016/S0960-9822(99)80420-5 30.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Gerontol 2004; 39:1369-78; PMID:15489060; http://dx.doi.org/10.1016/j.exger.2004.07.002 31.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Free Radic Biol Med 2000; 28:361-73; PMID:10699747; http://dx.doi.org/10.1016/S0891-5849(99)00249-X 32.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
PLoS One 2010; 5:e9188; PMID:20169192; http://dx.doi.org/10.1371/journal.pone.0009188 33.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Aging Cell 2006; 5:379-89; PMID:16911562; http://dx.doi.org/10.1111/j.1474-9726.2006.00231.x 35.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Invest Dermatol 2004; 122:1277-83; PMID:15140232; http://dx.doi.org/10.1111/j.0022-202X.2004.22502.x,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
EMBO J 2000; 19:1929-34; PMID:10790359; http://dx.doi.org/10.1093/emboj/19.9.1929 37.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Biol Chem 2001; 276:2531-7; PMID:11060295; http://dx.doi.org/10.1074/jbc.M006809200 39.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
FEBS Lett 2002; 531:499-504; PMID:12435600; http://dx.doi.org/10.1016/S0014-5793(02)03604-9 40.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
FEBS Lett 2005; 579:3651-9; PMID:15963989; http://dx.doi.org/10.1016/j.febs-let.2005.05.056 41.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Cell Sci 2004; 117:667-75; PMID:14754903; http://dx.doi.org/10.1242/jcs.01005 42.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Int J Biochem Cell Biol 2002; 34:1331-9; PMID:12200029; http://dx.doi.org/10.1016/S1357-2725(02)00022-5 43.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Cell Sci 2005; 118:743-58; PMID:15671065; http://dx.doi.org/10.1242/jcs.01651 44.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Ann N Y Acad Sci 2007; 1119:72-7; PMID:18056956; http://dx.doi.org/10.1196/annals.1404.002 45.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
"J Pharm Pharmacol 2006; 58:1577-83; PMID:17331320; http://dx.doi.org/10.1211/jpp.58.12.0003 46.  de M agalhães JP , Chainiaux F , Remacle J, Toussaint  O. Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts.",Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
FEBS Lett 2002; 523:157-62; PMID:12123824; http://dx.doi.org/10.1016/S0014-5793(02)02973-3 47.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Nat  Rev Mol Cell Biol 2000; 1:169-78; PMID:11252892; http://dx.doi.org/10.1038/3504305148.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Cell Sci 2003; 116:217-24; PMID:12482908; http://dx.doi.org/10.1242/jcs.00229 49.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Free Radic Biol Med 2008; 44:1817-32; PMID:18329388; http://dx.doi.org/10.1016/j.freerad-biomed.2008.02.001 50.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Free Radic Biol Med 2002; 33:1334-46; PMID:12419465; http://dx.doi.org/10.1016/S0891-5849(02)01044-4 51.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Mech Ageing Dev 2008; 129:109-19; PMID:18068755; http://dx.doi.org/10.1016/j.mad.2007.10.014 52.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Biochem Biophys Res Commun 1983; 112:638-46; PMID:6303326; http://dx.doi.org/10.1016/0006-291X(83)91511-5 54.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Dermatol 2003; 12:629-37; PMID:14705804; http://dx.doi.org/10.1034/j.1600-0625.2003.00024.x 55.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Gerontol 2007; 42:911-23; PMID:17574363; http://dx.doi.org/10.1016/j.exger.2007.04.009 56.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Cell Res 2002; 274:299-309; PMID:11900490; http://dx.doi.org/10.1006/excr.2002.5476 57.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Gerontol 2002; 37:1197-201; PMID:12470831; http://dx.doi.org/10.1016/S0531-5565(02)00143-2 58.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
J Biol Chem 1999; 274:15345-9; PMID:10336420; http://dx.doi.org/10.1074/jbc.274.22.1534559.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Am J Pathol 2009; 174:423-35; PMID:19147823; http://dx.doi.org/10.2353/ajpath.2009.080332 61.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Cancer Res 2009; 69:7917-25; PMID:19826058; http://dx.doi.org/10.1158/0008-5472.CAN-08-2510 62.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Gerontol 2008; 43:947-57; PMID:18761079; http://dx.doi.org/10.1016/j.exger.2008.08.003 63.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Mol Biol Cell 2008; 19:1346-53; PMID:18216278; http://dx.doi.org/10.1091/mbc.E07-10-1041 64.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Cell Res 2000; 258:288-97; PMID:10896780; http://dx.doi.org/10.1006/excr.2000.4943 65.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Exp Cell Res 2003; 287:272-81; PMID:12837283; http://dx.doi.org/10.1016/S0014-4827(03)00061-2 66.,OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Mol Cell Biol 2000; 20:1436-47; PMID:10648628; http://dx.doi.org/10.1128/MCB.20.4.1436-1447.2000 67.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
Biogerontology 2010; 11:167-81; PMID:19554468; http://dx.doi.org/10.1007/s10522-009-9238-y 68.,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
PLoS One 2010; 5:e10462; PMID:20454669; http://dx.doi.org/10.1371/journal.pone.0010462,Non-OADS,/arxiv_data1/oa_pdf/51/de/de-4-236.PMC3583883.pdf
"Do not distribute.www.landesbioscience.com  Dermato-Endocrinology  241D ermato-Endocrinology 4:3, 241–244; July–December 2012; © 2012 Landes BioscienceREVIEW  REVIEW Correspondence to: Jörg Reichrath; Email: Joerg.reichrath@uks.eu Submitted: 12/30/11; Accepted: 06/29/12http://dx.doi.org/10.4161/de.21312The skin is the only tissue in the human body that represents  both a target tissue for biologically active vitamin D compounds including 1,25-dihydroxyvitamin D [1,25(OH) 2D] and has the capacity for the synthesis of 1,25(OH)2D from  7-dehydrocholesterol (7-DHC).",Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
N Engl J Med  2007; 357:266-81; PMID:17634462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Prog Biophys Mol Biol 2006; 92:9-16; PMID:16603232; http://dx.doi.org/10.1016/j.pbiomolbio.2006.02.010 3.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Exp Dermatol 2007; 16:618-25; PMID:17576242; http://dx.doi.org/10.1111/j.1600-0625.2007.00570.x 4.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Dermatol Sci 1998; 18:11-8; PMID:9747657; http://dx.doi.org/10.1016/S0923-1811(98)00015-2 6.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Cell Biochem 2003; 89:663-73; PMID:12858333; http://dx.doi.org/10.1002/jcb.10540 7.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Arch Dermatol Res 2004; 295:527-34; PMID:15042383; http://dx.doi.org/10.1007/s00403-004-0451-x 8.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Photochem Photobiol 2005; 78:141-8; http://dx.doi.org/10.1016/j.jphoto-biol.2004.09.010 9.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Dermatoendocrinol 2009; 1:239-45; PMID:20592798; http://dx.doi.org/10.4161/derm.1.4.970510.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Steroid Biochem Mol Biol 2010; 121:164-8; PMID:20399269; http://dx.doi.org/10.1016/j.jsbmb.2010.03.082 11.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Cancer Prev Res (Phila) 2011; 4:1485-94; PMID:21733837; http://dx.doi.org/10.1158/1940-6207.CAPR-11-0165 12.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Dermatol Sci 1995; 9:203-8; PMID:8664218; http://dx.doi.org/10.1016/0923-1811(94)00378-R 13.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Invest Dermatol 2001; 117:1241-9; PMID:11710939; http://dx.doi.org/10.1046/j.0022-202x.2001.01496.x 15.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Biol Chem 1997; 272:8997- 9001; PMID:9083023; http://dx.doi.org/10.1074/jbc.272.14.8997 16.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Invest Dermatol 1996; 106:510-6; PMID:8648185; http://dx.doi.org/10.1111/1523-1747.ep12343866 17.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Invest Dermatol 2007; 127:707-15; PMID:17170736; http://dx.doi.org/10.1038/sj.jid.570059719.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Cell Stem Cell 2009; 5:64-75; PMID:19570515; http://dx.doi.org/10.1016/j.stem.2009.04.003 21.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Cell Death Differ 2012;19:186-93; PMID:22158419; http://dx.doi.org/10.1038/cdd.2011.181 22.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Psychoneuroendocrinology 2009; 34(Suppl 1):S278-86; PMID:19660871; http://dx.doi.org/10.1016/j.psyneuen.2009.07.003 23.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Steroid Biochem Mol Biol 2009; 115:91-7; PMID:19500727; http://dx.doi.org/10.1016/j.jsbmb.2009.03.007 24.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Steroid Biochem   Mol Biol 2009; 114:78-84; PMID:19444937; http://dx.doi.org/10.1016/j.jsbmb.2008.12.020 25.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Steroid Biochem Mol Biol 2010; 121:88-97; PMID:20227497; http://dx.doi.org/10.1016/j.jsbmb.2010.03.019 26.,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Mol Endocrinol 2002; 16:1243-56; PMID:12040012; http://dx.doi.org/10.1210/me.16.6.1243 27.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
J Clin   Oncol 2007; 25:1844-51; PMID:17488982; http://dx.doi.org/10.1200/JCO.2007.10.8928 28.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
PLoS One 2011; 6:e26891;  PMID:22132081; http://dx.doi.org/10.1371/journal.pone.0026891 29.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
Cell Stem Cell 2009; 5:64-75; PMID:19570515; http://dx.doi.org/10.1016/j.stem.2009.04.003,OADS,/arxiv_data1/oa_pdf/42/cd/de-4-241.PMC3583884.pdf
"Do not distribute.www.landesbioscience.com  Dermato-Endocrinology  245D ermato-Endocrinology 4:3, 245–252; July–December 2012; © 2012 Landes BiosciencerEvi Ew *Correspondence to: Tobias W. Fischer; Email: Tobias.Fischer@uk-sh.de Submitted: 03/12/12; Accepted: 09/24/12http://dx.doi.org/10.4161/derm.22344Introduction Melatonin ( N1-acetyl-5-methoxytryptamine) was initially iso - lated from bovine pineal tissue.1 Subsequently, it was docu - mented that in mammals the nocturnal increase in blood levels  of melatonin is almost exclusively a result of its nighttime syn - thesis and secretion from the pineal gland.2 Considering chronobiological aspects of melatonin, it regu - lates the circadian day-night-rhythm and seasonal bio-rhythms,3,4  and independent of that, melatonin has been shown in the mam - malian system to modulate immune defense responses,5,6 body  weight and reproduction4 and to exert tumor growth-inhibitory  and anti-jet lag effects.7-10 Additionally, melatonin serves as a  direct, receptor-independent potent antioxidant,11-13 a chemo - toxicity-reducing agent,14-16 a putative general anti-aging sub - stance17,18 and an anti-cancer agent.19 For decades, investigations concerning occurrence of melato - nin in different body compartments revealed that significantly high concentrations are found in the bile fluid, 20 bone marrow,21  cerebrospinal fluid,22 ovary,23 eye,24 lymphocytes5 or skin25 and  is differentially distributed in subcellular organelles.21,26-28 It was  reported that melatonin levels in organs mentioned above may Like the whole organism, skin follows the process of aging  during life-time.",Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Am Chem Soc 1958; 80:2587; http://dx.doi.org/10.1021/ja01543a060 2.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Mol Cell Endocrinol 1991; 79:C153-8; PMID:1936532; http://dx.doi.org/10.1016/0303-7207(91)90087-9 3.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Exp Zool 1987; 241:81-9; PMID:3559501; http://dx.doi.org/10.1002/jez.1402410110 4.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Neuroendocrinology  1993; 57:359-64; PMID:7685505; http://dx.doi.org/10.1159/000126380 5.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Curr Top Med Chem 2002; 2:167-79; PMID:11899099; http://dx.doi.org/10.2174/1568026023394335 7.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Melanoma Res 1997; 7:27-31; PMID:9067962; http://dx.doi.org/10.1097/00008390-199702000-00005 8.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Lancet 2007; 369:1117-29; PMID:17398311; http://dx.doi.org/10.1016/S0140-6736(07)60529-7 9.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Curr Top Med Chem 2002; 2:181-97; PMID:11899100; http://dx.doi.org/10.2174/1568026023394443 13.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Ann N Y Acad Sci 1994; 719:1-12; PMID:8010585; http://dx.doi.org/10.1111/j.1749-6632.1994.tb56817.x 14.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pharm Pharmacol 2002; 54:1299-321; PMID:12396291; http://dx.doi.org/10.1211/002235702760345374 15.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Mol Cell Biochem 2006; 282:31-7; PMID:16317509; http://dx.doi.org/10.1007/s11010-006-1153-9 16.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2003; 35:85-90; PMID:12887650; http://dx.doi.org/10.1034/j.1600-079X.2003.00059.x 17.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 1998; 24:83-9; PMID:9510432; http://dx.doi.org/10.1111/j.1600-079X.1998.tb00371.x 50.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Free Radic Biol Med 1999; 27:838-47; PMID:10515588; http://dx.doi.org/10.1016/S0891-5849(99)00131-8 51.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2004; 36:1-9; PMID:14675124; http://dx.doi.org/10.1046/j.1600-079X.2003.00092.x 52.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2002; 33:204-12; PMID:12390502; http://dx.doi.org/10.1034/j.1600-079X.2002.02113.x 53.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2005; 39:21-6; PMID:15978053; http://dx.doi.org/10.1111/j.1600-079X.2005.00210.x 54.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Dermatology 1997; 195:248-52; PMID:9407172; http://dx.doi.org/10.1159/000245953 55.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Arch Dermatol Res 1996; 288:522-6; PMID:8874746; http://dx.doi.org/10.1007/BF02505248 56.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Dermatology 1999; 198:52-5; PMID:10026402; http://dx.doi.org/10.1159/000018064 57.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Br J Dermatol 1998; 139:332-9; PMID:9767255; http://dx.doi.org/10.1046/j.1365-2133.1998.02447.x 58.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Dermatol Sci 2001; 27:162-9; PMID:11641055; http://dx.doi.org/10.1016/S0923-1811(01)00133-5 60.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2006; 40:18-26; PMID:16313494; http://dx.doi.org/10.1111/j.1600-079X.2005.00273.x 61.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2008; 44:397-407; PMID:18086147; http://dx.doi.org/10.1111/j.1600-079X.2007.00542.x34.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Neuron 1994; 13:1177-85; PMID:7946354; http://dx.doi.org/10.1016/0896-6273(94)90055-8 35.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2006; 41:297-305; PMID:17014686; http://dx.doi.org/10.1111/j.1600-079X.2006.00369.x 36.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Front Biosci 2003; 8:d1093-108; PMID:12957828; http://dx.doi.org/10.2741/1089 37.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Mol Endocrinol 1994; 8:757-70; PMID:7935491; http://dx.doi.org/10.1210/me.8.6.757 39.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Biol Chem 2000; 275:31311-7; PMID:10913150; http://dx.doi.org/10.1074/jbc.M005141200 40.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Biochem Pharmacol 2001; 61:1369-79; PMID:11331072; http://dx.doi.org/10.1016/S0006-2952(01)00615-3 41.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Biochim Biophys Acta 2004; 1680:67-70; PMID:15488986; http://dx.doi.org/10.1016/j.bba-exp.2004.09.002 42.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Cell Physiol 2003; 196:144-53; PMID:12767050; http://dx.doi.org/10.1002/jcp.10287 43.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2004; 37:48-54; PMID:15230868; http://dx.doi.org/10.1111/j.1600-079X.2004.00135.x 44.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2003; 34:1-10; PMID:12485365; http://dx.doi.org/10.1034/j.1600-079X.2003.02112.x 45.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Chronobiol Int 2003; 20:921-62; PMID:14680136; http://dx.doi.org/10.1081/CBI-120025245 46.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Nutr Metab 2005; 2:22; http://dx.doi.org/10.1186/1743-7075-2-22 47.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2007; 42:28-42; PMID:17198536; http://dx.doi.org/10.1111/j.1600-079X.2006.00407.x18.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Ann N Y Acad Sci 2002; 959:238-50; PMID:11976199; http://dx.doi.org/10.1111/j.1749-6632.2002.tb02096.x 19.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Life Sci 1999; 65:2523-9; PMID:10622237; http://dx.doi.org/10.1016/S0024-3205(99)00519-6 21.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Biochim Biophys Acta 1999; 1472:206-14; PMID:10572942; http://dx.doi.org/10.1016/S0304-4165(99)00125-7 22.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Endocrinology 1999; 140:4399-405; PMID:10499491; http://dx.doi.org/10.1210/en.140.10.4399 23.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Mol Hum Reprod 1999; 5:402-8; PMID:10338362; http://dx.doi.org/10.1093/molehr/5.5.402 24.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Vis Neurosci 1992; 8:487-90; PMID:1586650; http://dx.doi.org/10.1017/S0952523800005009 25.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
FASEB J 2006; 20:1564-6; PMID:16793870; http://dx.doi.org/10.1096/fj.05-5227fje 26.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 1993;  15:59-69; PMID:8283386; http://dx.doi.org/10.1111/j.1600-079X.1993.tb00511.x 27.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2003; 34:79-80; PMID:12485376; http://dx.doi.org/10.1034/j.1600-079X.2003.2e114.x 28.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2005; 39:215-6; PMID:16098101; http://dx.doi.org/10.1111/j.1600-079X.2005.00261.x 29.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Exp Dermatol 2008; 17:713-30; PMID:18643846; http://dx.doi.org/10.1111/j.1600-0625.2008.00767.x 30.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
FASEB J 2005; 19:176-94; PMID:15677341; http://dx.doi.org/10.1096/fj.04-2079rev 31.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Endocrine 2005; 27:137-48; PMID:16217127; http://dx.doi.org/10.1385/ENDO:27:2:137 32.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2000; 28:193-202; PMID:10831154; http://dx.doi.org/10.1034/j.1600-079X.2000.280401.x,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
FEBS Lett 1993; 331:304-6; PMID:8375513; http://dx.doi.org/10.1016/0014-5793(93)80357-Z 80.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Invest Dermatol 1995; 105(Suppl):67S-70S; PMID:7616000; http://dx.doi.org/10.1038/jid.1995.14 81.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Biol Chem 1999; 274:15345-9; PMID:10336420; http://dx.doi.org/10.1074/jbc.274.22.15345 82.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2003; 34:75-8; PMID:12485375; http://dx.doi.org/10.1034/j.1600-079X.2003.02111.x 83.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Neurosci Biobehav Rev 1993; 17:347-57; PMID:8272286; http://dx.doi.org/10.1016/S0149-7634(05)80016-8 84.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Clin Endocrinol (Oxf)  1988; 29:205-29; PMID:3073883; http://dx.doi.org/10.1111/j.1365-2265.1988.tb00263.x 85.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Skin Pharmacol Physiol 2004; 17:190-4; PMID:15258450; http://dx.doi.org/10.1159/00007882269.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Curr Probl Dermatol 2001; 29:165-74; PMID:11225196; http://dx.doi.org/10.1159/000060665 71.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Dermatol Sci 2001; 26:194-200; PMID:11390204; http://dx.doi.org/10.1016/S0923-1811(01)00088-3 73.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Exp Dermatol 1994; 3:45-50; PMID:8061934; http://dx.doi.org/10.1111/j.1600-0625.1994.tb00265.x 74.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Dermatoendocrinol 2011; 3:27-31; PMID:21519406; http://dx.doi.org/10.4161/derm.3.1.14842 75.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Biol Signals Recept 2000; 9:137-59; PMID:10899700; http://dx.doi.org/10.1159/000014635 76.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2004; 37:107-12; PMID:15298669; http://dx.doi.org/10.1111/j.1600-079X.2004.00142.x 63.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Skin Pharmacol Appl Skin Physiol 2002; 15:367-73; PMID:12239433; http://dx.doi.org/10.1159/000064543 64.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Neuroimmunol 2005; 165:139-49; PMID:15975667; http://dx.doi.org/10.1016/j.jneuroim.2005.05.002 66.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2005; 38:107-15; PMID:15683465; http://dx.doi.org/10.1111/j.1600-079X.2004.00180.x 67.,OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
Redox Rep 2003; 8:205-13; PMID:14599344; http://dx.doi.org/10.1179/135100003225002709 68.,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
J Pineal Res 2002; 32:257-61; PMID:11982796; http://dx.doi.org/10.1034/j.1600-079X.2002.01866.x,Non-OADS,/arxiv_data1/oa_pdf/fb/2c/de-4-245.PMC3583885.pdf
"For example, reactive oxygen species (ROS), arising from oxidative  *Correspondence to: George Karakiulakis; Email: gkaraki@med.auth.gr Submitted: 08/12/12; Revised: 08/20/12; Accepted: 08/22/12http://dx.doi.org/10.4161/derm.21923Skin aging is a multifactorial process consisting of two distinct  and independent mechanisms: intrinsic and extrinsic aging.",Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Aging Cell 2006; 5:331-44; PMID:16805856; http://dx.doi.org/10.1111/j.1474-9726.2006.00223.x 3.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Arch Dermatol 2002; 138:1462-70; PMID:12437452; http://dx.doi.org/10.1001/arch - derm.138.11.1462 5.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Invest Dermatol 2000; 115:177-82; PMID:10951233; http://dx.doi.org/10.1046/j.1523-1747.2000.00009.x 6.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Pathol  2007; 211:241-51; PMID:17200942; http://dx.doi.org/10.1002/path.2098 7.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Matrix Biol 2007; 26:58-68; PMID:17055233; http://dx.doi.org/10.1016/j.matbio.2006.08.261 8.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Biomacromolecules 2006; 7:659-68; PMID:16529395; http://dx.doi.org/10.1021/bm050867v 9.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Clin Orthop Relat Res 2004; (Suppl):S152-62; PMID:15480059; http://dx.doi.org/10.1097/01.blo.0000143804.26638.82 10.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Cells Tissues Organs 2005; 179:66-72; PMID:15942194; http://dx.doi.org/10.1159/00008451011.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Curr Pharm Biotechnol 2008; 9:249-52; PMID:18691085; http://dx.doi.org/10.2174/138920108785161569 12.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Matrix Biol 2002; 21:25-9; PMID:11827789; http://dx.doi.org/10.1016/S0945-053X(01)00184-6 13.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Am J Respir Crit Care Med 2003; 167:1169-75; PMID:12714341; http://dx.doi.org/10.1164/rccm.200205-449PP 14.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Immunol Rev 2009; 230:216-31; PMID:19594639; http://dx.doi.org/10.1111/j.1600-065X.2009.00803.x 15.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Physiol Rev 2011; 91:221-64; PMID:21248167; http://dx.doi.org/10.1152/phys-rev.00052.2009 16.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Clin Dermatol 2008; 26:106-22; PMID:18472055; http://dx.doi.org/10.1016/j.clindermatol.2007.09.013 17.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Am Chem Soc 1954; 76:1753-7; http://dx.doi.org/10.1021/ja01636a010 18.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Nature 1955; 175:435; PMID:14356201; http://dx.doi.org/10.1038/175435a0 23.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Gen Microbiol 1956; 15:485-91; PMID:13385432; http://dx.doi.org/10.1099/00221287-15-3-48524.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Intern Med 1997;  242:61-6; PMID:9260568; http://dx.doi.org/10.1046/j.1365-2796.1997.00175.x 26.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Invest Dermatol 1988; 90:412-4; PMID:2450149; http://dx.doi.org/10.1111/1523-1747.ep12456530 27.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Dermatol Sci 2011; 61:69-72; PMID:21087840; http://dx.doi.org/10.1016/j.jderm-sci.2010.10.010 29.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Exp Dermatol 2009; 18:1028-35; PMID:19601984; http://dx.doi.org/10.1111/j.1600-0625.2009.00889.x 30.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Acta Physiol Scand 1988; 134:405-11; PMID:3227957; http://dx.doi.org/10.1111/j.1748-1716.1988.tb08508.x 31.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Clin Invest 1958; 37:57-64; PMID:13491713; http://dx.doi.org/10.1172/JCI103585 33.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Clin Invest 1949; 28:56-9; http://dx.doi.org/10.1172/JCI102053 34.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Nat Rev Cancer 2004; 4:528-39; PMID:15229478; http://dx.doi.org/10.1038/nrc1391 35.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 1997; 272:13997-4000;  PMID:9206724; http://dx.doi.org/10.1074/jbc.272.22.13997 67.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 1999; 274:25085-92; PMID:10455188; http://dx.doi.org/10.1074/jbc.274.35.25085 68.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
IUBMB Life 2002; 54:195-9; PMID:12512858; http://dx.doi.org/10.1080/15216540214929 69.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Chem Rev 2006; 106:818-39; PMID:16522010; http://dx.doi.org/10.1021/cr050247k 73.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Protein Sci 1995; 4:1666-9; PMID:8528065; http://dx.doi.org/10.1002/pro.5560040902 74.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Matrix Biol 2001; 20:499-508; PMID:11731267; http://dx.doi.org/10.1016/S0945-053X(01)00172-X 75.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Anal Biochem 1997; 251:263-9; PMID:9299025; http://dx.doi.org/10.1006/abio.1997.2262 76.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Matrix 1992; 12:388-96; PMID:1484506; http://dx.doi.org/10.1016/S0934-8832(11)80035-1 77.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Clin Chim Acta 1989; 181:317-23; PMID:2474393; http://dx.doi.org/10.1016/0009-8981(89)90237-4 78.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
N Engl J Med 1996; 335:1029-33; PMID:8793927; http://dx.doi.org/10.1056/NEJM199610033351405 79.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 1998; 273:22466-70; PMID:9712871; http://dx.doi.org/10.1074/jbc.273.35.22466 80.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Glycobiology 2008; 18:280-9; PMID:18234732; http://dx.doi.org/10.1093/glycob/cwn006 81.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Biopolymers 1991; 31:1429-35; PMID:1667853; http://dx.doi.org/10.1002/bip.360311209 82.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Curr Opin Cell Biol 1990; 2:839-44; PMID:1707285; http://dx.doi.org/10.1016/0955-0674(90)90081-O 84.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Am J Respir Crit Care Med 2005; 172:92-8; PMID:15790861; http://dx.doi.org/10.1164/rccm.200405-652OC 51.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2003; 278:45801-10; PMID:12954618; http://dx.doi.org/10.1074/jbc.M308168200 53.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Exp Med 2005; 201:1269-79; PMID:15837812; http://dx.doi.org/10.1084/jem.20042057 54.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Nat Med 2005; 11:1173-9; PMID:16244651; http://dx.doi.org/10.1038/nm1315 55.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Cell Res 2006; 16:693-701; PMID:16894359; http://dx.doi.org/10.1038/sj.cr.7310085 56.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2006; 281:26512-9; PMID:16809345; http://dx.doi.org/10.1074/jbc.M605607200 57.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Science 1985; 228:1324-6; PMID:2408340; http://dx.doi.org/10.1126/sci-ence.2408340 61.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 1997; 272:8013-8; PMID:9065473; http://dx.doi.org/10.1074/jbc.272.12.8013 62.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Am J Respir Cell Mol Biol 2012; In press; PMID:22865625; http://dx.doi.org/10.1165/rcmb.2012-0101OC 64.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 1996; 271:22945-8; PMID:8798477; http://dx.doi.org/10.1074/jbc.271.38.2294536.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Pharmacol Exp Ther 2002; 301:830-7; PMID:12023510; http://dx.doi.org/10.1124/jpet.301.3.830 37.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Eur Respir J 2008; 32:1504-12; PMID:18768572; http://dx.doi.org/10.1183/09031936.00159507 38.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Eur Respir J 2009; 34:616-28; PMID:19282346; http://dx.doi.org/10.1183/09031936.00070808 39.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Br J Pharmacol 2009; 157:1111-27; PMID:19508395; http://dx.doi.org/10.1111/j.1476-5381.2009.00279.x 40.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Glycobiology 1998; 8:821-30; PMID:9639543; http://dx.doi.org/10.1093/glycob/8.8.821 41.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Prostate 2000; 44:104-10; PMID:10881019; http://dx.doi.org/10.1002/1097-0045(20000701)44:2<104::AID-PROS2>3.0.CO;2-6 42.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Int J Biochem Cell Biol 2000; 32:975-82; PMID:11084377; http://dx.doi.org/10.1016/S1357-2725(00)00038-8 43.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Curr Opin Cell Biol 2000; 12:581-6; PMID:10978893; http://dx.doi.org/10.1016/S0955-0674(00)00135-6 44.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Theor Biol 1986; 119:219-34; PMID:3736072; http://dx.doi.org/10.1016/S0022-5193(86)80076-5 45.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2002; 277:41046-59; PMID:12194965; http://dx.doi.org/10.1074/jbc.M109443200 46.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Clin Invest 1996; 98:2403-13; PMID:8941660; http://dx.doi.org/10.1172/JCI119054 47.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 1998; 273:35088-94; PMID:9857043; http://dx.doi.org/10.1074/jbc.273.52.35088 48.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Mol Cell 2004; 13:483-96; PMID:14992719; http://dx.doi.org/10.1016/S1097-2765(04)00080-2,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Cell Biol 1997; 137:1137-47; PMID:9166413; http://dx.doi.org/10.1083/jcb.137.5.1137 107.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Cell Adhes Commun 1998; 6:157-60; PMID:9823467; http://dx.doi.org/10.3109/15419069809004472 108.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Cell 1995; 82:19-26; PMID:7541721; http://dx.doi.org/10.1016/0092-8674(95)90048-9 109.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Carbohydr Res 1987; 159:127-36; PMID:3829041; http://dx.doi.org/10.1016/S0008-6215(00)90010-7 110.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Br J Dermatol 1996; 135:867-75; PMID:8977705; http://dx.doi.org/10.1046/j.1365-2133.1996.d01-1088.x 111.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Br J Dermatol 1996; 135:255-62; PMID:8881669; http://dx.doi.org/10.1111/j.1365-2133.1996.tb01156.x 112.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
N Engl  J Med 1997; 337:1463-5; PMID:9358147; http://dx.doi.org/10.1056/NEJM199711133372011 113.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2011; 286:18268-76; PMID:21454612; http://dx.doi.org/10.1074/jbc.M110.201665 114.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Exp Dermatol 2011; 20:454-6; PMID:21426414; http://dx.doi.org/10.1111/j.1600-0625.2011.01258.x97.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Ann Surg 1991; 213:292-6; PMID:2009010; http://dx.doi.org/10.1097/00000658-199104000-00003 98.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2004; 279:8753-60; PMID:14676202; http://dx.doi.org/10.1074/jbc.M303945200 99.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2003; 278:49495-504; PMID:14506240; http://dx.doi.org/10.1074/jbc.M310445200 100.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Am J Respir Cell Mol Biol 2004; 31:92-9; PMID:14764429; http://dx.doi.org/10.1165/rcmb.2003-0380OC 101.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Biol Chem 2001; 276:20428-35; PMID:11262389; http://dx.doi.org/10.1074/jbc.M007601200 102.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Kidney Int 2000; 58:1953-62; PMID:11044215; http://dx.doi.org/10.1111/j.1523-1755.2000.00367.x 103.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Invest Dermatol 2005; 124:898-905; PMID:15854028; http://dx.doi.org/10.1111/j.0022-202X.2005.23697.x 105.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Am Acad Dermatol 2009; 61:629-38; PMID:19559501; http://dx.doi.org/10.1016/j.jaad.2009.03.04285.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Cancer  Metastasis Rev 1992; 11:21-30; PMID:1380898; http://dx.doi.org/10.1007/BF00047600 86.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Cell Biol 1992; 117:1343-50; PMID:1376732; http://dx.doi.org/10.1083/jcb.117.6.1343 87.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Exp Med 1996; 183:1663-8; PMID:8666924; http://dx.doi.org/10.1084/jem.183.4.1663 90.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Cell Biol 1993; 123:749-58; PMID:7693717; http://dx.doi.org/10.1083/jcb.123.3.749 91.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Cell Biol 1988; 106:845-55; PMID:2450100; http://dx.doi.org/10.1083/jcb.106.3.845 92.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
J Invest Dermatol 1994; 102:385-9; PMID:8120424; http://dx.doi.org/10.1111/1523-1747.ep12371800 93.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Histochemistry 1992; 98:105-12; PMID:1429018; http://dx.doi.org/10.1007/BF00717001 94.,Non-OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Br J Plast Surg 1994; 47:483-9; PMID:7524987; http://dx.doi.org/10.1016/0007-1226(94)90031-0 95.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Matrix 1989; 9:224-31; PMID:2779482; http://dx.doi.org/10.1016/S0934-8832(89)80054-X 96.,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
Matrix 1991; 11:63-8; PMID:2027330; http://dx.doi.org/10.1016/S0934-8832(11)80228-3,OADS,/arxiv_data1/oa_pdf/44/c4/de-4-253.PMC3583886.pdf
"Aged skin shows disturbed skin permeability, angiogenesis, lipid and sweat production, immune  *Correspondence to: Markus Böhm; Email: bohmm@uni-muenster.de Submitted: 08/19/12; Accepted: 08/30/12http://dx.doi.org/10.4161/derm.22028Aging is the progressive accumulation of damage to an  organism over time leading to disease and death.",Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 2003; 52:2441-4; PMID:12941787; http://dx.doi.org/10.2337/diabetes.52.9.2441 36.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem Soc T rans 2003; 31:1341-2; PMID:14641059; http://dx.doi.org/10.1042/BST0311341 37.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Semin Cell Dev Biol 2011; 22:293-301; PMID:21320620; http://dx.doi.org/10.1016/j.semcdb.2011.02.013 38.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Biochem Biophys 2003; 419:16-24; PMID:14568004; http://dx.doi.org/10.1016/j.abb.2003.08.011 39.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Amino Acids 2012; 42:1143-50; PMID:20967558; http://dx.doi.org/10.1007/s00726-010-0780-3 40.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2005; 1043:824-36; PMID:16037310; http://dx.doi.org/10.1196/annals.1333.095 41.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Mol Med (Berl) 2005; 83:876-86; PMID:16133426; http://dx.doi.org/10.1007/s00109-005-0688-7 42.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1994; 93:521-8; PMID:8113390; http://dx.doi.org/10.1172/JCI117002 43.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
PLoS One 2010; 5:e11093; PMID:20559423; http://dx.doi.org/10.1371/journal.pone.0011093 44.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Glycobiology 2005; 15:16R-28R; PMID:15764591; http://dx.doi.org/10.1093/glycob/cwi053 45.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Invest Dermatol 2006; 126:291-9; PMID:16374460; http://dx.doi.org/10.1038/sj.jid.5700070 46.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Invest Dermatol 2010; 130:405-14; PMID:19865095; http://dx.doi.org/10.1038/jid.2009.269 47.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Exp Dermatol 2012; 21:123-9; PMID:22229442; http://dx.doi.org/10.1111/j.1600-0625.2011.01408.x19.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1993; 91:2463-9; PMID:8514858; http://dx.doi.org/10.1172/JCI116481 20.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Br J Dermatol 2001; 145:10-8; PMID:11453901; http://dx.doi.org/10.1046/j.1365-2133.2001.04275.x 21.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Free Radic Biol Med 2010; 49:847-56; PMID:20541005; http://dx.doi.org/10.1016/j.freeradbiomed.2010.06.003 22.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2007; 282:23427-36; PMID:17567584; http://dx.doi.org/10.1074/jbc.M701586200 23.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Invest Dermatol 1997; 108:797-802; PMID:9129235; http://dx.doi.org/10.1111/1523-1747.ep12292244 24.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetologia 2006; 49:2488-98; PMID:16955213; http://dx.doi.org/10.1007/s00125-006-0355-8 25.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2005; 280:12310-5; PMID:15677467; http://dx.doi.org/10.1074/jbc.M500733200 27.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 1998; 273:18714-9; PMID:9668043; http://dx.doi.org/10.1074/jbc.273.30.18714 29.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochemistry 1995; 34:10872-8; PMID:7662668; http://dx.doi.org/10.1021/bi00034a021 31.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Connect Tissue Res 1989; 19:77-92; PMID:2791558; http://dx.doi.org/10.3109/03008208909016816 32.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem J 1999; 344:109-16; PMID:10548540; http://dx.doi.org/10.1042/0264-6021:3440109 33.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
IUBMB  Life 2007; 59:249-54; PMID:17505961; http://dx.doi.org/10.1080/15216540601178067 2.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Clin Dermatol 2011; 29:3-14; PMID:21146726; http://dx.doi.org/10.1016/j.clindermatol.2010.07.001 3.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Dermatology 2007; 214:352-60; PMID:17460411; http://dx.doi.org/10.1159/000100890 4.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2007; 1119:40-50; PMID:18056953; http://dx.doi.org/10.1196/annals.1404.027 5.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Dermatol 2002; 138:1462-70; PMID:12437452; http://dx.doi.org/10.1001/arch - derm.138.11.1462 6.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Exp Gerontol 2007; 42:160-5; PMID:17084574; http://dx.doi.org/10.1016/j.exger.2006.09.016 7.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biol Rev Camb Philos Soc 1990; 65:375-98; PMID:2205304; http://dx.doi.org/10.1111/j.1469-185X.1990.tb01428.x 8.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Science 1999; 286:774-9; PMID:10531063; http://dx.doi.org/10.1126/sci-ence.286.5440.774 11.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Antioxid  Redox Signal 2003; 5:557-61; PMID:14580310; http://dx.doi.org/10.1089/152308603770310202 12.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biogerontology 2001; 2:219-29; PMID:11868897; http://dx.doi.org/10.1023/A:1013222629919 13.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Res Clin Pract 2005; 67:3-21; PMID:15620429; http://dx.doi.org/10.1016/j.diabres.2004.09.004 14.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Agric Food Chem 1953; 1:928-43; http://dx.doi.org/10.1021/jf60015a004 16.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Int J Biochem Cell Biol 1996; 28:1297-310; PMID:9022289; http://dx.doi.org/10.1016/S1357-2725(96)00079-9 17.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Amino Acids 2003; 25:275-81; PMID:14661090; http://dx.doi.org/10.1007/s00726-003-0017-9 18.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochim Biophys Acta 2011; 1814:1246-52; PMID:21708295; http://dx.doi.org/10.1016/j.bba-pap.2011.06.006,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Curr Opin Pharmacol 2004; 4:301- 5; PMID:15140424; http://dx.doi.org/10.1016/j.coph.2004.01.007 77.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Invest Dermatol 2012; 132:315-23; PMID:21956123; http://dx.doi.org/10.1038/jid.2011.298 78.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
"Clin Biomech (Bristol, Avon) 2000; 15:379-86; PMID:10758300; http://dx.doi.org/10.1016/S0268-0033(99)00085-6 79.",OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Skin Res Technol 2002; 8:250-4; PMID:12423544; http://dx.doi.org/10.1034/j.1600-0846.2002.00332.x 80.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1994; 94:110-7; PMID:8040253; http://dx.doi.org/10.1172/JCI117296 81.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Aging Cell 2012; 11:1-13; PMID:21967227; http://dx.doi.org/10.1111/j.1474-9726.2011.00752.x 82.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biosci Biotechnol Biochem 1997; 61:2039-42; PMID:9438984; http://dx.doi.org/10.1271/bbb.61.2039 83.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2002; 959:360-7; PMID:11976210; http://dx.doi.org/10.1111/j.1749-6632.2002.tb02107.x 84.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Dermatol Res 2011; 303:339-50; PMID:21132435; http://dx.doi.org/10.1007/s00403-010-1102-z 85.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Invest Dermatol 2002; 119:489-98; PMID:12190875; http://dx.doi.org/10.1046/j.1523-1747.2002.01788.x 86.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2007; 1100:524-9; PMID:17460218; http://dx.doi.org/10.1196/annals.1395.058 87.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2005; 280:12087-95; PMID:15590648; http://dx.doi.org/10.1074/jbc.M406313200 88.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biogerontology 2008; 9:177-82; PMID:18297408; http://dx.doi.org/10.1007/s10522-008-9129-762.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arthritis Rheum 2001; 44:2562-71; PMID:11710713; http://dx.doi.org/10.1002/1529-0131(200111)44:11<2562::AID-ART437>3.0.CO;2-1 63.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1997; 99:457-68; PMID:9022079; http://dx.doi.org/10.1172/JCI119180 65.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Exp Gerontol 2008; 43:663-7; PMID:18334287; http://dx.doi.org/10.1016/j.exger.2008.01.012 66.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2000; 275:39027-31; PMID:10976109; http://dx.doi.org/10.1074/jbc.M006700200 67.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochemistry 1991; 30:1205-10; PMID:1899338; http://dx.doi.org/10.1021/bi00219a007 68.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Pathol Biol (Paris) 2010; 58:226-31; PMID:19896301; http://dx.doi.org/10.1016/j.pat-bio.2009.09.009 69.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Invest Dermatol 1991; 97:938-41; PMID:1919057; http://dx.doi.org/10.1111/1523-1747.ep12491727 70.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Care 2006; 29:2654-9; PMID:17130200; http://dx.doi.org/10.2337/dc05-2173 72.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Am Diet Assoc 2004; 104:1287-91; PMID:15281050; http://dx.doi.org/10.1016/j.jada.2004.05.214 73.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Gerontol A Biol Sci Med Sci 2007; 62:427-33; PMID:17452738; http://dx.doi.org/10.1093/gerona/62.4.427 74.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Pathol Biol (Paris) 2006; 54:387-95; PMID:16962252; http://dx.doi.org/10.1016/j.pat-bio.2006.07.005 75.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1993; 91:2155-68; PMID:8387541; http://dx.doi.org/10.1172/JCI116442 49.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Immunology 2010; 129:437-45; PMID:19922418; http://dx.doi.org/10.1111/j.1365-2567.2009.03199.x 50.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2000; 275:25781-90; PMID:10829018; http://dx.doi.org/10.1074/jbc.M001235200 52.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Metab Res Rev 2001; 17:436-43; PMID:11757079; http://dx.doi.org/10.1002/dmrr.233 53.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Am J Pathol 2008; 173:327-36; PMID:18599606; http://dx.doi.org/10.2353/ajpath.2008.080152 55.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Leukoc Biol 2009; 86:505-12; PMID:19477910; http://dx.doi.org/10.1189/jlb.0409230 56.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem J 2000; 350:381-7; PMID:10947951; http://dx.doi.org/10.1042/0264-6021:3500381 57.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Appl Physiol 2007; 103:2068-76; PMID:17901242; http://dx.doi.org/10.1152/japplphysiol.00670.2007 58.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetologia 1993; 36:936-41; PMID:8243873; http://dx.doi.org/10.1007/BF02374476 59.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
FASEB J 2007; 21:3542-52; PMID:17567569; http://dx.doi.org/10.1096/fj.06-7896com 61.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Br J Ophthalmol 2001; 85:746-53; PMID:11371498; http://dx.doi.org/10.1136/bjo.85.6.746,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Rejuvenation Res 2006; 9:264-73; PMID:16706654; http://dx.doi.org/10.1089/rej.2006.9.264 118.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem Soc T rans 2003; 31:1349-53; PMID:14641061; http://dx.doi.org/10.1042/BST0311349 119.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1998; 101:1142-7; PMID:9486985; http://dx.doi.org/10.1172/JCI119885 120.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Exp Cell Res 2012; 318:152-9; PMID:22036650; http://dx.doi.org/10.1016/j.yexcr.2011.10.013 121.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2011; 286:1374-80; PMID:21056979; http://dx.doi.org/10.1074/jbc.M110.144097 122.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem J 2012; 443:213-22; PMID:22188542; http://dx.doi.org/10.1042/BJ20111648 123.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 2001; 276:48967-72; PMID:11677237; http://dx.doi.org/10.1074/jbc.M108196200 124.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Int J Vitam Nutr Res 2003; 73:453-60; PMID:14743550; http://dx.doi.org/10.1024/0300-9831.73.6.453 125.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biol T race Elem Res 2011; 143:717-25; PMID:21165710; http://dx.doi.org/10.1007/s12011-010-8915-7 126.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Obes Metab 2005; 7:294-7; PMID:15811148; http://dx.doi.org/10.1111/j.1463-1326.2004.00418.x 127.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 2003; 52:499-505; PMID:12540627; http://dx.doi.org/10.2337/diabetes.52.2.499 128.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arthritis Res Ther 2009; 11:R71; PMID:19445683; http://dx.doi.org/10.1186/ar2700 129.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Nutr Biochem 1996; 7:659-63; http://dx.doi.org/10.1016/S0955-2863(96)00128-3 130.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Med Food 2008; 11:275-81; PMID:18598169; http://dx.doi.org/10.1089/jmf.2007.536103.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 2005; 54:3103-11; PMID:16249432; http://dx.doi.org/10.2337/diabetes.54.11.3103 104.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Technol Ther 2012; 14:285-92; PMID:22023375; http://dx.doi.org/10.1089/dia.2011.0108 105.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Semin Cutan Med Surg 2011; 30:163-6; PMID:21925370; http://dx.doi.org/10.1016/j.sder.2011.05.004 106.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Curr Diabetes Rev 2012; 8:92-108; PMID:22268395; http://dx.doi.org/10.2174/157339912799424528 107.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 1992; 41:26-9; PMID:1727735; http://dx.doi.org/10.2337/diabetes.41.1.26 108.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Drug Discov Today 2006; 11:646-54; PMID:16793534; http://dx.doi.org/10.1016/j.drudis.2006.05.016 109.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Exp Gerontol 2008; 43:584-8; PMID:18485649; http://dx.doi.org/10.1016/j.exger.2008.04.004 110.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Gerontol A Biol Sci Med Sci 2001; 56:B405-11; PMID:11524442; http://dx.doi.org/10.1093/gerona/56.9.B405 111.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Kidney Int 2002; 61:939-50; PMID:11849448; http://dx.doi.org/10.1046/j.1523-1755.2002.00207.x 112.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2005; 1043:807-16; PMID:16037308; http://dx.doi.org/10.1196/annals.1333.093 113.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Biochem Biophys 2003; 419:89-96; PMID:14568012; http://dx.doi.org/10.1016/j.abb.2003.08.016 114.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Circ Res 2003; 92:785-92; PMID:12623881; http://dx.doi.org/10.1161/01.RES.0000065620.39919.20 115.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Am J Hypertens 2004; 17:23S-30S; PMID:15607432; http://dx.doi.org/10.1016/j.amjhyper.2004.08.022 116.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Biochem Biophys 2003; 412:42-6; PMID:12646266; http://dx.doi.org/10.1016/S0003-9861(03)00015-889.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Gerontol Geriatr 2009; 48:151-4; PMID:18207583; http://dx.doi.org/10.1016/j.arch-ger.2007.12.004 90.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biogerontology 2009; 10:203-11; PMID:18758988; http://dx.doi.org/10.1007/s10522-008-9172-4 91.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1995; 96:1395-403; PMID:7544803; http://dx.doi.org/10.1172/JCI118175 92.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 2002; 51:1535-42; PMID:11978653; http://dx.doi.org/10.2337/diabe-tes.51.5.1535 93.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem Biophys Res Commun 1997; 235:306-10; PMID:9199187; http://dx.doi.org/10.1006/bbrc.1997.6780 94.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2001; 928:48-53; PMID:11795527; http://dx.doi.org/10.1111/j.1749-6632.2001.tb05634.x 95.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Biol Chem 1998; 273:25272-8; PMID:9737992; http://dx.doi.org/10.1074/jbc.273.39.25272 96.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem Biophys Res Commun 1998; 250:385-9; PMID:9753639; http://dx.doi.org/10.1006/bbrc.1998.9326 97.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Ann N Y Acad Sci 2005; 1043:290-8; PMID:16037251; http://dx.doi.org/10.1196/annals.1333.036 99.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Technol Ther 2006; 8:523-35; PMID:17037967; http://dx.doi.org/10.1089/dia.2006.8.523 100.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biomed Opt Express 2010; 2:218-30; PMID:21339868; http://dx.doi.org/10.1364/BOE.2.000218 101.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes Technol Ther 2011; 13:773-9; PMID:21510765; http://dx.doi.org/10.1089/dia.2011.0034 102.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Curr Opin Nephrol Hypertens 2010; 19:527-33; PMID:20844429; http://dx.doi.org/10.1097/MNH.0b013e32833e9259,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Biochem Pharmacol 2010; 79:1379-86; PMID:20096667; http://dx.doi.org/10.1016/j.bcp.2010.01.013 147.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Am J Pathol 2001; 159:513-25; PMID:11485910; http://dx.doi.org/10.1016/S0002-9440(10)61723-3 148.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Am J Ther 2012; 19:e69-89; PMID:20861720; http://dx.doi.org/10.1097/MJT.0b013e3181e71fb7 149.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Crit Rev Ther Drug Carrier Syst 2010; 27:85-154; PMID:20486899; http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v27.i2.10 150.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Dermatolog T reat 2011; In press; PMID:21756141; http://dx.doi.org/10.3109/09546634.2010.521812139.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Mol Nutr Food Res 2007; 51:1079-84; PMID:17854003; http://dx.doi.org/10.1002/mnfr.200700035 140.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Curr Pharm Des 2007; 13:2832-6; PMID:17897026; http://dx.doi.org/10.2174/138161207781757051 141.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Nat Rev Endocrinol 2011; 7:526-39; PMID:21610689; http://dx.doi.org/10.1038/nrendo.2011.74 142.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 2003; 52:2805-13; PMID:14578300; http://dx.doi.org/10.2337/diabetes.52.11.2805 143.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Clin Invest 1991; 87:1910-5; PMID:1904067; http://dx.doi.org/10.1172/JCI115216 144.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Diabetes 1999; 48:870-80; PMID:10102706; http://dx.doi.org/10.2337/diabe-tes.48.4.870 145.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Arch Biochem Biophys 2003; 419:80-8; PMID:14568011; http://dx.doi.org/10.1016/j.abb.2003.08.030131.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Food Chem Toxicol 2011; 49:1521-9; PMID:21443916; http://dx.doi.org/10.1016/j.fct.2011.03.043 132.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Cosmet Dermatol 2009; 8:147-51; PMID:19527341; http://dx.doi.org/10.1111/j.1473-2165.2009.00428.x 133.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Agric Food Chem 2005; 53:3167-73; PMID:15826074; http://dx.doi.org/10.1021/jf048550u 134.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Science 1999; 285:1390-3; PMID:10464095; http://dx.doi.org/10.1126/sci-ence.285.5432.1390 135.,OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
J Gerontol A Biol Sci Med Sci 1995; 50:B337-41; PMID:7583789; http://dx.doi.org/10.1093/gerona/50A.6.B337 136.,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
Semin Nephrol 2009; 29:594-603; PMID:20006791; http://dx.doi.org/10.1016/j.semnephrol.2009.07.013,Non-OADS,/arxiv_data1/oa_pdf/1a/da/de-4-259.PMC3583887.pdf
M.J. Peters; Email: eva.peters@eva-peters.com Submitted: 08/08/12; Accepted: 08/30/12http://dx.doi.org/10.4161/derm.22023Research over the past decade has revealed close interaction  between the nervous and immune systems in regulation of peripheral inflammation linking psychosocial stress with chronic somatic disease and aging.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2009; 16:300-17; PMID:19571591; http://dx.doi.org/10.1159/000216188 35.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2011; 25:6-13; PMID:20934505; http://dx.doi.org/10.1016/j.bbi.2010.10.003 36.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 2001; 119:37-50; PMID:11525798; http://dx.doi.org/10.1016/S0165-5728(01)00362-9 37.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2001; 9:78-87; PMID:11549889; http://dx.doi.org/10.1159/000049010 38.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Invest Dermatol 2006; 126:1697-704; PMID:16845409; http://dx.doi.org/10.1038/sj.jid.5700104 39.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Dermatol Ther 2008; 21:22-31; PMID:18318882; http://dx.doi.org/10.1111/j.1529-8019.2008.00166.x 40.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 2007; 184:113-26; PMID:17222461; http://dx.doi.org/10.1016/j.jneuroim.2006.11.020 43.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2002; 16:622-53; PMID:12480495; http://dx.doi.org/10.1016/S0889-1591(02)00021-1 44.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 1999; 13:225-39; PMID:10469524; http://dx.doi.org/10.1006/brbi.1998.0541 45.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Exp Dermatol 2010; 19:401-5; PMID:20113345; http://dx.doi.org/10.1111/j.1600-0625.2009.01060.x 46.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 1999; 93:15-25; PMID:10378865; http://dx.doi.org/10.1016/S0165-5728(98)00173-8 47.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Immunol 2011; 186:848-55; PMID:21172866; http://dx.doi.org/10.4049/jimmunol.0903878 48.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Br J Dermatol 2004; 151:335-45; PMID:15327540; http://dx.doi.org/10.1111/j.1365-2133.2004.06036.x17.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Semin Cutan Med Surg 2011; 30:113-7; PMID:21767773; http://dx.doi.org/10.1016/j.sder.2011.04.002 18.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Scand J Immunol 2012; 75:641-6; PMID:22443369; http://dx.doi.org/10.1111/j.1365-3083.2012.02698.x 19.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Cell Immunol 2011; 267:1-8; PMID:21092942; http://dx.doi.org/10.1016/j.cellimm.2010.10.004 20.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2008; 15:224-40; PMID:19047800; http://dx.doi.org/10.1159/000156466 21.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Mech Ageing Dev 2007; 128:92-105; PMID:17116321; http://dx.doi.org/10.1016/j.mad.2006.11.016 22.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
T rends Mol Med 2010; 16:238-46; PMID:20444648; http://dx.doi.org/10.1016/j.molmed.2010.03.003 23.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Biochem Soc T rans 2003; 31:457-61; PMID:12653662; http://dx.doi.org/10.1042/BST0310457 24.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2004; 18:262-73; PMID:15050653; http://dx.doi.org/10.1016/j.bbi.2003.09.003 31.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2007; 21:736-45; PMID:17467231; http://dx.doi.org/10.1016/j.bbi.2007.03.008 32.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2006; 13:257-67; PMID:17709947; http://dx.doi.org/10.1159/000104853References 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Psychother Psychosom 1993; 60:46-56; PMID:7901868; http://dx.doi.org/10.1159/000288679 2.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Arch Dermatol 2003; 139:1479-88; PMID:14623709; http://dx.doi.org/10.1001/arch - derm.139.11.1479 4.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Auton Autacoid Pharmacol 2003; 23:1-25; PMID:14565534; http://dx.doi.org/10.1046/j.1474-8673.2003.00280.x 5.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
T rends Pharmacol Sci 2004; 25:640-6; PMID:15530642; http://dx.doi.org/10.1016/j.tips.2004.10.007 6.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2007; 21:34-44; PMID:17157762; http://dx.doi.org/10.1016/j.bbi.2006.09.008 7.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Exp Dermatol 2008; 17:214-27; PMID:18261087; http://dx.doi.org/10.1111/j.1600-0625.2007.00653.x 8.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Dermatoendocrinol 2011; 3:37-40; PMID:21519408; http://dx.doi.org/10.4161/derm.3.1.14618 9.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 1991; 5:116-31; PMID:1906353; http://dx.doi.org/10.1016/0889-1591(91)90011-X 11.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Immunol  Today 1988; 9:43-5; PMID:3256315; http://dx.doi.org/10.1016/0167-5699(88)91258-3 12.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuron 2009; 64:28-32; PMID:19840545; http://dx.doi.org/10.1016/j.neuron.2009.09.039 13.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 2010; 219:75-80; PMID:20031236; http://dx.doi.org/10.1016/j.jneu-roim.2009.12.001 14.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Immunol Invest 2012; 41:61-74; PMID:21877936; http://dx.doi.org/10.3109/08820139.2011.581730 15.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2010; 24:316-23; PMID:19887104; http://dx.doi.org/10.1016/j.bbi.2009.10.016 16.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Immunol Res 2004; 30:81-94; PMID:15258312; http://dx.doi.org/10.1385/IR:30:1:081,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 1996; 68:131-8; PMID:8784269; http://dx.doi.org/10.1016/0165-5728(96)00081-1 81.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Immunopharmacol Immunotoxicol 1995; 17:511-28; PMID:8576543; http://dx.doi.org/10.3109/08923979509016384 82.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Dermatol Sci 2007; 48:123-32; PMID:17692507; http://dx.doi.org/10.1016/j.jdermsci.2007.06.007 83.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Br J Dermatol 2001; 144:46-54; PMID:11167682; http://dx.doi.org/10.1046/j.1365-2133.2001.03951.x 84.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Stress 2000; 3:209-20; PMID:10938582; http://dx.doi.org/10.3109/10253890009001125 89.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
"Brain Res 2000; 855:192-7; PMID:10650150; http://dx.doi.org/10.1016/S0006-8993(99)02409-9 90.  del R ey A, Randolf A, Wildmann J, Besedovsky HO,  Jessop DS.",OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2009; 23:776-83; PMID:19254758; http://dx.doi.org/10.1016/j.bbi.2009.02.009 91.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neurosci Res 1987; 18:1-9; PMID:3316677; http://dx.doi.org/10.1002/jnr.490180103 92.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Lancet 1995; 345:99-103; PMID:7815892; http://dx.doi.org/10.1016/S0140-6736(95)90066-7 93.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2006; 20:527-31; PMID:16631347; http://dx.doi.org/10.1016/j.bbi.2006.02.00464.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2005; 12:255-69; PMID:16166805; http://dx.doi.org/10.1159/000087104 65.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Cell Immunol 1988; 117:339-51; PMID:2848630; http://dx.doi.org/10.1016/0008-8749(88)90123-2 66.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Annu Rev Pharmacol Toxicol 1995; 35:417-48; PMID:7598501; http://dx.doi.org/10.1146/annurev.pa.35.040195.002221 67.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Peptides 2011; 32:1027-34; PMID:21334411; http://dx.doi.org/10.1016/j.peptides.2011.02.012 72.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2004; 11:84-92; PMID:14758054; http://dx.doi.org/10.1159/000075317 75.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Infect Immun 2008; 76:3651-6; PMID:18505813; http://dx.doi.org/10.1128/IAI.00358-08 77.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Cell Tissue Res 1990; 262:125-33; PMID:2175253; http://dx.doi.org/10.1007/BF00327753 78.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
FEBS J 2012; 279:384-94; PMID:22111578; http://dx.doi.org/10.1111/j.1742-4658.2011.08431.x49.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Clin Exp Allergy 2006; 36:1408-16; PMID:17083351; http://dx.doi.org/10.1111/j.1365-2222.2006.02576.x 50.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neurochem Int 2008; 52:40-51; PMID:17716784; http://dx.doi.org/10.1016/j.neuint.2007.06.037 52.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuropsychobiology 1993; 28:110-2; PMID:7902965; http://dx.doi.org/10.1159/000119011 54.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Ann N Y Acad Sci 1998; 840:262-8; PMID:9629254; http://dx.doi.org/10.1111/j.1749-6632.1998.tb09566.x 55.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
"J Neurosci Res 1987; 18:28-36, 118-21; PMID:3316680; http://dx.doi.org/10.1002/jnr.490180107 56.",Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
"J Neurosci Res 1987; 18:55-63, 126-9; PMID:3682028; http://dx.doi.org/10.1002/jnr.490180110 57.",Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 1991; 5:29-40; PMID:1712652; http://dx.doi.org/10.1016/0889-1591(91)90005-U 58.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Ann N Y Acad Sci 1990; 594:17-33; PMID:2165757; http://dx.doi.org/10.1111/j.1749-6632.1990.tb40464.x 59.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Chem Immunol 1997; 69:99-131; PMID:9353963; http://dx.doi.org/10.1159/000058655 60.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Leukoc Biol 2006; 79:1093-104; PMID:16531560; http://dx.doi.org/10.1189/jlb.1105625 62.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2012; 19:69-78; PMID:22248722; http://dx.doi.org/10.1159/000329002 63.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Ann N Y Acad Sci 1998; 840:21-32; PMID:9629233; http://dx.doi.org/10.1111/j.1749-6632.1998.tb09545.x 124.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Inflamm Res 2008; 57:558-63; PMID:19109735; http://dx.doi.org/10.1007/s00011-008-7243-2 125.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
JAMA 2011; 306:1993-2000; PMID:22068991; http://dx.doi.org/10.1001/jama.2011.1604 126.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Ann N Y Acad Sci 2000; 917:876-93; PMID:11268419; http://dx.doi.org/10.1111/j.1749-6632.2000.tb05454.x 128.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Int Arch Allergy Immunol 2003; 132:380-3; PMID:14707470; http://dx.doi.org/10.1159/000074906 129.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2003; 17:134-8; PMID:12676575; http://dx.doi.org/10.1016/S0889-1591(03)00025-4 130.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Physiol Behav 2003; 80:395-8; PMID:14637240; http://dx.doi.org/10.1016/j.physbeh.2003.09.004 131.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Invest Dermatol 2006; 126:1719-27; PMID:16845411; http://dx.doi.org/10.1038/sj.jid.5700270 132.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Eur J Pharmacol 2006; 533:195-206; PMID:16458292; http://dx.doi.org/10.1016/j.ejphar.2005.12.061 133.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2005; 19:252-62; PMID:15797314; http://dx.doi.org/10.1016/j.bbi.2004.08.005 135.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Nutr Rev 2007; 65:S173-6; PMID:18240544; http://dx.doi.org/10.1301/nr.2007.dec.S173-S176109.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2009; 16:325-32; PMID:19571593; http://dx.doi.org/10.1159/000216190 110.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Invest Dermatol 2011; 131:735-43; PMID:21085186; http://dx.doi.org/10.1038/jid.2010.317 111.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Int Arch Allergy Immunol 1998; 115:179-90; PMID:9531159; http://dx.doi.org/10.1159/000023899 114.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Med Res Rev 2002; 22:146-67; PMID:11857637; http://dx.doi.org/10.1002/med.10001 115.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Curr Allergy Asthma Rep 2004; 4:263-9; PMID:15175139; http://dx.doi.org/10.1007/s11882-004-0069-2 116.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Curr Opin Allergy Clin Immunol 2005; 5:419-24; PMID:16131917; http://dx.doi.org/10.1097/01.all.0000183111.78558.4d 117.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Cell Immunol 2012; 273:124-32; PMID:22316526; http://dx.doi.org/10.1016/j.cellimm.2012.01.001 118.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Psychosom Med 2003; 65:811-5; PMID:14508025; http://dx.doi.org/10.1097/01.PSY.0000088582.50468.A3 119.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Ann N Y Acad Sci 1998; 840:747-54; PMID:9629301; http://dx.doi.org/10.1111/j.1749-6632.1998.tb09613.x 120.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Clin Endocrinol Metab 2002; 87:4245-51; PMID:12213879; http://dx.doi.org/10.1210/jc.2001-010872 121.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Psychother Psychosom 2001; 70:6-16; PMID:11150933; http://dx.doi.org/10.1159/000056219 122.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 2002; 129:161-7; PMID:12161032; http://dx.doi.org/10.1016/S0165-5728(02)00168-694.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Pain 2012; 153:382-90; PMID:22136749; http://dx.doi.org/10.1016/j.pain.2011.10.036 95.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Invest Dermatol 2008; 128:434-46; PMID:17914449; http://dx.doi.org/10.1038/sj.jid.5701079 96.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Mol Med (Berl) 2007; 85:1369-78; PMID:17639286; http://dx.doi.org/10.1007/s00109-007-0236-8 97.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2008; 22:15-21; PMID:17697764; http://dx.doi.org/10.1016/j.bbi.2007.06.011 98.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Neuroimmunol 2011; 233:54-64; PMID:21186063; http://dx.doi.org/10.1016/j.jneuroim.2010.11.012 100.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Gut 2008; 57:911-21; PMID:18308830; http://dx.doi.org/10.1136/gut.2007.125401 101.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Brain Behav Immun 2009; 23:276-85; PMID:18984038; http://dx.doi.org/10.1016/j.bbi.2008.10.004 102.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Neuroimmunomodulation 2010; 17:165-8; PMID:20134193; http://dx.doi.org/10.1159/000258714 103.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
J Immunol 2011; 186:4340-6; PMID:21339364; http://dx.doi.org/10.4049/jimmu-nol.1003722 105.,Non-OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
Auton Neurosci 2000; 85:1-17; PMID:11189015; http://dx.doi.org/10.1016/S1566-0702(00)00215-0 108.,OADS,/arxiv_data1/oa_pdf/ea/f5/de-4-271.PMC3583888.pdf
"Exposed areas of the body e.g.,  *Correspondence to: Christos C. Zouboulis;   Email: christos.zouboulis@klinikum-dessau.de Submitted: 09/24/12; Accepted: 09/24/12http://dx.doi.org/10.4161/derm.22372Skin aging is a complex process and underlies multiple  influences with the probable involvement of heritable and various environmental factors.",Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Rejuvenation Res 2006; 9:264-73; PMID:16706654; http://dx.doi.org/10.1089/rej.2006.9.264 2.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Maturitas 1994; 18:199-206; PMID:8015503; http://dx.doi.org/10.1016/0378-5122(94)90126-0 3.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Exp Gerontol 2007; 42:668-75; PMID:17482402; http://dx.doi.org/10.1016/j.exger.2007.03.006 4.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Exp Gerontol 2010; 45:801-13; PMID:20719245; http://dx.doi.org/10.1016/j.exger.2010.08.005 5.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Exp Gerontol 2007; 42:879-86; PMID:17689905; http://dx.doi.org/10.1016/j.exger.2007.07.0026.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Clin Dermatol 2011; 29:3-14; PMID:21146726; http://dx.doi.org/10.1016/j.clindermatol.2010.07.001 7.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Rejuvenation Res 2012; 15:302-12; PMID:22533363; http://dx.doi.org/10.1089/rej.2011.1249 8.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Curr Opin Biotechnol 2007; 18:355-9; PMID:17681777; http://dx.doi.org/10.1016/j.cop-bio.2007.07.004 9.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Exp Gerontol 2006; 41:387-97; PMID:16530368; http://dx.doi.org/10.1016/j.exger.2006.01.012 10.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Aging Cell 2006; 5:331-44; PMID:16805856; http://dx.doi.org/10.1111/j.1474-9726.2006.00223.x14.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
PLoS Biol 2004; 2:e427; PMID:15562319; http://dx.doi.org/10.1371/journal.pbio.0020427 15.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Science 2003; 299:1355-9; PMID:12610296; http://dx.doi.org/10.1126/science.1079161 16.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Science 2000; 287:2486-92; PMID:10741968; http://dx.doi.org/10.1126/science.287.5462.2486 18.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
J Clin Endocrinol Metab 1998; 83:382-95; PMID:9467546; http://dx.doi.org/10.1210/jc.83.2.382 19.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Lancet 2001; 357:425-31; PMID:11273062; http://dx.doi.org/10.1016/S0140-6736(00)04006-X,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Br J  Dermatol 2006; 155:890-4; PMID:17034515; http://dx.doi.org/10.1111/j.1365-2133.2006.07465.x 30.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
J Dermatol Sci 2009; 53:135-9; PMID:18990545; http://dx.doi.org/10.1016/j.jdermsci.2008.08.008 31.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Arch Dermatol Res 2010; 302:661-7; PMID:20567839; http://dx.doi.org/10.1007/s00403-010-1062-3 32.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
PLOS One 2012; 7:e50393; PMID:23226273; http://dx.doi.org/10.1371/journal.pone.005039325.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
J Dermatol Sci 2005; 40:187-93; PMID:16154324; http://dx.doi.org/10.1016/j.jdermsci.2005.06.006 27.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Int J Dermatol 2007; 46(Suppl 1):11-4; PMID:17919198; http://dx.doi.org/10.1111/j.1365-4632.2007.03455.x20.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Mech Ageing Dev 2005; 126:305-7; PMID:15621211; http://dx.doi.org/10.1016/j.mad.2004.08.022 21.,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
J Invest Dermatol 2005; 124:22-7; PMID:15654949; http://dx.doi.org/10.1111/j.0022-202X.2004.23545.x 22.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Skin Pharmacol 1994; 7:201-9; PMID:8024801; http://dx.doi.org/10.1159/000211295 23.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
PLoS One 2012; 7:e42357; PMID:22848760; http://dx.doi.org/10.1371/journal.pone.0042357 24.,Non-OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
Int J Cosmet Sci 2006; 28:79-93; PMID:18492142; http://dx.doi.org/10.1111/j.1467-2494.2006.00302.x,OADS,/arxiv_data1/oa_pdf/cf/f5/de-4-280.PMC3583889.pdf
"Anti-tumor immune response, which plays  *Correspondence to: Fragkiski Tsatsou; Email: ftsatsou@yahoo.com Submitted: 08/12/12; Accepted: 10/11/12http://dx.doi.org/10.4161/derm.22519Age-associated skin lesions linked to UV radiation (UVR) include  actinic keratosis, non-melanoma skin cancer—such as basal cell carcinoma and squamous cell carcinoma—lentigo senilis and lentigo maligna.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Clin Dermatol  2011; 29:3-14; PMID:21146726; http://dx.doi.org/10.1016/j.clindermatol.2010.07.001 2.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
The determinants of periorbital skin ageing in participants of a melanoma case-control study in the U.K. Br J Dermatol 2011; 165:1011-21; PMID:21787368; http://dx.doi.org/10.1111/j.1365-2133.2011.10536.x 3.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Med Hypotheses 2007; 68:853-5; PMID:17052858; http://dx.doi.org/10.1016/j.mehy.2006.08.039 4.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
An Bras Dermatol 2012; 87:425-34; PMID:22714759; http://dx.doi.org/10.1590/S0365-05962012000300012 6.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 2009; 161(Suppl 3):69-77; PMID:19775360; http://dx.doi.org/10.1111/j.1365-2133.2009.09452.x 7.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Adv Exp Med Biol 2008; 624:162-78; PMID:18348455; http://dx.doi.org/10.1007/978-0-387-77574-6_13 8.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Cell 2012; 149:1207-20; PMID:22682244; http://dx.doi.org/10.1016/j.cell.2012.03.048 9.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 2012; 167:150-9; PMID:22329784; http://dx.doi.org/10.1111/j.1365-2133.2012.10887.x 11.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Eur Acad Dermatol Venereol 2012; 26:1063-6; PMID:22220503; http://dx.doi.org/10.1111/j.1468-3083.2011.04432.x 12.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Indian J Dermatol 2012; 57:239-41; PMID:22707785; http://dx.doi.org/10.4103/0019-5154.9621714.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Am Acad Dermatol 1992; 27:406-10; PMID:1401276; http://dx.doi.org/10.1016/0190-9622(92)70208-W 15.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Curr T reat Options Oncol 2012; 13:354-76; PMID:22592596; http://dx.doi.org/10.1007/s11864-012-0195-3 17.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Cutan Aesthet Surg 2012; 5:3-10; PMID:22557848; http://dx.doi.org/10.4103/0974-2077.94323 18.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Invest Dermatol 2012; 132:1591-6; PMID:22377757; http://dx.doi.org/10.1038/jid.2012.29 19.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Clin Invest 2012; 122:455-63; PMID:22293184; http://dx.doi.org/10.1172/JCI58779 20.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
"Br J Dermatol 2007; 156(Suppl 3):1-7; PMID:17488399; http://dx.doi.org/10.1111/j.1365-2133.2007.07861.x 21.  de  Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil  SC, Saksela O, et al.",OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Arch Dermatol 2012; 148:347-54; PMID:22431775; http://dx.doi.org/10.1001/archdermatol.2011.2244 22.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
An Bras Dermatol 2011; 86:292-305; PMID:21603813; http://dx.doi.org/10.1590/S0365-05962011000200013 23.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Semin Cutan Med Surg 2011; 30(Suppl):S6-9; PMID:22177103; http://dx.doi.org/10.1016/j.sder.2011.11.001 25.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Ther Adv Med Oncol 2010; 2:237-50; PMID:21789137; http://dx.doi.org/10.1177/1758834010366430 26.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Clin Oncol 2010; 28:5321-6; PMID:21041712; http://dx.doi.org/10.1200/JCO.2010.27.9943 27.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Dermatol Surg 2012; 38:1604-21; PMID:22646842; http://dx.doi.org/10.1111/j.1524-4725.2012.02452.x28.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
"J Am Acad Dermatol 2002; 47:1-17, quiz 18-20; PMID:12077575; http://dx.doi.org/10.1067/mjd.2002.125579 29.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Am Acad Dermatol 2005; 53:458-63; PMID:16112353; http://dx.doi.org/10.1016/j.jaad.2005.04.089 32.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Indian J Dermatol Venereol Leprol 2011; 77:251; PMID:21393972; http://dx.doi.org/10.4103/0378-6323.77483 33.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Cutan Pathol 2012; 39:526-34; PMID:22515224; http://dx.doi.org/10.1111/j.1600-0560.2012.01871.x 34.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Semin Cutan Med Surg 2011; 30(Suppl):S10-3; PMID:22177101; http://dx.doi.org/10.1016/j.sder.2011.11.004 35.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
PLoS One 2012; 7:e40767; PMID:22808258; http://dx.doi.org/10.1371/journal.pone.0040767 38.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 2011; 164:1201-13; PMID:21418174; http://dx.doi.org/10.1111/j.1365-2133.2011.10322.x 40.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Am J Epidemiol 2012; 175:685-95; PMID:22419740; http://dx.doi.org/10.1093/aje/kwr373,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Arch Dermatol 1996; 132:1297-302; PMID:8915306; http://dx.doi.org/10.1001/arch-derm.1996.03890350035006 71.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
"J Am Acad Dermatol 2011; 65:427-8, 428, e1; PMID:21763569; http://dx.doi.org/10.1016/j.jaad.2010.11.041 74.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Curr Probl Dermatol 2012; 43:171-96; PMID:22377929; http://dx.doi.org/10.1159/000335799 75.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Dermatol Surg 2012; 38:1622-30; PMID:22805312; http://dx.doi.org/10.1111/j.1524-4725.2012.02520.x 77.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
2011;v.1: Available at http://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf 78.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
"NCCN  Clinical Practice Guidelines in Oncology,Melanoma.Version1.2013.http://www.nccn.org/professionals/phy-sician_gls/pdf/melanoma.pdf 79.",Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Cancer 2012; 118:2128-37; PMID:21882176; http://dx.doi.org/10.1002/cncr.26374 81.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Invest Dermatol 2012; 132:1532-5; PMID:22584499; http://dx.doi.org/10.1038/jid.2012.136 83.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Invest Dermatol 2012; 132:1583-90; PMID:22318383; http://dx.doi.org/10.1038/jid.2011.48356.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Arch Dermatol 1997; 133:209-11; PMID:9041835; http://dx.doi.org/10.1001/archderm.1997.03890380081012 58.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 1992; 127(Suppl 41):48-50; PMID:1390186; http://dx.doi.org/10.1111/j.1365-2133.1992.tb16989.x 60.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 2012; 167:280-7; PMID:22404578; http://dx.doi.org/10.1111/j.1365-2133.2012.10932.x 61.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Arch Dermatol 2012; 148:164-70; PMID:22004881; http://dx.doi.org/10.1001/archdermatol.2011.291 62.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Cancer Causes Control 2005; 16:893-9; PMID:16132799; http://dx.doi.org/10.1007/s10552-005-2300-4 65.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Int J Epidemiol 1999; 28:418-27; PMID:10405843; http://dx.doi.org/10.1093/ije/28.3.418 66.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Am J Dermatopathol 2003; 25:300-7; PMID:12876487; http://dx.doi.org/10.1097/00000372-200308000-00004 67.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Dermatol 2011; 38:53-8; PMID:21175756; http://dx.doi.org/10.1111/j.1346-8138.2010.01132.x 68.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 2012; 167:280-7; PMID:22404578; http://dx.doi.org/10.1111/j.1365-2133.2012.10932.x 69.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Br J Dermatol 2010; 163:1212-7; PMID:21083845; http://dx.doi.org/10.1111/j.1365-2133.2010.10025.x41.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Arch Oral Biol 2011; 56:1154-61; PMID:21489402; http://dx.doi.org/10.1016/j.archoralbio.2011.03.008 42.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Invest Dermatol 2012; 132:1591-6; PMID:22377757; http://dx.doi.org/10.1038/jid.2012.29 43.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Hautarzt 2010; 61:195-206; PMID:20177652; http://dx.doi.org/10.1007/s00105-009-1858-2 45.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Dermatol Surg 2012; 38:1604-21; PMID:22646842; http://dx.doi.org/10.1111/j.1524-4725.2012.02452.x 46.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Curr T reat Options Oncol 2012; 13:354-76; PMID:22592596; http://dx.doi.org/10.1007/s11864-012-0195-3 47.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
T ransplant Proc 2010; 42:3871-5; PMID:21094874; http://dx.doi.org/10.1016/j.transproceed.2010.07.090 48.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Photochem Photobiol 1996; 63:432-5; PMID:8934758; http://dx.doi.org/10.1111/j.1751-1097.1996.tb03064.x 50.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Am Acad Dermatol 1992; 26:467-84; PMID:1564155; http://dx.doi.org/10.1016/0190-9622(92)70074-P 51.,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
N Engl J Med 2001; 344:975-83; PMID:11274625; http://dx.doi.org/10.1056/NEJM200103293441306 52.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
Actas Dermosifiliogr 2012; 103:567-78; PMID:22261673; http://dx.doi.org/10.1016/j.adengl.2012.08.004 54.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
ANZ J Surg 2012; 82:230-3; PMID:22510179; http://dx.doi.org/10.1111/j.1445-2197.2011.05994.x 55.,OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
J Surg Oncol 2012; In Press; PMID:22592943; http://dx.doi.org/10.1002/jso.23155,Non-OADS,/arxiv_data1/oa_pdf/35/b6/de-4-285.PMC3583890.pdf
The best prevention strategy against the harmful action of free radicals is a well regulated lifestyle  *Correspondence to: Christos C. Zouboulis;   Email: christos.zouboulis@klinikum-dessau.de Submitted: 02/16/12; Revised: 10/28/12; Accepted: 11/13/12http://dx.doi.org/10.4161/derm.22876Skin has been reported to reflect the general inner-health status  and aging.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Exp Dermatol 2009; 18:1028-35; PMID:19601984; http://dx.doi.org/10.1111/j.1600-0625.2009.00889.x 2.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Exp Gerontol 2007; 42:879-86; PMID:17689905; http://dx.doi.org/10.1016/j.exger.2007.07.002 3.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Free Radic Biol Med 2011; 51:327-36; PMID:21619928; http://dx.doi.org/10.1016/j.fre-eradbiomed.2011.05.010 4.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Cell Sci 2007; 120:2479-87; PMID:17646672; http://dx.doi.org/10.1242/jcs.0012226.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Clin Dermatol 2010; 28:400-8; PMID:20620756; http://dx.doi.org/10.1016/j.clinder-matol.2010.03.019 7.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Clin  Dermatol 1996; 14:389-406; PMID:8862916; http://dx.doi.org/10.1016/0738-081X(96)00068-5 8.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Int J Cosmet Sci 1998; 20:151-8; PMID:18505499; http://dx.doi.org/10.1046/j.1467-2494.1998.171747.x 9.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Invest Dermatol 2005; 124:304-7; PMID:15675947; http://dx.doi.org/10.1111/j.0022-202X.2004.23560.x 10.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
"J Am Acad Dermatol 2003; 48:1-19, quiz 20-2; PMID:12522365; http://dx.doi.org/10.1067/mjd.2003.16 11.",Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Expert Opin Drug Deliv 2011; 8:905-19; PMID:21599565; http://dx.doi.org/10.1517/17425247.2011.58165712.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Am Acad Dermatol 2011; 65:525-30; PMID:21624700; http://dx.doi.org/10.1016/j.jaad.2010.07.009 13.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Drug Discov Today Dis Mech 2008; 5:e153-62; http://dx.doi.org/10.1016/j.ddmec.2008.05.008 14.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
"Chan A C. Partners in defense, vitamin E and vita- min C. Can J Physiol Pharmacol 1993; 71:725-31; PMID:8313238; http://dx.doi.org/10.1139/y93-109 15.",Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Int J Cosmet Sci 2002; 24:331-9; PMID:18494887; http://dx.doi.org/10.1046/j.1467-2494.2002.00159.x 16.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Evidence for the photoprotective  effects of vitamin E. Photochem Photobiol 1993; 58:304-12; PMID:8415922; http://dx.doi.org/10.1111/j.1751-1097.1993.tb09566.x 18.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Arch Dermatol 1992; 128:1130-1; PMID:1497375; http://dx.doi.org/10.1001/arch-derm.1992.01680180126023 51.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Horm Metab Res 2007; 39:71-84; PMID:17326003; http://dx.doi.org/10.1055/s-2007-958715 52.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
"Hautarzt  2005; 56:328, 330-4, 336-9; PMID:15750677; http://dx.doi.org/10.1007/s00105-005-0909-6 53.",OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
N Engl J Med 1997; 337:1419-28; PMID:9358139; http://dx.doi.org/10.1056/NEJM199711133372003 54.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Evid Based Complement Alternat Med 2012; 2012:190370; PMID:21912567; http://dx.doi.org/10.1155/2012/190370 55.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Clin Invest 2000; 106:663-70; PMID:10974019; http://dx.doi.org/10.1172/JCI9362 56.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
N Engl J Med 1996; 334:1150-5; PMID:8602180; http://dx.doi.org/10.1056/NEJM199605023341802 57.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Cell Biochem 2003; 89:663-73; PMID:12858333; http://dx.doi.org/10.1002/jcb.10540 58.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Photochem Photobiol B 2005; 78:141-8; PMID:15664501; http://dx.doi.org/10.1016/j.jphotobiol.2004.09.010 59.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Steroid Biochem Mol Biol 2005; 97:137-43; PMID:16039116; http://dx.doi.org/10.1016/j.jsbmb.2005.06.006 60.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Invest Dermatol 2005; 124:1080-2; PMID:15854055; http://dx.doi.org/10.1111/j.0022-202X.2005.23687.x 61.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Clin Invest 1985; 76:1536-8; PMID:2997282; http://dx.doi.org/10.1172/JCI112134 62.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Cancer Causes Control 2010; 21:2315-6; PMID:20882333; http://dx.doi.org/10.1007/s10552-010-9646-y 63.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Gerontology 2011; 57:350-3; PMID:21196703; http://dx.doi.org/10.1159/000322521 64.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Exp Dermatol 2009; 18:97-108; PMID:19146580; http://dx.doi.org/10.1111/j.1600-0625.2008.00810.x 65.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Invest Dermatol 1988; 90:55-7; PMID:3335790; http://dx.doi.org/10.1111/1523-1747.ep12462564 37.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Photochem Photobiol Sci 2003; 2:655-9; PMID:12859149; http://dx.doi.org/10.1039/b300808h 38.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
T rends Biotechnol 2000; 18:160-7; PMID:10740262; http://dx.doi.org/10.1016/S0167-7799(00)01433-5 39.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Biol Pharm Bull 2006; 29:684-8; PMID:16595899; http://dx.doi.org/10.1248/bpb.29.684 40.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Mol Nutr Food Res 2011; 55:150-65; PMID:21207519; http://dx.doi.org/10.1002/mnfr.201000414 41.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Crit Rev Food Sci Nutr 2006; 46:185-96; PMID:16431409; http://dx.doi.org/10.1080/10408690590957188 42.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Dermatol Sci 2002; 30:73-84; PMID:12354422; http://dx.doi.org/10.1016/S0923-1811(02)00063-4 43.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Exp Dermatol 2009; 18:222-31; PMID:18803658; http://dx.doi.org/10.1111/j.1600-0625.2008.00790.x 44.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Dermatol Sci 2010; 58:136-42; PMID:20219323; http://dx.doi.org/10.1016/j.jdermsci.2010.02.009 45.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Photochem Photobiol Sci 2006; 5:238-42; PMID:16465309; http://dx.doi.org/10.1039/b505312a 46.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Arch Dermatol Res 2008; 300:397-413; PMID:18690467; http://dx.doi.org/10.1007/s00403-008-0879-519.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Mol Carcinog 1999; 24:169-76; PMID:10204801; http://dx.doi.org/10.1002/(SICI)1098-2744(199903)24:3<169::AID-MC3>3.0.CO;2-A 20.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Dermatol Sci 1991; 2:171-8; PMID:1831657; http://dx.doi.org/10.1016/0923-1811(91)90064-5 21.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Hautarzt 2006; 57:291-6; PMID:16477469; http://dx.doi.org/10.1007/s00105-005-1090-7 23.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Cosmet Dermatol 2005; 4:4-9; PMID:17134414; http://dx.doi.org/10.1111/j.1473-2165.2005.00151.x 24.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Arch Biochem Biophys 2010; 504:34-9; PMID:20637178; http://dx.doi.org/10.1016/j.abb.2010.07.004 25.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Nutr 2010; 140:2268S-85S; PMID:20980645; http://dx.doi.org/10.3945/jn.109.119024 27.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Histochem Cytochem 2004; 52:491-9; PMID:15034000; http://dx.doi.org/10.1177/002215540405200407 28.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Photochem Photobiol 2008; 84:284-8; PMID:18086246; http://dx.doi.org/10.1111/j.1751-1097.2007.00253.x 30.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Annu Rev Nutr 2004; 24:173-200; PMID:15189118; http://dx.doi.org/10.1146/annurev.nutr.24.012003.132320 31.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Skin Pharmacol Appl Skin Physiol 2002; 15:291-6; PMID:12239422; http://dx.doi.org/10.1159/000064532 33.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Invest Dermatol 1972; 59:349-53; PMID:4569104; http://dx.doi.org/10.1111/1523-1747.ep12627408 34.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Proc Soc Exp Biol Med 2000; 223:170-4; PMID:10654620; http://dx.doi.org/10.1046/j.1525-1373.2000.22323.x 35.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Photochem Photobiol 1995; 62:855-61; PMID:8570723; http://dx.doi.org/10.1111/j.1751-1097.1995.tb09147.x 99.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Am Acad Dermatol 2001; 44:425-32; PMID:11209110; http://dx.doi.org/10.1067/mjd.2001.112919 100.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Invest Dermatol 1994; 102:122-4; PMID:8288904; http://dx.doi.org/10.1111/1523-1747.ep12371744 101.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Free Radic Biol Med 2002; 33:627-38; PMID:12208349; http://dx.doi.org/10.1016/S0891-5849(02)00916-4 102.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Biofactors 2003; 18:289-97; PMID:14695946; http://dx.doi.org/10.1002/biof.5520180233 103.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
PLoS One 2010; 5:e11897; PMID:20689595; http://dx.doi.org/10.1371/journal.pone.0011897 104.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Free Radic Biol Med 2006; 40:480-7; PMID:16443163; http://dx.doi.org/10.1016/j.freerad-biomed.2005.08.037 105.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Appl  Bacteriol 1989; 66:365-78; PMID:2666378; http://dx.doi.org/10.1111/j.1365-2672.1989.tb05105.x 107.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Clin  Plast Surg 2012; 39:59-64; PMID:22099848; http://dx.doi.org/10.1016/j.cps.2011.09.009 109.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Dermatoendocrinol 2009; 1:275-9; PMID:20808516; http://dx.doi.org/10.4161/derm.1.5.9849 110.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Pediatr Allergy Immunol 2011; 22:537-42; PMID:21771085; http://dx.doi.org/10.1111/j.1399-3038.2010.01132.x82.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Radiat Oncol 2012; 7:12;  PMID:22289566; http://dx.doi.org/10.1186/1748-717X-7-12 83.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Ann N Y Acad Sci 2002; 957:210-29; PMID:12074974; http://dx.doi.org/10.1111/j.1749-6632.2002.tb02918.x 84.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Cosmet Dermatol 2008; 7:2-7; PMID:18254804; http://dx.doi.org/10.1111/j.1473-2165.2008.00354.x 85.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
PLoS One 2010; 5:e12935; PMID:20886076; http://dx.doi.org/10.1371/journal.pone.0012935 86.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Med Food 2011; 14:34-9; PMID:21128830; http://dx.doi.org/10.1089/jmf.2010.0022 88.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Int J Dermatol 2010; 49:608-22; PMID:20618464; http://dx.doi.org/10.1111/j.1365-4632.2010.04468.x 90.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Mol Nutr Food Res 2011; 55:430-42; PMID:20938987; http://dx.doi.org/10.1002/mnfr.201000221 91.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Cancer Lett 2008; 269:199-225; PMID:18479807; http://dx.doi.org/10.1016/j.canlet.2008.03.009 92.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Science 2004; 304:600-2; PMID:15105504; http://dx.doi.org/10.1126/science.1093941 93.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Photochem Photobiol 1993; 58:695-700; PMID:8284325; http://dx.doi.org/10.1111/j.1751-1097.1993.tb04954.x 94.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
"Dermatol Surg 2005; 31:855-60, discussion 860; PMID:16029678; http://dx.doi.org/10.1111/j.1524-4725.2005.31731 95.",Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Biochim Biophys Acta 2000; 1478:51-60; PMID:10719174; http://dx.doi.org/10.1016/S0167-4838(00)00009-166.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Agric Food Chem 1997; 45:590-5; http://dx.doi.org/10.1021/jf960339y 71.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Sci Food Agric 2000; 80:1033-43; http://dx.doi.org/10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T 72.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Arch Dermatol Res 2010; 302:71-83; PMID:19898857; http://dx.doi.org/10.1007/s00403-009-1001-3 73.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Biosci Biotechnol Biochem 2011; 75:854-8; PMID:21597195; http://dx.doi.org/10.1271/bbb.100774 77.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Arch Pharm Res 2007; 30:290-8; PMID:17424933; http://dx.doi.org/10.1007/BF02977608 79.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Carcinogenesis 2006; 27:1627-35; PMID:16522663; http://dx.doi.org/10.1093/carcin/bgi367 80.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Dermatoendocrinol 2012; 4:20-32; PMID:22870349; http://dx.doi.org/10.4161/derm.19828 81.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Carcinogenesis 1993; 14:2205-17;  PMID:8242845; http://dx.doi.org/10.1093/car-cin/14.11.2205 120.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Arch Facial Plast Surg 2005; 7:12-6; PMID:15655168; http://dx.doi.org/10.1001/archfaci.7.1.12 121.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Photodermatol Photoimmunol Photomed 2007; 23:155-62; PMID:17803593; http://dx.doi.org/10.1111/j.1600-0781.2007.00298.x 117.,OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Toxicol Pathol 2009; 37:47-51; PMID:19075044; http://dx.doi.org/10.1177/0192623308329476 118.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
Carcinogenesis 2003; 24:1225-31; PMID:12807724; http://dx.doi.org/10.1093/carcin/bgg077112.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Am Acad Dermatol 1989; 20:1045-53; PMID:2526823; http://dx.doi.org/10.1016/S0190-9622(89)70130-4 113.,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
J Invest Dermatol 1995; 105:532-5; PMID:7561154; http://dx.doi.org/10.1111/1523-1747.ep12323389,Non-OADS,/arxiv_data1/oa_pdf/a2/5b/de-4-298.PMC3583891.pdf
"20 On the other side, many of  these features are targets to product application or procedures to accelerate the cell cycle, in the belief that a faster turnover rate  *Correspondence to: Christos C. Zouboulis;   Email: christos.zouboulis@klinikum-dessau.de Submitted: 10/03/12; Accepted: 10/16/12http://dx.doi.org/10.4161/derm.22804Skin aging is a complex biological process influenced by a  combination of endogenous or intrinsic and exogenous or extrinsic factors.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Expert Opin Biol Ther 2008; 8:1393-405; PMID:18694357; http://dx.doi.org/10.1517/14712598.8.9.1393 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
N Engl  J Med 1997; 337:1463-5; PMID:9358147; http://dx.doi.org/10.1056/NEJM199711133372011 3.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Science 2006; 312:1059-63; PMID:16645051; http://dx.doi.org/10.1126/sci-ence.1127168 4.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Horm Metab Res 2007; 39:96-105; PMID:17326005; http://dx.doi.org/10.1055/s-2007-961808 6.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Horm Metab Res 2007; 39:71-84; PMID:17326003; http://dx.doi.org/10.1055/s-2007-958715 7.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Exp Dermatol 2006; 15:83-94; PMID:16433679; http://dx.doi.org/10.1111/j.1600-0625.2005.00377.x 8.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"J Am Acad Dermatol 2005; 53:555-68, quiz 569-72; PMID:16198774; http://dx.doi.org/10.1016/j.jaad.2004.08.039 9.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Climacteric 2005; 8:110-23; PMID:16096167; http://dx.doi.org/10.1080/13697130500118100 10.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Fertil Steril 2005; 84:291-2, discussion 295; PMID:16084864; http://dx.doi.org/10.1016/j.fertnstert.2005.03.033 11.",OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Dermatol Sci 2005; 38:1-7; PMID:15795118; http://dx.doi.org/10.1016/j.jdermsci.2004.10.01112.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2005; 124:315-23; PMID:15675949; http://dx.doi.org/10.1111/j.0022-202X.2004.23588.x 13.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Exp Dermatol 2002; 11:398-405; PMID:12366692; http://dx.doi.org/10.1034/j.1600-0625.2002.110502.x 15.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Photodermatol Photoimmunol Photomed 1997; 13:153-8; PMID:9453085; http://dx.doi.org/10.1111/j.1600-0781.1997.tb00220.x 17.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatology 2007; 214:352-60; PMID:17460411; http://dx.doi.org/10.1159/000100890 18.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Ann N Y Acad Sci 2007; 1119:40-50; PMID:18056953; http://dx.doi.org/10.1196/annals.1404.027 19.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 1989; 93:353-7; PMID:2768836; http://dx.doi.org/10.1111/1523-1747.ep12280259 20.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Pathol  2007; 211:241-51; PMID:17200942; http://dx.doi.org/10.1002/path.209822.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2001; 116:672-8; PMID:11348454; http://dx.doi.org/10.1046/j.1523-1747.2001.01322.x 23.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Br J Dermatol 1999; 140:1038-47; PMID:10354068; http://dx.doi.org/10.1046/j.1365-2133.1999.02901.x 24.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Am J Pathol 2001; 158:931-42; PMID:11238041; http://dx.doi.org/10.1016/S0002-9440(10)64040-0 25.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Photochem Photobiol 1996; 64:877-85; PMID:8931389; http://dx.doi.org/10.1111/j.1751-1097.1996.tb01851.x 26.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Nature 1996; 379:335-9; PMID:8552187; http://dx.doi.org/10.1038/379335a0 27.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
N Engl J Med 1997; 337:1419-28; PMID:9358139; http://dx.doi.org/10.1056/NEJM199711133372003 28.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
FEBS Lett 1993; 331:304-6; PMID:8375513; http://dx.doi.org/10.1016/0014-5793(93)80357-Z 29.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Eur Acad Dermatol Venereol 2010; 24:281-92; PMID:19744174; http://dx.doi.org/10.1111/j.1468-3083.2009.03409.x 67.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Br J Plast Surg 1960; 13:158-69; PMID:13804881; http://dx.doi.org/10.1016/S0007-1226(60)80032-X 68.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Dermatol Res 1997; 289:404-9; PMID:9248619; http://dx.doi.org/10.1007/s004030050212 69.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Otolaryngol 1977; 103:271; PMID:856133; http://dx.doi.org/10.1001/archotol.1977.00780220065006 72.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Aesthetic Plast Surg 1995; 19:243-6; PMID:7668170; http://dx.doi.org/10.1007/BF00451097 73.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Int J Dermatol 2011; 50:1075-82; PMID:22126868; http://dx.doi.org/10.1111/j.1365-4632.2010.04712.x 74.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2001; 107:222-8; PMID:11176627; http://dx.doi.org/10.1097/00006534-200101000-00036 75.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Am Acad Dermatol 1995; 32:472-8; PMID:7868719; http://dx.doi.org/10.1016/0190-9622(95)90072-1 76.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2004; 30:179-88; PMID:14756647; http://dx.doi.org/10.1111/j.1524-4725.2004.30061.x 77.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2003; 32:120-8; PMID:12561045; http://dx.doi.org/10.1002/lsm.10127 78.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Dermatol Clin 2002; 20:97-111, ix; PMID:11859598; http://dx.doi.org/10.1016/S0733-8635(03)00049-4 79.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2004; 34:120-6; PMID:15004823; http://dx.doi.org/10.1002/lsm.2000049.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Nutrition 1999; 15:651-5; PMID:10467607; http://dx.doi.org/10.1016/S0899-9007(99)00119-7 51.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2005; 125:826-32; PMID:16185284; http://dx.doi.org/10.1111/j.0022-202X.2005.23768.x 52.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Int J Cosmet Sci 2004; 26:231-8; PMID:18492135; http://dx.doi.org/10.1111/j.1467-2494.2004.00228.x 53.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Exp Dermatol 2008; 17:946-52; PMID:18503551; http://dx.doi.org/10.1111/j.1600-0625.2008.00732.x 54.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Hautarzt 2011; 62:607-13; PMID:21755353; http://dx.doi.org/10.1007/s00105-011-2137-6 55.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Am Acad Dermatol 2008; 59:418-25; PMID:18603326; http://dx.doi.org/10.1016/j.jaad.2008.05.004 56.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Dermatol 2007; 6:2-6; PMID:17348987; http://dx.doi.org/10.1111/j.1473-2165.2007.00313.x 57.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Skin Pharmacol Physiol 2005; 18:288-93; PMID:16145283; http://dx.doi.org/10.1159/000088014 58.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Am Acad Dermatol 2001; 44:425-32; PMID:11209110; http://dx.doi.org/10.1067/mjd.2001.112919 59.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Dermatol 2007; 143:606-12; PMID:17515510; http://dx.doi.org/10.1001/archderm.143.5.606 60.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2000; 114:480-6; PMID:10692106; http://dx.doi.org/10.1046/j.1523-1747.2000.00902.x 61.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Int J Dermatol 1998; 37:286-92; PMID:9585903; http://dx.doi.org/10.1046/j.1365-4362.1998.00433.x 62.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol  Ther 2007; 20:343-9; PMID:18045359; http://dx.doi.org/10.1111/j.1529-8019.2007.00148.x 63.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Clinical improvement following dermabrasion of photoaged skin corre-lates with synthesis of collagen I. Arch Dermatol 1994; 130:1136-42; PMID:8085868; http://dx.doi.org/10.1001/archderm.1994.0169009006000830.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Br J Dermatol 1975; 93:639-43; PMID:1220811; http://dx.doi.org/10.1111/j.1365-2133.1975.tb05113.x 31.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Br J Dermatol 1996; 135:255-62; PMID:8881669; http://dx.doi.org/10.1111/j.1365-2133.1996.tb01156.x 32.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
NWSA J 2006; 18:13-30; http://dx.doi.org/10.2979/NWS.2006.18.1.13 34.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Gerontologist 2003; 43:787-96; PMID:14704376; http://dx.doi.org/10.1093/geront/43.6.787 36.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Anthropol Q 2006; 79:5-32; http://dx.doi.org/10.1353/anq.2006.0010 37.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Dermatol 2010; 9:50-8; PMID:20367673; http://dx.doi.org/10.1111/j.1473-2165.2010.00475.x 38.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Ther 2005; 18:191-208; PMID:16229721; http://dx.doi.org/10.1111/j.1529-8019.2005.05019.x 40.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatology 2000; 200:308-13; PMID:10894961; http://dx.doi.org/10.1159/000018393 41.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatology  2000; 200:285-9; PMID:10960243; http://dx.doi.org/10.1159/000018388 42.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2000; 114:480-6; PMID:10692106; http://dx.doi.org/10.1046/j.1523-1747.2000.00902.x 43.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2001; 116:853-9; PMID:11407971; http://dx.doi.org/10.1046/j.0022-202x.2001.01362.x 44.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 1996; 106:505-9; PMID:8648184; http://dx.doi.org/10.1111/1523-1747.ep12343819 46.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Clin Exp Dermatol 2001; 26:573-7; PMID:11696060; http://dx.doi.org/10.1046/j.1365-2230.2001.00893.x 47.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Clin Nutr 2005; 24:172-83; PMID:15784476; http://dx.doi.org/10.1016/j.clnu.2004.10.003 48.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Hautarzt 2011; 62:614-7; PMID:21732161; http://dx.doi.org/10.1007/s00105-011-2138-5,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Br J Dermatol 2001; 144:260-6; PMID:11251556; http://dx.doi.org/10.1046/j.1365-2133.2001.04010.x 112.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2009; 129:205-16; PMID:18580963; http://dx.doi.org/10.1038/jid.2008.175 113.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Dermatol 2004; 140:1326-32; PMID:15545540; http://dx.doi.org/10.1001/archderm.140.11.1326 115.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2003; 32:78-87; PMID:12561039; http://dx.doi.org/10.1002/lsm.10145 116.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Clin Dermatol 2008; 26:177-81; PMID:18472058; http://dx.doi.org/10.1016/j.clinder-matol.2007.09.011 117.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2006; 32:465-80; PMID:16681654; http://dx.doi.org/10.1111/j.1524-4725.2006.32100.x 118.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Plast Reconstr Aesthet Surg 2008; 61:1321-4; PMID:17954040; http://dx.doi.org/10.1016/j.bjps.2007.03.039 119.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2005; 115:1420-4; PMID:15809611; http://dx.doi.org/10.1097/01.PRS.0000162227.94032.ED 120.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Laser Ther 2005; 7:147-54; PMID:16414902; http://dx.doi.org/10.1080/14764170500430234 121.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Ther 2008; 21(Suppl 3):S1-5; PMID:19076625; http://dx.doi.org/10.1111/j.1529-8019.2008.00234.x 122.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2006; 32:1467-72; PMID:17199654; http://dx.doi.org/10.1111/j.1524-4725.2006.32353.x 124.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2006; 118:98e-106e; PMID:16980841; http://dx.doi.org/10.1097/01.prs.0000232436.91409.30 126.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Dermatol 2006; 5:157-67; PMID:17173591; http://dx.doi.org/10.1111/j.1473-2165.2006.00243.x95.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Laser Ther 2002; 4:39-43; PMID:12470517; http://dx.doi.org/10.1080/147641702320602555 96.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Facial Plast Surg 2003; 5:218-23; PMID:12756114; http://dx.doi.org/10.1001/archfaci.5.3.218 97.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2000; 26:196-200; PMID:10685092; http://dx.doi.org/10.1002/(SICI)1096-9101(2000)26:2<196::AID-LSM10>3.0.CO;2-9 98.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2002; 28:651-5; PMID:12174053; http://dx.doi.org/10.1046/j.1524-4725.2002.02010.x 100.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 1996; 98:791-4; PMID:8823015; http://dx.doi.org/10.1097/00006534-199610000-00005 101.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 1995; 21:1025-9; PMID:7496669; http://dx.doi.org/10.1016/1076-0512(96)82352-1 102.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Dermatol 1996; 132:395-402; PMID:8629842; http://dx.doi.org/10.1001/arch-derm.1996.03890280047007 103.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 1997; 23:685-7; PMID:9256915; http://dx.doi.org/10.1016/S1076-0512(97)00179-9 104.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2009; 41:177-8; PMID:19291748; http://dx.doi.org/10.1002/lsm.20764 105.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2004; 34:426-38; PMID:15216537; http://dx.doi.org/10.1002/lsm.20048 106.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Dermatol 2009; 8:119-26; PMID:19527336; http://dx.doi.org/10.1111/j.1473-2165.2009.00441.x 107.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2006; 38:142-9; PMID:16392146; http://dx.doi.org/10.1002/lsm.20254 108.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Skin Res Technol 2011; 17:119-28; PMID:21226879; http://dx.doi.org/10.1111/j.1600-0846.2010.00477.x 109.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2007; 39:96-107; PMID:17311274; http://dx.doi.org/10.1002/lsm.20468 110.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Wound Repair Regen 2007; 15:866-74; PMID:18028135; http://dx.doi.org/10.1111/j.1524-475X.2007.00306.x80.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2000; 26:915-8; PMID:11050492; http://dx.doi.org/10.1046/j.1524-4725.2000.026010915.x 81.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2002; 30:79-81; PMID:11870784; http://dx.doi.org/10.1002/lsm.10011 82.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2002; 28:926-31; PMID:12410677; http://dx.doi.org/10.1046/j.1524-4725.2002.02078.x 83.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 1999; 25:229-36; PMID:10495300; http://dx.doi.org/10.1002/(SICI)1096-9101(1999)25:3<229::AID-LSM7>3.0.CO;2-D 85.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Dermatol Surg 2003; 29:161-3, discussion 163-4; PMID:12562346; http://dx.doi.org/10.1046/j.1524-4725.2003.29040.x 86.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2002; 30:82-5; PMID:11870785; http://dx.doi.org/10.1002/lsm.10042 87.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Laser Ther 2003; 5:71-5; PMID:12850799; http://dx.doi.org/10.1080/14769170310001249 88.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Dermatol Surg 2003; 29:681-4, discussion 685; PMID:12828690; http://dx.doi.org/10.1046/j.1524-4725.2003.29181.x 89.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2002; 30:298-305; PMID:11948600; http://dx.doi.org/10.1002/lsm.10036 90.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Dermatol Surg 2001; 27:627-31, discussion 632; PMID:11442612; http://dx.doi.org/10.1046/j.1524-4725.2001.01002.x 91.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Lasers Surg Med 2003; 32:46-9; PMID:12516070; http://dx.doi.org/10.1002/lsm.10119 92.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Dermatol Surg 2003; 29:997-9, discussion 999-1000; PMID:12974694; http://dx.doi.org/10.1046/j.1524-4725.2003.29290.x",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"J Oral Maxillofac Surg 2004; 62:1046,  author reply 1047-8; PMID:15278876; http://dx.doi.org/10.1016/j.joms.2004.05.205 163.",OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Biomaterials 2003; 24:3095-100; PMID:12895582; http://dx.doi.org/10.1016/S0142-9612(03)00114-5 167.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Oral Maxillofac Surg 2005; 63:362-9; PMID:15742288; http://dx.doi.org/10.1016/j.joms.2004.07.016 168.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Ann Plast Surg 2007; 58:469-73; PMID:17452827; http://dx.doi.org/10.1097/01.sap.0000244968.16977.1f 169.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Clin Interv Aging 2007; 2:81-3; PMID:18044078; http://dx.doi.org/10.2147/ciia.2007.2.1.81 170.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
):S18-25; PMID:17241409; http://dx.doi.org/10.1111/j.1524-4725.2006.32327.x 171.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatology 2000; 200:287-91; PMID:10894957; http://dx.doi.org/10.1159/000018389 172.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 1996; 22:39-43; PMID:8556256; http://dx.doi.org/10.1016/1076-0512(95)00464-5 175.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Am Acad Dermatol 1996; 34:788-97; PMID:8632076; http://dx.doi.org/10.1016/S0190-9622(96)90016-X 176.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 1994; 93:913-8; PMID:8134483; http://dx.doi.org/10.1097/00006534-199404001-00003 177.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2007; 120(Suppl):33S-40S; PMID:18090341; http://dx.doi.org/10.1097/01.prs.0000248808.75700.5f 145.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Blood Coagul Fibrinolysis 1991; 2:173-8; PMID:1772987; http://dx.doi.org/10.1097/00001721-199102000-00026 146.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Dermatol 2008; 7:251-8; PMID:19146600; http://dx.doi.org/10.1111/j.1473-2165.2008.00402.x 147.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2006; 118:98e-106e; PMID:16980841; http://dx.doi.org/10.1097/01.prs.0000232436.91409.30 148.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2008; 34(Suppl 1):S115-48; PMID:18547175; http://dx.doi.org/10.1111/j.1524-4725.2008.34253.x 151.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Cosmet Laser Ther 2009; 11:240-7; PMID:19951196; http://dx.doi.org/10.3109/14764170903341731 153.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Int J Dermatol 1994; 33:119-22; PMID:8157393; http://dx.doi.org/10.1111/j.1365-4362.1994.tb01540.x 154.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2007; 120(Suppl):55S-66S; PMID:18090343; http://dx.doi.org/10.1097/01.prs.0000285109.34527.b9 155.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dermatol Surg 2008; 34(Suppl 1):S9-15; PMID:18547188; http://dx.doi.org/10.1111/j.1524-4725.2008.34237.x 156.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Dermatol Surg 2006; 32:1530-2, author reply 1532; PMID:17199668; http://dx.doi.org/10.1111/j.1524-4725.2006.32369.x 157.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Am Acad Dermatol 2005; 52:233-9; PMID:15692467; http://dx.doi.org/10.1016/j.jaad.2004.08.056 159.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
ANZ J Surg 2011; 81:9-17; PMID:21299793; http://dx.doi.org/10.1111/j.1445-2197.2010.05351.x 160.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
T ransfusion 2001; 41:1217-24; PMID:11606819; http://dx.doi.org/10.1046/j.1537-2995.2001.41101217.x 161.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Oral Maxillofac Surg 2004; 62:489-96; PMID:15085519; http://dx.doi.org/10.1016/j.joms.2003.12.003127.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Facial Plast Surg 2004; 20:21-9; PMID:15034810; http://dx.doi.org/10.1055/s-2004-822955 128.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Ann Plast Surg 2005; 55:30-5, discussion 35; PMID:15985788; http://dx.doi.org/10.1097/01.sap.0000168292.69753.73 129.",OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Am J Clin Dermatol 2006; 7:107-20; PMID:16605291; http://dx.doi.org/10.2165/00128071-200607020-00004 130.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Exp Dermatol 2009; 18:1028-35; PMID:19601984; http://dx.doi.org/10.1111/j.1600-0625.2009.00889.x 132.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Curr Opin Cell Biol 1994; 6:726-33; PMID:7530464; http://dx.doi.org/10.1016/0955-0674(94)90100-7 134.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Cancer  Metastasis Rev 1992; 11:21-30; PMID:1380898; http://dx.doi.org/10.1007/BF00047600 135.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Glycobiology 1998; 8:821-30; PMID:9639543; http://dx.doi.org/10.1093/glycob/8.8.821 136.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Biol Chem 2002; 277:4581-4; PMID:11717316; http://dx.doi.org/10.1074/jbc.R100037200 137.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Invest Dermatol 2003; 120:842-8; PMID:12713591; http://dx.doi.org/10.1046/j.1523-1747.2003.12148.x 138.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Arch Dermatol Res 1997; 289:567-72; PMID:9373715; http://dx.doi.org/10.1007/s004030050241 139.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Matrix Biol 2010; 29:107-16; PMID:19913615; http://dx.doi.org/10.1016/j.matbio.2009.11.002 142.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Annu Rev Cell Dev Biol 2007; 23:435-61; PMID:17506690; http://dx.doi.org/10.1146/annurev.cellbio.23.090506.123337 143.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Free Radic Res Commun 1987; 3:85-92; PMID:3508446; http://dx.doi.org/10.3109/10715768709069773,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Clin Endocrinol Metab 2006; 91:2986-93; PMID:16735495; http://dx.doi.org/10.1210/jc.2005-2484 203.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
N Engl J Med 2006; 355:1647-59; PMID:17050889; http://dx.doi.org/10.1056/NEJMoa054629 204.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Psychoneuroendocrinology 1999; 24:209-26; PMID:10101729; http://dx.doi.org/10.1016/S0306-4530(98)00076-6 205.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Clin Endocrinol Metab 2001; 86:3292-5; PMID:11443203; http://dx.doi.org/10.1210/jc.86.7.3292 206.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Exp Gerontol 2008; 43:88-94; PMID:17764865; http://dx.doi.org/10.1016/j.exger.2007.06.010 207.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Endocrine 2005; 27:179-88; PMID:16217131; http://dx.doi.org/10.1385/ENDO:27:2:179 208.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Dtsch Med Wochenschr 2005; 130:829-34; PMID:15789305; http://dx.doi.org/10.1055/s-2005-865097192.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Exp Neurol 1997; 147:96; PMID:9294406; http://dx.doi.org/10.1006/exnr.1997.6580 193.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2002; 109:1191-7; PMID:11884859; http://dx.doi.org/10.1097/00006534-200203000-00066 195.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 1999; 103:701-13; PMID:9950563; http://dx.doi.org/10.1097/00006534-199902000-00055 196.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Ann N Y Acad Sci 2005; 1057:448-65; PMID:16399912; http://dx.doi.org/10.1196/annals.1322.035 197.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
CMAJ 2006; 175:52-9; PMID:16818910; http://dx.doi.org/10.1503/cmaj.050929 198.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Internist (Berl) 2008; 49:570-80, 572-6, 578-9; PMID:18389196; http://dx.doi.org/10.1007/s00108-008-2110-3 200.",Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Clin Endocrinol Metab 1994; 78:1360-7; PMID:7515387; http://dx.doi.org/10.1210/jc.78.6.1360 201.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Clin Exp Dermatol 2001; 26:619-30; PMID:11696067; http://dx.doi.org/10.1046/j.1365-2230.2001.00901.x 180.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Am Acad Dermatol 2000; 43:249-59; PMID:10906647; http://dx.doi.org/10.1067/mjd.2000.105567 185.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
J Eur Acad Dermatol Venereol 2010; 24(Suppl 1):1-14; PMID:19930409; http://dx.doi.org/10.1111/j.1468-3083.2009.03475.x 186.,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Plast Reconstr Surg 2004; 114:1S-22S; PMID:15507786; http://dx.doi.org/10.1097/01.PRS.0000144795.76040.D3 188.,OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
Muscle Nerve 1991; 14:672-5; PMID:1922173; http://dx.doi.org/10.1002/mus.880140711,Non-OADS,/arxiv_data1/oa_pdf/5e/cd/de-4-308.PMC3583892.pdf
"Ten MACEs (5 ustekinumab, 5 briakinumab) have been recorded in actively-treated patients during the placebo-controlled phase of phase II and III studies compared with zero events in placebo-treated patients, along with a total of 53 MACEs (26 ustekinumab, 27  *Correspondence to: Christos C. Zouboulis;   Email: christos.zouboulis@klinikum-dessau.deSubmitted: 11/28/12; Accepted: 11/28/12http://dx.doi.org/10.4161/derm.23100Safety concerns have been raised regarding possible  association of major adverse cardiovascular events (MAC es )  with use of anti- iL -12/23 biologic agents for the treatment of  chronic plaque psoriasis (CPP).",Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
JAMA 2011; 306:864-71; PMID:21862748; http://dx.doi.org/10.1001/jama.2011.1211 2.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Eur Acad Dermatol Venereol 2012; In press; PMID:22404103; http://dx.doi.org/10.1111/j.1468-3083.2012.04500.x 3.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Invest Dermatol 2012; 132:304-14; PMID:22011907; http://dx.doi.org/10.1038/jid.2011.304 4.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Br J Dermatol 2011; 165:652-60; PMID:21574983; http://dx.doi.org/10.1111/j.1365-2133.2011.10418.x 5.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Dermatol 2012; 39:242-52; PMID:21955098; http://dx.doi.org/10.1111/j.1346-8138.2011.01347.x 6.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Arch Dermatol 2008; 144:200-7; PMID:18283176; http://dx.doi.org/10.1001/archder-matol.2007.63 7.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
N Engl J Med 2007; 356:580-92; PMID:17287478; http://dx.doi.org/10.1056/NEJMoa062382 8.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Lancet 2008; 371:1665-74; PMID:18486739; http://dx.doi.org/10.1016/S0140-6736(08)60725-4 9.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Lancet 2008; 371:1675-84; PMID:18486740; http://dx.doi.org/10.1016/S0140-6736(08)60726-6 10.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Br J Dermatol 2011; 165:661-8; PMID:21574984; http://dx.doi.org/10.1111/j.1365-2133.2011.10419.x11.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Dermatol Sci 2011; 63:154-63; PMID:21741220; http://dx.doi.org/10.1016/j.jdermsci.2011.05.005 12.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Stat Med 2007; 26:53-77; PMID:16596572; http://dx.doi.org/10.1002/sim.2528 13.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Stat Med 2002; 21:1575-600; PMID:12111921; http://dx.doi.org/10.1002/sim.1188 14.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
"JAMA 2011; 306:2095, author reply 2095-6; PMID:22089716; http://dx.doi.org/10.1001/jama.2011.1660 15.",Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Br J Dermatol 2011; 165:1066-73; PMID:21777216; http://dx.doi.org/10.1111/j.1365-2133.2011.10525.x 16.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Stat Med 1990; 9:247-52; PMID:2343220; http://dx.doi.org/10.1002/sim.4780090307 17.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Br J Dermatol 2011; 164:862-72; PMID:21332467; http://dx.doi.org/10.1111/j.1365-2133.2011.10257.x 18.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
N Engl J Med 2010; 362:118-28; PMID:20071701; http://dx.doi.org/10.1056/NEJMoa0810652 20.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Epidemiol Community Health 2007; 61:115-21; PMID:17234869; http://dx.doi.org/10.1136/jech.2005.044842 21.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Hypertens 2002; 20:1973-80; PMID:12359975; http://dx.doi.org/10.1097/00004872-200210000-00016 22.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Eur Heart J 2003; 24:1903-11; PMID:14585248; http://dx.doi.org/10.1016/j.ehj.2003.09.00224.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Eur Heart J 2003; 24:937-45; PMID:12714025; http://dx.doi.org/10.1016/S0195-668X(03)00081-2 25.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Am Heart J 2007; 154:87-93; PMID:17584559; http://dx.doi.org/10.1016/j.ahj.2007.03.022 26.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Med Klin (Munich) 2004; 99:651-61; PMID:15583875; http://dx.doi.org/10.1007/s00063-004-1097-3 27.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Int J Cardiol 2009; 133:346-53; PMID:18485502; http://dx.doi.org/10.1016/j.ijcard.2008.01.004 28.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Eur J Cardiovasc Prev Rehabil 2005; 12:442-50; PMID:16210930; http://dx.doi.org/10.1097/01.hjr.0000183909.52118.9f 29.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
N Engl J Med 2011; 365:1586-96; PMID:22029980; http://dx.doi.org/10.1056/NEJMoa1010858 30.,OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
"Safety Results from a Pooled Analysis of Randomized, Controlled Phase II and III Clinical T rials and Interim Data from an Open-Label Extension T rial of the Interleukin-12/23 Monoclonal Antibody, Briakinumab, in Moderate to Severe Psoriasis  Journal of European Academy of Dermatology Venereology 2012; In press; http://dx.doi.org/10.1111/j.1468-3083.2012.04705.x 31.",Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
J Dermatol 2010; 37:413-25; PMID:20536646; http://dx.doi.org/10.1111/j.1346-8138.2010.00802.x 32.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
Arthritis Care Res (Hoboken) 2011; 63:1729-35; PMID:21905258; http://dx.doi.org/10.1002/acr.20627 33.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
JAMA 1995; 274:845-6; PMID:7650811; http://dx.doi.org/10.1001/jama.1995.03530100085040 34.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
JAMA 2012; 307:1641-3; PMID:22511693; http://dx.doi.org/10.1001/jama.2012.482 35.,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
JAMA 2012; 307:1585-6; PMID:22511683; http://dx.doi.org/10.1001/jama.2012.469,Non-OADS,/arxiv_data1/oa_pdf/db/94/de-4-320.PMC3583893.pdf
"Do not distribute.Dermato-Endocrinology 4:3, 324–330; July–December 2012; © 2012 Landes Bioscience Bri Ef rEport 324 D ermato-Endocrinology  V olume 4 i ssue 3*Correspondence to: Sergei A. Grando; Email: sgrando@uci.edu Submitted: 08/27/12; Accepted: 10/19/12http://dx.doi.org/10.4161/derm.22594Introduction Restoration of the epidermal barrier, i.e., epithelialization, is a  major component of the natural cutaneous response to a stress imposed by wounding.",Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
"Dermatol Surg 2005; 31:674-86, discussion 686; PMID:15996419; http://dx.doi.org/10.1111/j.1524-4725.2005.31612 2.",Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Toxicol Pathol 2007; 35:767-79; PMID:17943650; http://dx.doi.org/10.1080/01926230701584189 3.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Exp Dermatol 2006; 15:265-82; PMID:16512874; http://dx.doi.org/10.1111/j.0906-6705.2006.00410.x 4.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Horm Metab Res 2007; 39:125-35; PMID:17326008; http://dx.doi.org/10.1055/s-2007-961816 5.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Invest Dermatol 2006; 126:1948-65; PMID:16912692; http://dx.doi.org/10.1038/sj.jid.5700151 6.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Investig Dermatol Symp Proc 2004; 9:84-91; PMID:14870992; http://dx.doi.org/10.1111/j.1087-0024.2004.00826.x 9.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Arch Dermatol 2004; 140:327-34; PMID:15023776; http://dx.doi.org/10.1001/archderm.140.3.327 10.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Int J Dermatol 2006; 45:743-6; PMID:16796640; http://dx.doi.org/10.1111/j.1365-4632.2006.02766.x 12.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Dermatolog T reat 2004; 15:122-5; PMID:15204166; http://dx.doi.org/10.1080/09546630310019364 13.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Dermatolog T reat 2010; 21:317-8; PMID:19821785; http://dx.doi.org/10.3109/09546630903271563 14.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Clin Rheumatol 2002; 21:341-2; PMID:12296287; http://dx.doi.org/10.1007/s10067020009015.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
N Engl J Med 2000; 343:1816-7; PMID:11185607; http://dx.doi.org/10.1056/NEJM200012143432418 16.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Hum Mol Genet 2003; 12:3017-24; PMID:14506129; http://dx.doi.org/10.1093/hmg/ddg320 17.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Invest Dermatol 2005; 125:1236-41; PMID:16354194; http://dx.doi.org/10.1111/j.0022-202X.2005.23973.x 18.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Cell Physiol 2006; 208:238-45; PMID:16575903; http://dx.doi.org/10.1002/jcp.20661 19.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Wound Repair Regen 2012; 20:103-13; PMID:22168155; http://dx.doi.org/10.1111/j.1524-475X.2011.00753.x 20.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Genomics 2003; 81:26-33; PMID:12573258; http://dx.doi.org/10.1016/S0888-7543(02)00025-3 22.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Life Sci 2007; 80:2365-8; PMID:17286989; http://dx.doi.org/10.1016/j.lfs.2006.12.028 23.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Br J Dermatol 2011; 164:47-53; PMID:20854438; http://dx.doi.org/10.1111/j.1365-2133.2010.10059.x 24.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Life Sci 2007; 80:2243-7; PMID:17280689; http://dx.doi.org/10.1016/j.lfs.2007.01.003 25.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Cell Biol 2004; 166:261-72; PMID:15263021; http://dx.doi.org/10.1083/jcb.200401034 26.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
BMC Genomics 2010; 11:471; PMID:20704739; http://dx.doi.org/10.1186/1471-2164-11-471 27.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Injury 2006; 37(Suppl 1):S5-12; PMID:16616753; http://dx.doi.org/10.1016/j.injury.2006.02.035 29.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Surg Clin North Am 2003; 83:483-507; PMID:12822721; http://dx.doi.org/10.1016/S0039-6109(02)00200-1 33.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
T rends Cell Biol 2005; 15:599-607; PMID:16202600; http://dx.doi.org/10.1016/j.tcb.2005.09.002 34.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Invest Dermatol 2007; 127:514-25; PMID:17299434; http://dx.doi.org/10.1038/sj.jid.5700701 35.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Surgery 2005; 137:571-3; PMID:15855932; http://dx.doi.org/10.1016/j.surg.2005.01.006 36.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Diabetes 2003; 52:2821-32; PMID:14578302; http://dx.doi.org/10.2337/diabetes.52.11.2821 38.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Dermatol Sci 2000; 24(Suppl 1):S29-38; PMID:11137393; http://dx.doi.org/10.1016/S0923-1811(00)00138-9 39.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Vet Immunol  Immunopathol 2002; 88:1-12; PMID:12088639; http://dx.doi.org/10.1016/S0165-2427(02)00136-8 40.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Curr Allergy Asthma Rep 2004; 4:276-84; PMID:15175141; http://dx.doi.org/10.1007/s11882-004-0071-8 41.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Neuroinflammation 2010; 7:38; PMID:20624304; http://dx.doi.org/10.1186/1742-2094-7-38 42.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Invest Dermatol 1993; 101:804-10; PMID:8245509; http://dx.doi.org/10.1111/1523-1747.ep12371699 59.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Cell Sci 2004; 117:5665-79; PMID:15494367; http://dx.doi.org/10.1242/jcs.01492 60.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Exp Cell Res 2007; 313:3542-55; PMID:17706194; http://dx.doi.org/10.1016/j.yexcr.2007.07.011 61.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Br J Dermatol 1990; 122:777-84; PMID:2369558; http://dx.doi.org/10.1111/j.1365-2133.1990.tb06266.x 62.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Surg Res 2002; 102:193-7; PMID:11796018; http://dx.doi.org/10.1006/jsre.2001.6316 63.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Alcohol Clin Exp Res 2007; 31:317-23; PMID:17250625; http://dx.doi.org/10.1111/j.1530-0277.2006.00307.x 64.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Am J Physiol Regul Integr Comp Physiol 2008; 294:R179-84; PMID:18003791; http://dx.doi.org/10.1152/ajpregu.00177.200751.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Neurosci Res 2009; 87:2740-7; PMID:19396877; http://dx.doi.org/10.1002/jnr.22102 52.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Neurosci Res 2009; 64:403-12; PMID:19409425; http://dx.doi.org/10.1016/j.neures.2009.04.014 53.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Life Sci 2007; 80:2314-9; PMID:17383684; http://dx.doi.org/10.1016/j.lfs.2007.02.036 54.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Pharmacol Sci 2008; 106:174-9; PMID:18285656; http://dx.doi.org/10.1254/jphs.FM0070087 55.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Br J Pharmacol 2008; 154:1558-71; PMID:18500366; http://dx.doi.org/10.1038/bjp.2008.185 56.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Invest Dermatol 2007; 127:301-8; PMID:17008884; http://dx.doi.org/10.1038/sj.jid.5700551 57.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Int Immunopharmacol 2010; 10:308-15; PMID:20004742; http://dx.doi.org/10.1016/j.intimp.2009.12.001 45.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Surg Res 2008; 145:199-204; PMID:17644111; http://dx.doi.org/10.1016/j.jss.2007.05.031 46.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Arch Dermatol 1997; 133:823-5; PMID:9236519; http://dx.doi.org/10.1001/archderm.1997.03890430023004 47.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Neuroimmunol 2008; 193:130-9; PMID:18077004; http://dx.doi.org/10.1016/j.jneu-roim.2007.10.029 48.,OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
J Exp Med 2005; 201:1113-23; PMID:15809354; http://dx.doi.org/10.1084/jem.20040463 49.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Wound Repair Regen 2010; 18:186-92; PMID:20163570; http://dx.doi.org/10.1111/j.1524-475X.2010.00569.x 50.,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
Am J Physiol Cell Physiol 2010; 299:C903-11; PMID:20660165; http://dx.doi.org/10.1152/ajpcell.00216.2010,Non-OADS,/arxiv_data1/oa_pdf/93/52/de-4-324.PMC3583894.pdf
"We have recently shown that lowering the pH to values most fre - quently detected within the tumor mass (pH 6–6.5) causes the establishment of a state of anergy in both human and mouse tumor-specific CD8 + T lymphocytes in  vitro.3 This condition is characterized by a The acidity of the tumor microenvironment   is a mechanism of immune escape that   can be overcome by proton pump inhibitors Matteo Bellone,1,* Arianna Calcinotto,1 Paola Filipazzi,2 Angelo De Milito,3,4 stefano Fais,3 and Licia r ivoltini2,* 1Cellular Immunology u nit; s an r affaele s cientific Institute; Milan, Italy; 2unit of Immunotherapy of h uman t umors;   Fondazione I rCCs Istituto Nazionale t umori; Milan, Italy; 3Department of t herapeutic r esearch and Medicines e valuation; u nit of Antitumor Drugs;   Istituto s uperiore di s anità; r ome, Italy; 4Oncology-Pathology; Cancer Center Karolinska; Karolinska Institute; s tockholm, s weden Keywords:  anergy, T cell, melanoma, prostate cancer, adoptive immunotherapy, active immunotherapy *Correspondence to: Matteo Bellone and Licia Rivoltini; Email: bellone.matteo@hsr.it and licia.rivoltini@istitutotumori.mi.it Submitted: 08/28/12; Accepted: 09/01/12http://dx.doi.org/10.4161/onci.22058Citation: Bellone M, Calcinotto A, Filipazzi P , De Milito A, Fais S, Rivoltini L. The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Drug Discov Today 2009; 14:647- 60; PMID:19443264; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Immunol Lett 2010; 134:83-92; PMID:20837061;  http://dx.doi.org/10.1016/j.imlet.2010.09.002.5.,OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Anticancer  Drugs 2004; 15:7-14; PMID:15090737; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Blood  2007; 109:3812-9; PMID:17255361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Nat Rev Drug Discov 2003;  2:132-9; PMID:12563304; http://dx.doi.org/10.1038/ nrd1010.References 1.,OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Nat Rev Cancer 2011; 11:85-95;  PMID:21258394; http://dx.doi.org/10.1038/nrc2981.,Non-OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Nat Rev Cancer 2004; 4:891-9; PMID:15516961; http://dx.doi.org/10.1038/nrc1478.,Non-OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Cancer Res  2012; 72:2746-56; PMID:22593198; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
Annu Rev Immunol 2007; 25:267-96;  PMID:17134371; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/f4/0b/onci-2-e22058.PMC3583905.pdf
"Using a simple mouse Improving the outcome of adoptive cell transfer  by targeting tumor escape Karen M. Kaluza1,* and r ichard Vile2 1Ovarian Cancer r esearch Center; u niversity of Pennsylvania; Philadelphia, PA us A; 2Department of Immunology; Mayo Clinic; r ochester, MN us A Keywords:  adoptive T cell therapy, cyclophosphamide, immunostimulatory chemotherapy, melanoma, tumor escape *Correspondence to: Karen M. Kaluza; Email: kkaluza@mail.med.upenn.edu Submitted: 08/29/12; Accepted: 09/01/12http://dx.doi.org/10.4161/onci.22059Citation: Kaluza KM, Vile R. Improving the outcome of adoptive cell transfer by targeting tumor escape.",Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Cancer Res 2009; 69:4309-18;  PMID:19435909; http://dx.doi.org/10.1158/0008- 5472.CAN-08-4102.,Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Cancer Res 2012; 72:4753-64; PMID:22836753; http://dx.doi.org/10.1158/0008- 5472.CAN-12-0600.4.,Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Semin Oncol 2012; 39:215-26; PMID:22484193;  http://dx.doi.org/10.1053/j.seminoncol.2012.01.006.,Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
T rends Biotechnol  2011; 29:550-7; PMID:21663987; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Nat Rev Immunol 2012; 12:269-81;  PMID:22437939; http://dx.doi.org/10.1038/nri3191.,Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Hum Gene Ther  2012; 23:1054–64; PMID:22734672; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0116.,Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849.,OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
Blood 2012; 119:3940-50; PMID:22308288; http://dx.doi.org/10.1182/blood- 2011-10-387969.,Non-OADS,/arxiv_data1/oa_pdf/a6/38/onci-2-e22059.PMC3583906.pdf
"2 These observations A delicate balance CD73-generated adenosine limits the severity   of graft vs. host disease but also constrains   the allogeneic graft vs. tumor effect Linda F. t hompson,1,* hiroki t sukamoto,2 Petya Chernogorova3 and r obert Zeiser3 1Oklahoma Medical r esearch Foundation; Oklahoma City, OK us A; 2saga u niversity Faculty of Medicine; s aga, Japan; 3Freiburg u niversity Medical Center; Freiburg, Germany Keywords:  adenosine receptor, CD73, graft vs. host disease, graft vs. tumor effect Abbreviations:  Ado, adenosine; AR, adenosine receptor; CML, chronic myelogenous leukemia; GvHD, graft vs. host disease;   GvT, graft vs. tumor; mAb, monoclonal antibody *Correspondence to: Linda F. Thompson; Email: linda-thompson@omrf.org Submitted: 09/05/12; Accepted: 09/06/12http://dx.doi.org/10.4161/onci.22107Citation: Thompson LF, Tsukamoto H, Chernogorova P , Zeiser R. A delicate balance: CD73-generated adenosine limits the severity of graft vs. host disease  but also constrains the allogeneic graft vs. tumor effect.",Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
Cancer Res 2011; 71:2892- 900.http://dx.doi.org/10.1158/0008-5472.CAN-10- 4246; PMID:21292811.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
J Clin Invest 2011; 121:2371- 82; PMID:21537079; http://dx.doi.org/10.1172/ JCI45559.5.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
Pharmacol  Rev 2011; 63:1-34; PMID:21303899; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
J Leukoc Biol 2010; 87:345- 54; PMID:19889728; http://dx.doi.org/10.1189/ jlb.0609388.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
J Nucl Cardiol 2010; 17:494-7; PMID:20221857;  http://dx.doi.org/10.1007/s12350-010-9211-9.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
Sci T ransl Med  2012; 4:ra108; PMID:22875828; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
Annu Rev Immunol 2007; 25:139-70; PMID:17129175; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
Blood 2012; 119:4554-64;  PMID:22262774; http://dx.doi.org/10.1182/blood-2011-09-375899.,Non-OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
Nat Med 2010; 16:1434-8; PMID:21102458; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/5e/onci-2-e22107.PMC3583907.pdf
"5–7  However, there is limited information describing whether immunogenic tumor Immunogenic tumor cell death induced   by chemoradiotherapy in a clinical setting Koji Kono1,2,* and Kousaku Mimura1 1Department of s urgery; National u niversity of s ingapore; s ingapore; 2Cancer s cience Institute of s ingapore; s ingapore Keywords:  cancer-testis antigens, calreticulin, chemoradiation, esophageal squamous cell carcinoma, HMGB1,   immunogenic cell death *Correspondence to: Koji Kono; Email: surkoji@nus.edu.sg Submitted: 09/10/12; Accepted: 09/11/12http://dx.doi.org/10.4161/onco.22197Citation: Kono K, Mimura K. Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting.",Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Nat Rev Cancer  2002; 2:277-88; PMID:12001989; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Science 1995; 267:1456-62;  PMID:7878464; http://dx.doi.org/10.1126/sci- ence.7878464.,OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Immunol Rev  2007; 220:47-59; PMID:17979839; http://dx.doi.org/10.1111/j.1600-065X.2007.00573.x.,Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Nat Med 2007; 13:1050-9;  PMID:17704786; http://dx.doi.org/10.1038/nm1622.,OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Clin Cancer Res 2010; 16:3100-4; PMID:20421432;  http://dx.doi.org/10.1158/1078-0432.CCR-09-2891.6.,Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Oncogene  2010; 29:482-91; PMID:19881547; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Nat  Med 2007; 13:54-61; PMID:17187072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Cancer Sci 2008; 99:1448-54;  PMID:18452554; http://dx.doi.org/10.1111/j.1349- 7006.2008.00844.x.9.,Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Cancer Sci 2009;  100:1502-9; PMID:19459850; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
Cancer Res  2012; 72:3967-76; PMID:22700877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/20/onci-2-e22197.PMC3583908.pdf
"ho and s tephan Gasser* Immunology Programme; Centre of Life s ciences, Department of Microbiology; Yong Loo Lin s chool of Medicine; National u niversity of s ingapore; s ingapore Keywords:  cytotoxicity, NK cells, signal transduction, tumor immunology *Correspondence to: Stephan Gasser; Email: micsg@nus.edu.sg Submitted: 09/12/12; Accepted: 09/15/12http://dx.doi.org/10.4161/onco.22244Citation: Ho SSW, Glasser S. NKG2D ligands link oncogenic RAS to innate immunity.",Non-OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Cell 2011; 144:646-74; PMID:21376230;  http://dx.doi.org/10.1016/j.cell.2011.02.013.,OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Nucleic Acids Res 2007; 35:7545-56; PMID:18055498; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Annu Rev Biochem  2004; 73:39-85; PMID:15189136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Nat Rev Mol Cell Biol 2008; 9:517-31;  PMID:18568040; http://dx.doi.org/10.1038/nrm2438.,OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10.1038/ nature05327.,OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Nature 2005;  436:1186-90; PMID:15995699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
Nat Rev Immunol 2003; 3:781-90;  PMID:14523385; http://dx.doi.org/10.1038/nri1199.9.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
J Immunol 2012; 189:1826-34;  PMID:22798674; http://dx.doi.org/10.4049/jimmu- nol.1200965.10.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/onci-2-e22244.PMC3583909.pdf
"7 In silico predictions, Metastamir-mediated immune evasion miR-10b downregulates the stress-induced molecule  MICB, hence avoid recognition by NKG2D receptor Pinchas t sukerman, Jonatan e nk and Ofer Mandelboim* Lautenberg Center for General and t umor Immunology; t he h ebrew u niversity; t he BioMedical r esearch Institute; h adassah Medical s chool; Jerusalem, Israel Abbreviations:  GFP, green fluorescent protein; MICA, MHC class I polypeptide-related sequence A; MICB, MHC Class I  polypeptide-related sequence B; NK, natural killer; NKG2D, natural killer group 2, member D; ULBP, UL16-binding protein;  UTR, untranslated region *Correspondence to: Ofer Mandelboim; Email: oferm@ekmd.huji.ac.il Submitted: 09/12/12; Accepted: 09/15/12http://dx.doi.org/10.4161/onco.22245Citation: Tsukerman P , Enk J, Mandelboim O. Metastamir-mediated immune evasion: miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptor.",Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Breast Cancer Res 2010; 12:210; PMID:21067538;  http://dx.doi.org/10.1186/bcr2720.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
J Clin Invest 2007; 117:1137-46; PMID:17476343; http://dx.doi.org/10.1172/JCI31405.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Nat Immunol 2010; 11:806-13;  PMID:20694010; http://dx.doi.org/10.1038/ni.1916.5.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Immunity 2008; 28:492-4;  PMID:18400193; http://dx.doi.org/10.1016/j.immu- ni.2008.03.007.,OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Nat Immunol 2008; 9:1065-73;  PMID:18677316; http://dx.doi.org/10.1038/ni.1642.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Cancer Res 2012; In Press; PMID:22915757;  http://dx.doi.org/10.1158/0008-5472.CAN-11-2671.References 1.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Semin Oncol 2011; 38:724-33;  PMID:22082758; http://dx.doi.org/10.1053/j.semi - noncol.2011.08.006.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Nature 2007; 449:682-8; PMID:17898713;  http://dx.doi.org/10.1038/nature06174.,Non-OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
Science  2011; 331:44-9; PMID:21212348; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/c3/onci-2-e22245.PMC3583910.pdf
"4Single-dose cyclophosphamide synergizes   with immune responses to the   renal cell cancer vaccine IMA901 steffen w alter,* t oni w einschenk, Carsten r einhardt and h arpreet s ingh-Jasuja Immatics Biotechnologies Gmb h; tuebingen, Germany Keywords:  biomarkers, cancer, immunomonitoring, immunotherapy, low-dose cyclophosphamide, peptides,   randomized clinical trial, renal cell cancer, regulatory T cells, T cells, vaccine Abbreviations:  Cy, cyclophosphamide; ELISPOT, enzyme-linked immunospot; GM-CSF, granulocyte macrophage colony- stimulating factor; MDSC, myeloid-derived suppressor cell; HLA, human leukocyte antigen; HR, hazard ratio; IFN, interferon;  RCC, renal cell cancer; Treg, regulatory T cell; TUMAP, tumor-associated peptide *Correspondence to: Steffen Walter; Email: walter@immatics.com Submitted: 09/14/12; Accepted: 09/15/12http://dx.doi.org/10.4161/onco.22246Citation: Walter S, Weinschenk T, Reinhardt C, Singh-Jasuja H. Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901.",Non-OADS,/arxiv_data1/oa_pdf/c3/0b/onci-2-e22246.PMC3583911.pdf
N Engl J Med 2010; 363:411-22;  PMID:20818862; http://dx.doi.org/10.1056/ NEJMoa1001294.,OADS,/arxiv_data1/oa_pdf/c3/0b/onci-2-e22246.PMC3583911.pdf
N Engl J Med 2011; 364:2119- 27; PMID:21631324; http://dx.doi.org/10.1056/ NEJMoa1012863.,OADS,/arxiv_data1/oa_pdf/c3/0b/onci-2-e22246.PMC3583911.pdf
Nat Med 2012; In Press; PMID:22842478;  http://dx.doi.org/10.1038/nm.2883.,OADS,/arxiv_data1/oa_pdf/c3/0b/onci-2-e22246.PMC3583911.pdf
Clin Cancer Res  2008; 14:6674-82; PMID:18927310; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/0b/onci-2-e22246.PMC3583911.pdf
Clin Cancer Res 2009; 15:2148-57;  PMID:19276286; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332.,Non-OADS,/arxiv_data1/oa_pdf/c3/0b/onci-2-e22246.PMC3583911.pdf
"Keywords:  cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, signal-interception based therapy,   tumor immunosurveillance *Correspondence to: Eva Zebedin-Brandl; Email: eva-maria.zebedin@meduniwien.ac.at Submitted: 09/15/12; Accepted: 09/17/12http://dx.doi.org/10.4161/onco.22272Citation: Prchal-Murphy M, Putz EM, Freissmuth M, Sexl V, Zebedin-Brandl E. Targeting PI3Kδ:One man’s meat is another man’s poison.",Non-OADS,/arxiv_data1/oa_pdf/5a/a9/onci-2-e22272.PMC3583912.pdf
Clin Cancer Res 2012; 18:4013-8; PMID:22711705; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/a9/onci-2-e22272.PMC3583912.pdf
Blood  2008; 112:4364-5; PMID:19029450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5a/a9/onci-2-e22272.PMC3583912.pdf
Blood 2008; 112:4655-64;  PMID:18684865; http://dx.doi.org/10.1182/blood- 2008-02-139105.,Non-OADS,/arxiv_data1/oa_pdf/5a/a9/onci-2-e22272.PMC3583912.pdf
Leuk Lymphoma  2008; 49:620-4; PMID:18398721; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/a9/onci-2-e22272.PMC3583912.pdf
"4 Such a dual  potential of exosomes suggest that they might consistute an ideal tool for “ther - anostic.” This new discipline of nano - medicine focuses on a multi-disciplinary research approach to build new systems NK cell-released exosomes Natural nanobullets against tumors stefano Fais unit of Antitumor Drugs; Department of t herapeutic r esearch and Medicines e valuation; Istituto s uperiore di s anità; r ome, Italy Keywords:  exosomes, natural killer, nanomedicine, perorin, theranostic Correspondence to: Stefano Fais; Email: stefano.fais@iss.it Submitted: 09/18/12; Accepted: 09/22/12http://dx.doi.org/10.4161/onco.22337Citation: Fais S. NK cell-released exosomes: Natural nanobullets against tumors.",Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
J Exp Med 2002; 195:1303-16; PMID:12021310;  http://dx.doi.org/10.1084/jem.20011624.,Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
Gastroenterology 2005;  128:1796-804; PMID:15940614; http://dx.doi.org/10.1053/j.gastro.2005.03.045.3.,Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
J Biol Chem 2009; 284:34211-22; PMID:19801663; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
J Immunol 2012; 189:2833-42; PMID:22904309; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
J Exp Med  1996; 183:1161-72; PMID:8642258; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
Immunogenetics 2004; 56:360-7; PMID:15322778;  http://dx.doi.org/10.1007/s00251-004-0688-8.7.,Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
Eur J Immunol  1989; 19:1469-75; PMID:2789142; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
Int Immunol 2002; 14:1085-98;  PMID:12356674; http://dx.doi.org/10.1093/intimm/ dxf086.,OADS,/arxiv_data1/oa_pdf/54/d4/onci-2-e22337.PMC3583913.pdf
"1 In this context,  we have observed that BT infiltration by plasmacytoid dendritic cells (pDCs) is associated with an adverse clinical out - come, 2 suggesting that pDCs might con - tribute to the immune evasion of BTs and ultimately to their outgrowth.Plasmacytoid dendritic cells deficient in IFNα  production promote the amplification of FOXP3+  regulatory T cells and are associated with poor  prognosis in breast cancer patients Vanja s isirak, Julien Faget, Nelly Vey, Jean-Yves Blay, Christine Ménétrier-Caux, Christophe Caux and Nathalie Bendriss-Vermare* université de Lyon; Lyon, France; u niversité Lyon 1; I sPB; Lyon, France; IN serM u 1052; Centre de r echerche en Cancérologie de Lyon; Lyon, France; CN rs u Mr5286;   Centre de r echerche en Cancérologie de Lyon; Lyon, France; Lab ex DeVweCAN; Lyon, France; Centre Léon Bérard; Lyon, France Keywords:  breast cancer, immunosuppression, plasmacytoid dendritic cells, regulatory T cells, tolerance *Correspondence to: Nathalie Bendriss-Vermare; Email: nathalie.bendriss-vermare@lyon.unicancer.fr Submitted: 09/19/12; Accepted: 09/22/12http://dx.doi.org/10.4161/onci.22338Citation: Sisirak V, Faget J, Vey N, Blay J-Y, Ménétrier-Caux C, Caux C, et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Nat Med 2012; In press; PMID:22820642;  http://dx.doi.org/10.1038/nm.2830.,OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Cancer  Res 2009; 69:2000-9; PMID:19244125; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Cancer Res  2011; 71:5423-34; PMID:21697280; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Cancer Immunol  Immunother 2012; 61:289-93; PMID:22237887;  http://dx.doi.org/10.1007/s00262-011-1181-5.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Clin Cancer Res 2004; 10:7466-74; PMID:15569976;  http://dx.doi.org/10.1158/1078-0432.CCR-04-0684.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Annu Rev Immunol 2011; 29:163-83;  PMID:21219184; http://dx.doi.org/10.1146/annurev- immunol-031210-101345.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
Eur J Immunol 2010; 40:2667- 76; PMID:20821731; http://dx.doi.org/10.1002/ eji.201040839.,Non-OADS,/arxiv_data1/oa_pdf/1a/6b/onci-2-e22338.PMC3583914.pdf
"Parker1,2,4,* 1research Division; Peter MacCallum Cancer Centre; e ast Melbourne, Australia; 2sir Peter MacCallum Department of Oncology; t he u niversity of Melbourne;   Parkville, Australia; 3Department of Pathology; t he u niversity of Melbourne; Parkville, Australia; 4Department of Biochemistry and Molecular Biology; t he u niversity   of Melbourne; Parkville, Australia; 5Centre for Innate Immunity and Infectious Diseases; Monash Institute of Medical r esearch; Monash u niversity; Clayton, Australia Keywords:  bone metastasis, breast cancer, interferon, tumor immune surveillance *Correspondence to: Belinda S. Parker; Email: belinda.parker@petermac.org Submitted: 09/21/12; Accepted: 09/22/12http://dx.doi.org/10.4161/onco.22339Citation: Slaney CY, Möller A, Hertzog PJ, Parker BS.",Non-OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Clin Cancer Res 2011; 17:1765-75;  PMID:21233400; http://dx.doi.org/10.1158/1078- 0432.CCR-10-2672.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Breast  Cancer Res T reat 1996; 39:235-8; PMID:8872332;  http://dx.doi.org/10.1007/BF01806190.4.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Nat Med 2012; In press; PMID:22820642;  http://dx.doi.org/10.1038/nm.2830.,OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Clin Cancer Res 2011; 17:2619-27; PMID:21372217;  http://dx.doi.org/10.1158/1078-0432.CCR-10-1114.Disclosure of Potential Conflicts of Interest No potential conflicts of interest were  disclosed.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Nat Rev Drug Discov  2012; 11:479-97; PMID:22653217; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Clin Cancer  Res 2012; In press; PMID:22908097; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/14/0b/onci-2-e22339.PMC3583915.pdf
"Parker,2,3 Mark J. smyth2,4 and Andreas Möller1,2,5,* 1Cancer Genomics and Genetics Laboratory; Peter MacCallum Cancer Centre; e ast Melbourne, VIC Australia; 2Department of Pathology and s ir Peter MacCallum Department  of Oncology; t he u niversity of Melbourne; Parkville; VIC Australia; 3Metastasis Laboratory; Peter MacCallum Cancer Centre; e ast Melbourne, VIC Australia;   4Cancer Immunology Program; Peter MacCallum Cancer Centre; e ast Melbourne, VIC Australia; 5tumour Microenvironment Laboratory; Queensland Institute of Medical  research; h erston, QLD Australia Keywords:  bone marrow-derived cells, breast cancer, hypoxia, immunosuppression, NK cells, MDSC, pre-metastatic niche *Correspondence to: Andreas Möller; Email: andreas.moller@qimr.edu.au Submitted: 09/21/12; Accepted: 09/24/12http://dx.doi.org/10.4161/onci.22355Citation: Sceneay J, Parker BS, Smyth MJ, Möller A. Hypoxia-driven immunosuppression contributes to the pre-metastatic niche.",Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Nat Rev Cancer 2009; 9:239-52;  PMID:19279573; http://dx.doi.org/10.1038/nrc2618.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Science  2008; 321:1785-7; PMID:18818347; http://dx.doi.org/10.1126/science.1164853.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Nat Rev Cancer 2009; 9:285-93;  PMID:19308068; http://dx.doi.org/10.1038/nrc2621.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
T rends  Pharmacol Sci 2012; 33:207-14; PMID:22398146;  http://dx.doi.org/10.1016/j.tips.2012.01.005.,OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Cancer Cell 2009; 15:35-44; PMID:19111879; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Cancer Res 2012; 72:3906-11;  PMID:22751463; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3873.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Nature 2005; 438:820-7;  PMID:16341007; http://dx.doi.org/10.1038/ nature04186.,OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Cancer Metastasis Rev 2011; 30:27-43;  PMID:21267772; http://dx.doi.org/10.1007/s10555-011-9268-1.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Cancer Lett 2007; 252:86-92; PMID:17257744; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938;  http://dx.doi.org/10.1038/nri3175.CD3−/NK1.1+ natural killer (NK)  cells were the only other BMDC popu - lation significantly accumulating in the  pre-metastatic lung upon HCM admin - istration.,Non-OADS,/arxiv_data1/oa_pdf/74/81/onci-2-e22355.PMC3583916.pdf
"Such an increase in nuclear DNA content may result from endomitosis (an abor - tive variant of mitosis that fails either before anaphase or at cytokinesis, gen - erating mononucleated or polynucleated tetraploid cells, respectively), cell-to-cell fusion (among somatic cells that express fusogenic proteins, most often of viral ori - gin) or endocycling (DNA replication not An anticancer therapy-elicited  immunosurveillance system that eliminates  tetraploid cells Laura s enovilla,1,2,3 Ilio Vitale,1,2,3 Isabelle Martins,1,2,3 Oliver Kepp,1,2,3 Lorenzo Galluzzi,2,4 Laurence Zitvogel,2,3,5,6   Maria Castedo1,2,3,* and Guido Kroemer1,4,7, 8,9,* 1INserM, u 848; Villejuif, France; 2Institut Gustave r oussy; Villejuif, France; 3université Paris s ud/Paris XI; Le Kremlin Bicêtre, France; 4université Paris Descartes/Paris V;  sorbonne Paris Cité; Paris, France; 5INserM, u 1015; Villejuif, France; 6Center of Clinical Investigations CB t507; Institut Gustave r oussy; Villejuif, France; 7Metabolomics Platform;  Institut Gustave r oussy; Villejuif, France; 8Centre de r echerche des Cordeliers; Paris, France; 9Pôle de Biologie; h ôpital e uropéen Georges Pompidou, AP- hP; Paris, France Keywords:  breast carcinoma, calreticulin, HMGB1, hyperploidy, immunogenic cell death, mitotic catastrophe *Correspondence to: Maria Castedo and Guido Kroemer; Email: castedo@igr.fr and kroemer@orange.fr Submitted: 09/28/12; Accepted: 09/28/12http://dx.doi.org/10.4161/onco.22409Citation: Senovilla L, Vitale I, Martins I, Kepp O, Galluzzi L, Zitvogel L, et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Nat Med 2009; 15:1170-8;  PMID:19767732; http://dx.doi.org/10.1038/nm.2028.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Science 2011; 334:1573- 7; PMID:22174255; http://dx.doi.org/10.1126/sci- ence.1208347.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Nat  Rev Drug Discov 2012; 11:215-33; PMID:22301798;  http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Science 2012; 337:1678- 84; PMID:23019653; http://dx.doi.org/10.1126/sci- ence.1224922.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Nat  Med 2007; 13:54-61; PMID:17187072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
EMBO J 2009; 28:578-90; PMID:19165151;  http://dx.doi.org/10.1038/emboj.2009.1.,Non-OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Nat Med 2007; 13:1050-9;  PMID:17704786; http://dx.doi.org/10.1038/nm1622.References 1.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Annu Rev Cell Dev Biol 2011; 27:585-610;  PMID:21801013; http://dx.doi.org/10.1146/annurev- cellbio-092910-154234.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Curr Opin Genet Dev  2007; 17:157-62; PMID:17324569; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Nature  2005; 437:1043-7; PMID:16222300; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PMID:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/bc/70/onci-2-e22409.PMC3583917.pdf
"1–3 TCRs for gene therapy have Limitations for TCR gene therapy   by MHC-restricted fratricide and TCR-mediated  hematopoietic stem cell toxicity Dolores J. s chendel1,2,* and Bernhard Frankenberger1 1Institute of Molecular Immunology; h elmholtz Zentrum München; German r esearch Center for e nvironmental h ealth; Munich, Germany; 2Clinical Cooperation Group  “Immune Monitoring”; h elmholtz Zentrum München; German r esearch Center for e nvironmental h ealth; Munich, Germany Keywords:  hematopoietic stem cell toxicity, hyluronan-mediated motility receptor, MHC-restricted fratricide, survivin,   TCR gene therapy Abbreviations:  AML, acute myeloid leukemia; CTL, cytotoxic T lymphocyte; DC, dendritic cell; DLI, donor lymphocyte  infusion; GvHD, graft versus host disease; HLA, human leukocyte antigen; HMMR, hyaluronan-mediated motility receptor;  HSC, hematopoietic stem cell; HSCT, HSC transplantation; LSC, leukemic stem cell; MHC, major histocompatibility complex;  PBL, peripheral blood lymphocyte; TCR, T-cell receptor *Correspondence to: Dolores J. Schendel; Email: schendel@helmholtz-muenchen.de Submitted: 09/28/12; Accepted: 09/28/12http://dx.doi.org/10.4161/onci.22410Citation: Schendel DJ, Frankenberger B.",Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Adv Hematol 2012;  2012:404081; PMID:22319532; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Curr Gene Ther 2011; 11:276-87; PMID:21453279; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Nat Rev Immunol 2012; 12:269- 81; PMID:22437939; http://dx.doi.org/10.1038/nri3191.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Clin Cancer Res  2009; 15:5323-37; PMID:19723653; http://dx.doi.org/10.1158/1078-0432.CCR-09-0737.5.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
J Clin Invest  2010; 120:3869-77; PMID:20978348; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Blood 2012; 119:3440-9; PMID:22371883;  http://dx.doi.org/10.1182/blood-2011-06-357939.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
OncoImmunology 2012; 1:129-40;  PMID:22720234; http://dx.doi.org/10.4161/ onci.1.2.18216.8.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Blood  2009; 114:2131-9; PMID:19587379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
J Immunol 2012; 189:598-605; PMID:22689880;  http://dx.doi.org/10.4049/jimmunol.1102165.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
Clin Cancer Res 2008; 14:7161-6; PMID:19010831;  http://dx.doi.org/10.1158/1078-0432.CCR-08-1102.,Non-OADS,/arxiv_data1/oa_pdf/40/05/onci-2-e22410.PMC3583918.pdf
"CD73 is highly expressed on  the surface of several types of cancer cells The adenosinergic system in cancer Key therapeutic target rosalinda s orrentino, Aldo Pinto and s ilvana Morello* Department of Pharmaceutical and Biomedical s ciences; u niversity of s alerno; s alerno, Italy Keywords:  adenosine, adenosine receptors, ATP, CD73, tumor immunity *Correspondence to: Silvana Morello; Email: smorello@unisa.it Submitted: 10/02/12; Accepted: 10/04/12http://dx.doi.org/10.4161/onci.22448Citation: Sorrentino R, Pinto A, Morello S. The adenosinergic system in cancer: Key therapeutic target.",Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
Oncogene 2010; 29:5346- 58; PMID:20661219; http://dx.doi.org/10.1038/ onc.2010.292.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
T rends Immunol 2012; 33:231-7; PMID:22487321;  http://dx.doi.org/10.1016/j.it.2012.02.009.,OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
Cancer Res 2010; 70:6407-11; PMID:20682793;  http://dx.doi.org/10.1158/0008-5472.CAN-10-1544.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
J Immunol 2012;  189:2226-33; PMID:22826317; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
J Exp Med 2007; 204:2103-14; PMID:17698588;  http://dx.doi.org/10.1084/jem.20062571.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
Eur J Immunol 2005; 35:31- 41; PMID:15580656; http://dx.doi.org/10.1002/ eji.200425524.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
PLoS One 2012; 7:e45401;  PMID:23028986; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
Cancer Res 2010; 70:855-8;  PMID:20086177; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3566.,Non-OADS,/arxiv_data1/oa_pdf/a3/9c/onci-2-e22448.PMC3583919.pdf
"An effective immunization by TAAs expressed by autologous tumor cells requires the uptake of these cells (or their debris) by antigen-presenting cells (APCs), which present In situ conversion of tumors into autologous  tumor-associated antigen vaccines by  intratumoral injection of α-gal glycolipids uri Galili Departments of s urgery; u niversity of Massachusetts Medical s chool; w orcester, MA us A Keywords:  α-gal epitopes, anti-Gal, autologous tumor vaccine, cancer immunotherapy Correspondence to: Uri Galili; Email: Uri.Galili@umassmed.edu Submitted: 10/02/12; Accepted: 10/02/12http://dx.doi.org/10.4161/onci.22449Citation: Galili U.",Non-OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
Immunol Today 1993; 14:480-2; PMID:7506033; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
Cancer Immunol Immunother  2009; 58:1545-56; PMID:19184002; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
J Exp Med 1984; 160:1519- 31; PMID:6491603; http://dx.doi.org/10.1084/ jem.160.5.1519.,Non-OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460;  http://dx.doi.org/10.1056/NEJMoa020177.,OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
Science  2006; 313:1960-4; PMID:17008531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
Semin Immunol 1996; 8:289-93; PMID:8956457;  http://dx.doi.org/10.1006/smim.1996.0037.,Non-OADS,/arxiv_data1/oa_pdf/7b/14/onci-2-e22449.PMC3583920.pdf
"2,3 Curative treatment  options, like liver resection, liver trans - plantation and image-guided percuta - neous ablation, are limited to very early T-cell suppression mediated by regulatory T cells  infiltrating hepatic tumors can be overcome by  GITRL treatment Alexander Pedroza-Gonzalez,1,* Jaap Kwekkeboom1 and Dave s prengers2,* 1Department of Gastroenterology and h epatology; e rasmus MC- university Medical Center; rotterdam, t he Netherlands;   2Department of Gastroenterology and h epatology; Academic Medical Center; Amsterdam, t he Netherlands Keywords:  colorectal cancer, GITRL, immunotherapy, hepatocellular carcinoma, liver cancer, liver metastasis, regulatory T cells, T cells Abbreviations:  GITR, glucocorticoid-induced tumor necrosis factor receptor; HCC, hepatocellular carcinoma; ICOS, inducible  T-cell costimulator; LM-CRC, liver metastases from colorectal cancer; Tregs, regulatory T cells; Ti-Tregs, tumor-infiltrating Tregs *Correspondence to: Alexander Pedroza-Gonzalez and Dave Sprengers; Email: a.pedrozagonzalez@erasmusmc.nl and d.sprengers@amc.uva.nl Submitted: 10/03/12; Accepted: 10/04/12http://dx.doi.org/10.4161/onci.22450Citation: Pedroza-Gonzalez A, Kwekkeboom J, Sprengers D. T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment.",Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Annu  Rev Immunol 2009; 27:147-63; PMID:19302037;  http://dx.doi.org/10.1146/annurev.immu- nol.021908.132629.,Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Curr  Opin Oncol 2010; 22:364-73; PMID:20520544;  http://dx.doi.org/10.1097/CCO.0b013e32833a6c8a.,OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Oncoimmunology 2012; 1:48-55;  PMID:22720211; http://dx.doi.org/10.4161/ onci.1.1.18344.,Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Nat Rev Cancer 2012; 12:265-77;  PMID:22437871; http://dx.doi.org/10.1038/nrc3258.5.,Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
J Exp Med 2011; 208:479- 90; PMID:21339324; http://dx.doi.org/10.1084/ jem.20102131.,Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Nat Med 2004; 10:942-9;  PMID:15322536; http://dx.doi.org/10.1038/nm1093.,OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Hepatology 2012; In  Press; PMID:22911397; http://dx.doi.org/10.1002/ hep.26013.8.,Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
Cancer Res  2011; 71:6143-52; PMID:21852386; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/ef/onci-2-e22450.PMC3583921.pdf
"Nicolas van Baren,1,2,3,* Jean-François Baurain2 and Pierre G. Coulie3 1Ludwig Institute for Cancer r esearch Ltd; Brussels, Belgium; 2Medical Oncology Department; Centre du Cancer des Cliniques u niversitaires s aint-Luc; Brussels, Belgium;   3de Duve Institute; u niversité Catholique de Louvain; Brussels, Belgium Keywords:  ectopic lymphoid structures, germinal center, humoral response, IgA, lymphoid neogenesis, melanoma, metastasis *Correspondence to: Nicolas van Baren; Email: nicolas.vanbaren@bru.licr.org Submitted: 10/09/12; Accepted: 10/09/12http://dx.doi.org/10.4161/onco.22505Citation: van Baren N, Baurain J-F, Coulie PG.",Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
Cancer Res 2012; 72:3997-4007;  PMID:22850419; http://dx.doi.org/10.1158/0008- 5472.CAN-12-1377.,Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
T rends Immunol 2012; 33:297- 305; PMID:22622061; http://dx.doi.org/10.1016/j.it.2012.04.006.3.,OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
Science 1991; 254:1643- 7; PMID:1840703; http://dx.doi.org/10.1126/sci- ence.1840703.,OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
Annu Rev Immunol 2006; 24:175-208;  PMID:16551247; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
Cancer Res 2011; 71:6391-9;  PMID:21900403; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0952.6.,Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
J Clin Oncol  2008; 26:4410-7; PMID:18802153; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
Cancer Res 2011; 71:5678-87;  PMID:21846823; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0431.,Non-OADS,/arxiv_data1/oa_pdf/91/4b/onci-2-e22505.PMC3583922.pdf
"3The role of soluble CD40L in immunosuppression Jeffrey s chlom,* Caroline Jochems, James L. Gulley and Jianping h uang Laboratory of t umor Immunology and Biology; Center for Cancer r esearch; National Cancer Institute; National Institutes of h ealth; Bethesda, MD us A Keywords:  immunosuppression, myeloid derived suppressor cells (MDSC), regulatory T cells (Tregs), sCD40L, vaccine therapy *Correspondence to: Jeffrey Schlom; Email: js141c@nih.gov Submitted: 10/10/12; Accepted: 10/13/12http://dx.doi.org/10.4161/onco.22546Citation: Schlom J, Jochems C, Gulley JL, Huang J.",Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Clin Cancer Res  2008; 14:3536-44; PMID:18519787; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Science  2006; 313:1960-4; PMID:17008531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Am Heart J 2006; 151:521.e1-521.e4; PMID:16442924;  http://dx.doi.org/10.1016/j.ahj.2005.10.021.5.,OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Cancer Immunol Immunother  2010; 59:663-74; PMID:19890632; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
J Urol 2005; 173:790-6; PMID:15711271; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Clin Cancer Res 2010; 16:3100-4; PMID:20421432;  http://dx.doi.org/10.1158/1078-0432.CCR-09-2891.References 1.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Clin Cancer Res 2004; 10:610-4;  PMID:14760083; http://dx.doi.org/10.1158/1078- 0432.CCR-0348-03.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
Neoplasma 2010; 57:145-50; PMID:20099978;  http://dx.doi.org/10.4149/neo_2010_02_145.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
J Clin Oncol  2010; 28:1099-105; PMID:20100959; http://dx.doi.org/10.1200/JCO.2009.25.0597.,Non-OADS,/arxiv_data1/oa_pdf/85/eb/onci-2-e22546.PMC3583923.pdf
"Tumor cells can secrete exosomes, Unraveling the physiological functions of  exosome secretion by tumors Angélique Bobrie and Clotilde t héry* Institut Curie s ection r echerché; Paris, France; IN serM u 932; Paris, France Keywords:  exosomes, extracellular vesicles, Rab27a, tumor immunity *Correspondence to: Clotilde Théry; Email: clotilde.thery@curie.fr Submitted: 10/11/12; Accepted: 10/15/12http://dx.doi.org/10.4161/onco.22565Citation: Bobrie A, Théry C. Unraveling the physiological functions of exosome secretion by tumors.",Non-OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
T raffic 2011; 12:1659-68; PMID:21645191;  http://dx.doi.org/10.1111/j.1600-0854.2011.01225.x.,Non-OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
J Exp Med  1996; 183:1161-72; PMID:8642258; http://dx.doi.org/10.1084/jem.183.3.1161.,Non-OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
Nat Med 1998; 4:594-600;  PMID:9585234; http://dx.doi.org/10.1038/nm0598-594.,OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
Nat Med 2001; 7:297-303; PMID:11231627;  http://dx.doi.org/10.1038/85438.,OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
Biotech Histochem  2012; 87:161-8; PMID:22216980; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
"Nat  Cell Biol 2010; 12:19-30, 1-13; PMID:19966785;  http://dx.doi.org/10.1038/ncb2000.",OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
Cancer Res 2012; 72:4920-30; PMID:22865453;  http://dx.doi.org/10.1158/0008-5472.CAN-12-0925.,Non-OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
Journal of Extracellular Vesicles 2012; 1:18397;  http://dx.doi.org/10.3402/jev.v1i0.18397.,Non-OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
Biol  Reprod 2012; 86:82; PMID:22133690; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/05/onci-2-e22565.PMC3583924.pdf
"A flexible and specific cell targeting sys - tem for LVs is based on engineered measles virus (MV) glycoproteins, enabling LVs to Cell type specific gene delivery by lentiviral  vectors New options in immunotherapy Qi Zhou and Christian J. Buchholz* Molecular Biotechnology and Gene t herapy; Paul- ehrlich-Institut; Langen, Germany Keywords:  gene transfer, lentiviral vector, CD8+ T lymphocytes, tumor, targeting *Correspondence to: Christian J. Buchholz; Email: christian.buchholz@pei.de Submitted: 10/13/12; Accepted: 10/15/12http://dx.doi.org/10.4161/onco.22566Citation: Zhou Q, Buchholz CJ.",Non-OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
J Immunol 2011; 187:654-63;  PMID:21677135; http://dx.doi.org/10.4049/jimmu- nol.1003941.5.,Non-OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
T rends Biotechnol 2009; 27:259- 65; PMID:19327858; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
Mol Ther 2011; 19:686- 93; PMID:21224833; http://dx.doi.org/10.1038/ mt.2010.298.,Non-OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
Mol Ther 2008; 16:1427-36; PMID:18578012;  http://dx.doi.org/10.1038/mt.2008.128.,OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
Hum Gene Ther 2011; 22:1249-54; PMID:21247346;  http://dx.doi.org/10.1089/hum.2010.184.References 1.,OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
Nat Rev Immunol 2012; 12:269-81;  PMID:22437939; http://dx.doi.org/10.1038/nri3191.,Non-OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
Nat Methods 2010; 7:929- 35; PMID:20935652; http://dx.doi.org/10.1038/ nmeth.1514.,OADS,/arxiv_data1/oa_pdf/0e/e1/onci-2-e22566.PMC3583925.pdf
"Arthur Localio Laboratory; New York u niversity s chool of Medicine; New York, NY us A;   2Department of Cell Biology; New York u niversity s chool of Medicine; New York, NY us A Keywords:  cancer-associated inflammation, dendritic cells, innate immunity, MYD88, pancreatic cancer,   pattern-recognition receptors, Toll-like receptors, tumor microenvironment *Correspondence to: George Miller; Email: george.miller@nyumc.org Submitted: 10/15/12; Accepted: 10/15/12http://dx.doi.org/10.4161/onco.22567Citation: Zambirinis CP , Miller G. Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword.",Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
Cell 2010; 140:805-20;  PMID:20303872; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
J Clin Invest 2012; PMID:23023703; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
J Exp Med 2012; 209:1671- 87; PMID:22908323; http://dx.doi.org/10.1084/jem.20111706.,Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
T rends Immunol  2012; 33:449-58; PMID:22721918; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
Immunity 2008; 29:12-20; PMID:18631453;  http://dx.doi.org/10.1016/j.immuni.2008.06.004.,OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
Nat Rev Immunol  2003; 3:984-93; PMID:14647480; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
Annu Rev Immunol 2010; 28:367-88;  PMID:20192808; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
J Exp Med 2011; 208:469- 78; PMID:21339327; http://dx.doi.org/10.1084/ jem.20101876.7.,Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/ onci.20696.,Non-OADS,/arxiv_data1/oa_pdf/f3/97/onci-2-e22567.PMC3583926.pdf
"www.landesbioscience.com OncoImmunology e22590-1OncoImmunology 2:1, e22590; January 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Shao-An Xue and Hans J. Stauss; Email: shao-an.xue@ucl.ac.uk and h.stauss@ucl.ac.uk Submitted: 09/17/12; Revised: 10/15/12; Accepted: 10/18/12http://dx.doi.org/10.4161/onci.22590.Citation: Xue S, Gao L, Ahmadi M, Ghorashian S, Barros RD, Pospori C, et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Supplemental Material Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/22590(CD4 + plus CD8+) EBV-specific T cells.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Hum Gene Ther 2003; 14:1155-68; PMID:12908967; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Blood 2003; 102:3530- 40; PMID:12869497; http://dx.doi.org/10.1182/ blood-2003-05-1524.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Nat Immunol 2001; 2:957-61;  PMID:11577349; http://dx.doi.org/10.1038/ni1001- 957.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Science 2006; 314:126-9; PMID:16946036;  http://dx.doi.org/10.1126/science.1129003.,OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Blood Rev 2006; 20:61-9; PMID:15978709; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Blood 2005; 106:3062-7;  PMID:16020516; http://dx.doi.org/10.1182/blood- 2005-01-0146.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Nat Immunol 2001; 2:962-70;  PMID:11577350; http://dx.doi.org/10.1038/ni1001- 962.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Immunol Today 1999; 20:180-3;  PMID:10203716; http://dx.doi.org/10.1016/S0167- 5699(99)01443-7.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Clin Oncol 2011; 29:917- 24; PMID:21282551; http://dx.doi.org/10.1200/JCO.2010.32.2537.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
N Engl J Med 2008; 358:2698-703; PMID:18565862;  http://dx.doi.org/10.1056/NEJMoa0800251.,OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Exp Med 2010; 207:637-50; PMID:20156971;  http://dx.doi.org/10.1084/jem.20091918.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Blood 2007; 110:2838-45; PMID:17609424;  http://dx.doi.org/10.1182/blood-2007-05-091280.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Virol 2010; 84:407- 17; PMID:19846527; http://dx.doi.org/10.1128/JVI.01303-09.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Clin Invest 2011; 121:4043- 55; PMID:21946257; http://dx.doi.org/10.1172/ JCI57147.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Immunol  2009; 183:1587-97; PMID:19587004; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Cancer Res 2007; 67:3898-903; PMID:17440104; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3986.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Cancer Res 2006; 66:8878-86; PMID:16951205;  http://dx.doi.org/10.1158/0008-5472.CAN-06-1450.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Blood 2007; 109:2331-8; PMID:17082316;  http://dx.doi.org/10.1182/blood-2006-05-023069.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Immunol 2010; 184:6223-31; PMID:20483785;  http://dx.doi.org/10.4049/jimmunol.0902055.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Immunogenetics 1985; 21:235-46; PMID:3872841; http://dx.doi.org/10.1007/ BF00375376.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Haematologica 2010; 95:126-34;  PMID:19679884; http://dx.doi.org/10.3324/haema- tol.2009.006486.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Exp Med 2001; 194:1043- 52; PMID:11602635; http://dx.doi.org/10.1084/ jem.194.8.1043.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
J Immunol 2010; 184:5988-98; PMID:20427771;  http://dx.doi.org/10.4049/jimmunol.1000189.,Non-OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
Nat Biotechnol 2005; 23:349-54; PMID:15723046;  http://dx.doi.org/10.1038/nbt1070.,OADS,/arxiv_data1/oa_pdf/1d/27/onci-2-e22590.PMC3583927.pdf
"Mattarollo1,2,* and Mark J. s myth1,3 1Cancer Immunology Program; Peter MacCallum Cancer Centre; e ast Melbourne, Victoria, Australia; 2the u niversity of Queensland Diamantina Institute;   Princess Alexandra h ospital; w oolloongabba, Queensland, Australia; 3sir Peter MacCallum Department of Oncology; u niversity of Melbourne; Victoria, Australia Keywords:  NKT cells, α -galactosylceramide, hematological malignancies, immunotherapy, tumor vaccine, immune adjuvants *Correspondence to: Stephen R. Mattarollo; Email: s.mattarollo@uq.edu.au Submitted: 10/13/12; Accepted: 10/21/12http://dx.doi.org/10.4161/onci.22615.Citation: Mattarollo SR, Smyth MJ.",Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
Int J Cancer 2004; 109:402- 11; PMID:14961579; http://dx.doi.org/10.1002/ ijc.11723.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
Blood 2008; 111:5637-45; PMID:18417738;  http://dx.doi.org/10.1182/blood-2007-05-092866.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
Blood 2012; 120:3019-29;  PMID:22932803; http://dx.doi.org/10.1182/blood- 2012-04-426643.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
Immunol Cell Biol 2012; In  press; PMID:23090488; http://dx.doi.org/10.1038/ icb.2012.58.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
J Exp Med 2007; 204:2641- 53; PMID:17923500; http://dx.doi.org/10.1084/jem.20070458.8.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
J Clin Invest  2011; 121:683-94; PMID:21245578; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
Blood 2004; 103:383-9; PMID:14512316;  http://dx.doi.org/10.1182/blood-2003-04-1155.,Non-OADS,/arxiv_data1/oa_pdf/28/a3/onci-2-e22615.PMC3583928.pdf
"Antibody levels are most com - monly used as correlates of protection, Predicting the efficacy of cancer vaccines   by evaluating T-cell responses suzanne van Duikeren and r amon Arens* Department of Immunohematology and Blood t ransfusion; Leiden u niversity Medical Center; Leiden, t he Netherlands Keywords:  cancer, T-cell responses, vaccines *Correspondence to: Ramon Arens; Email: R.Arens@lumc.nl Submitted: 10/16/12; Accepted: 10/21/12http://dx.doi.org/10.4161/onci.22616Citation: van Duikeren S, Arens R. Predicting the efficacy of cancer vaccines by evaluating T-cell responses.",Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
Adv Immunol 2012; 114:217-43;  PMID:22449784; http://dx.doi.org/10.1016/B978-0- 12-396548-6.00009-3.,Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
Curr Opin HIV AIDS 2007; 2:116- 22; PMID:19372876; http://dx.doi.org/10.1097/ COH.0b013e3280287a4d.5.,Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
Clin Vaccine Immunol 2010; 17:1055- 65; PMID:20463105; http://dx.doi.org/10.1128/ CVI.00131-10.,Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
J Immunol 2012;  189:3397-403; PMID:22914049; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
Nature 2011; 473:523-7; PMID:21562493;  http://dx.doi.org/10.1038/nature10003.References 1.,Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
Curr Opin Immunol 1997; 9:684-93;  PMID:9368778; http://dx.doi.org/10.1016/S0952- 7915(97)80050-7.,Non-OADS,/arxiv_data1/oa_pdf/26/13/onci-2-e22616.PMC3583929.pdf
"www.landesbioscience.com OncoImmunology e22620-1OncoImmunology 2:1, e22620; January 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Sorin Armeanu-Ebinger; Email: armeanu@uni-tuebingen.de Submitted: 08/09/12; Revised: 10/22/12; Accepted: 10/22/12http://dx.doi.org/10.4161/onci.22620.Citation: Armeanu-Ebinger S, Hoh A, Wenz J, Fuchs J.",Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
"CD45 is a tyrosine-protein phosphatase expressed on leuko - cytes and is overexpressed in up to 50% of HB cases, as revealed by a gene expression analysis (http://www.ebi.ac.uk/arrayex - press/experiments/E-MEXP-1851, data not shown).",Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Gene array analysis per - formed with hepatic tumor tissue from HB patients after several rounds of cytostatic drug application confirm our results in vivo (http://www.ebi.ac.uk/arrayexpress/experiments/E-EXP-1851).,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Mild toxicity was observed despite EpCAM expres - sion in normal liver cells including biliary duct and hepatic stem cells (http://clinicaltrials.gov/).,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Lancet 2000; 356:1981-2;  PMID:11130529; http://dx.doi.org/10.1016/S0140- 6736(00)03312-2.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Am J Clin Pathol 2008; 129:424- 9; PMID:18285265; http://dx.doi.org/10.1309/ H8JEEAEB69J3KYND.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
"Am J Obstet Gynecol  2010; 203:582, e1-7; PMID:20870202; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Cancer Res 2008; 68:1451-61;  PMID:18316609; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6013.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Oncogene  2004; 23:5748-58; PMID:15195135; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Br J Cancer 2007; 96:417-23;  PMID:17211480; http://dx.doi.org/10.1038/ sj.bjc.6603494.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Cancer  Res 2009; 69:5627-9; PMID:19584271; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Annu Rev Immunol 2000; 18:975-1026; PMID:10837080; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Hum Pathol 1983; 14:512-37;  PMID:6303939; http://dx.doi.org/10.1016/S0046-8177(83)80005-7.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Pediatr Radiol 2006; 36:187-91; PMID:16404555; http://dx.doi.org/10.1007/s00247- 005-0067-0.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Oncologist 2008; 13:812-20; PMID:18644850; http://dx.doi.org/10.1634/theoncologist.2008-0011.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
N  Engl J Med 2008; 359:378-90; PMID:18650514; http://dx.doi.org/10.1056/NEJMoa0708857.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Pediatr T ransplant 2009; 13:148-9; PMID:18764910;  http://dx.doi.org/10.1111/j.1399-3046.2008.01015.x.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
J Pathol 2000; 191:102-3;  PMID:10767726; http://dx.doi.org/10.1002/ (SICI)1096-9896(200005)191:1<102::AID- PATH542>3.0.CO;2-X.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Liver Int 2010; 30:102-11;  PMID:19793197; http://dx.doi.org/10.1111/j.1478- 3231.2009.02126.x.(BioGenex).,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Clin Dev Immunol 2011; 2011:587315; PMID:21253470;  http://dx.doi.org/10.1155/2011/587315.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Clin Dev Immunol  2010; 2010:732893; PMID:20396597; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Microbes Infect 1999; 1:175-86; PMID:10594981;  http://dx.doi.org/10.1016/S1286-4579(99)80032-X.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Cytotherapy 2008; 10:842-56; PMID:19016372; http://dx.doi.org/10.1080/14653240802419328.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Cancer Cell  2008; 14:471-84; PMID:19061838; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
J Clin Oncol 2010; 28:2584- 90; PMID:20406943; http://dx.doi.org/10.1200/ JCO.2009.22.4857.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Cancer  Res 2010; 70:7830-40; PMID:20940408; http://dx.doi.org/10.1158/0008-5472.CAN-10-0833.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Cancer Res 2007; 67:10831-9; PMID:18006828;  http://dx.doi.org/10.1158/0008-5472.CAN-07-0908.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
MAbs 2011; 3:31-7; PMID:21107020; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Immunobiology 2009; 214:441-53; PMID:19157637; http://dx.doi.org/10.1016/j.imbio.2008.11.014.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Mol Immunol  2006; 43:763-71; PMID:16360021; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Clin Cancer Res 2012; 18:465-74;  PMID:22096026; http://dx.doi.org/10.1158/1078- 0432.CCR-11-1270.33.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
PLoS One 2010; 5:e13474; PMID:20976159; http://dx.doi.org/10.1371/journal.pone.0013474.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
BMC  Cancer 2010; 10:501; PMID:20858262; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Pediatr Blood Cancer 2006; 46:501-5;  PMID:15806543; http://dx.doi.org/10.1002/ pbc.20404.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
Leuk Res  2010; 34:1139-42; PMID:20378168; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
PLoS One 2011; 6:e23419;  PMID:21853130; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
BMC Cancer 2011; 11:362; PMID:21854558;  http://dx.doi.org/10.1186/1471-2407-11-362.,Non-OADS,/arxiv_data1/oa_pdf/7b/d1/onci-2-e22620.PMC3583930.pdf
"www.landesbioscience.com OncoImmunology e22647-1OncoImmunology 2:1, e22647; January 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Amy M. Fulton; Email: afulton@umaryland.edu Submitted: 09/14/12; Revised: 10/23/12; Accepted: 10/23/12http://dx.doi.org/10.4161/onci.22647.Citation: Ma X, Holt D, Kundu N, Reader J, Goloubeva O, Take Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Immunol Immunother 2011; 60:1577-86;  PMID:21681369; http://dx.doi.org/10.1007/s00262- 011-1064-9.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
J Immunother 2012; 35:179-88; PMID:22306906;  http://dx.doi.org/10.1097/CJI.0b013e318247a5e9.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Exp Cell Res 2003; 289:265-74; PMID:14499627;  http://dx.doi.org/10.1016/S0014-4827(03)00269-6.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res 2006; 66:2923-7;  PMID:16540639; http://dx.doi.org /10.1158/0008- 5472.CAN-05-4348.7.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res 2006; 66:9794-7; PMID:17047037; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Breast Cancer Res T reat  2009; 117:235-42; PMID:18792778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Breast Cancer Res T reat 2012; 132:1001-8;  PMID:21761157; http://dx.doi.org/10.1007/s10549- 011-1675-z.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Life Sci 2008; 82:226- 32; PMID:18155068; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
J Clin Invest  2011; 121:3609-22; PMID:21841316; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Gastroenterolology 2011; 140:596-607;  PMID:21070778; http://dx.doi.org/10.1053/j.gas- tro.2010.11.007.13.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Proc Natl Acad Sci U S A 2009;  106:20847-52; PMID:19934056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
J Leukoc Biol 2010; 88:839- 48; PMID:20587738; http://dx.doi.org/10.1189/ jlb.1209821.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res  2012; 72:1407-15; PMID:22258454; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Curr Cancer  Drug Targets 2007; 7:31-40; PMID:17305476; http://dx.doi.org/10.2174/156800907780006896.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer  Metastasis Rev 2011; 30:449-63; PMID:22002714; http://dx.doi.org/10.1007/s10555-011-9303-2.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
J Biol Chem 2008; 283:3433-44; PMID:18083712;  http://dx.doi.org/10.1074/jbc.M705409200.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Proc Natl Acad Sci U S  A 2006; 103:1492-7; PMID:16432186; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res 2006; 66:9665-72;  PMID:17018624; http://dx.doi.org/10.1158/0008-5472.CAN-06-1271.24.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res  2009; 69:896-904; PMID:19176380; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res 2008; 68:7750-9; PMID:18829529; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6689.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res  2010; 70:1606-15; PMID:20145136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Res 2006; 66:3106-13; PMID:16540660; http://dx.doi.org/10.1158/0008-5472.CAN-05-3702.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Oncogene 2007; 26:3006-19; PMID:17130837;  http://dx.doi.org/10.1038/sj.onc.1210113.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Cancer Biol Ther 2012; 13:175-83; PMID:22353936;  http://dx.doi.org/10.4161/cbt.13.3.18874.,Non-OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
Exp Cell Res 2007; 313:2969- 79; PMID:17631291; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/cc/onci-2-e22647.PMC3583931.pdf
"Formerly, STAT3 was thought to act in pathways Involvement of STAT3 in immune evasion during  lung tumorigenesis hiroshi Kida,1,* shoichi Ihara1 and Atsushi Kumanogoh1,2 1Department of r espiratory Medicine, Allergy and r heumatic Diseases; Osaka u niversity Graduate s chool of Medicine; s uita, Osaka, Japan;   2Core r esearch for e volutionary s cience and t echnology (C rest ); Japan s cience and t echnology Agency (J st); Osaka u niversity Graduate s chool of Medicine; s uita, Osaka, Japan Keywords:  antitumor immunity, lung, MHC Class I, MICA, NK cell, STAT3, tumorigenesis Abbreviations:  MHC, major histocompatibility complex; NK, natural killer; NSCLC, non-small cell lung carcinoma;   STAT3, signal transducer and activator of transcription 3 *Correspondence to: Hiroshi Kida; Email: hiroshi.kida@imed3.med.osaka-u.ac.jp Submitted: 10/20/12; Accepted: 10/24/12http://dx.doi.org/10.4161/onci.22653Citation: Kida H, Ihara S, Kumanogoh A.",Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
Cell  1999; 98:295-303; PMID:10458605; http://dx.doi.org/10.1016/S0092-8674(00)81959-5.,OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
N  Engl J Med 2012; 366:1905-13; PMID:22591296;  http://dx.doi.org/10.1056/NEJMoa1114885.,OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
PLoS One 2012; 7:e30820;  PMID:22319590; http://dx.doi.org/10.1371/journal.pone.0030820.,Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
Nat Rev Immunol 2007; 7:41-51; PMID:17186030; http://dx.doi.org/10.1038/nri1995.,Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
Cancer  Res 2012; 72:2990-9; PMID:22659452; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
Blood 2005; 105:2428- 35; PMID:15536145; http://dx.doi.org/10.1182/ blood-2004-09-3458.,Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
Cancer Cell 2012;  22:7-8; PMID:22789534; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
"Immunity 1999; 10:39- 49; PMID:10023769; http://dx.doi.org/10.1016/ S1074-7613(00)80005-9.Consequently, STAT3 blockade in can - cer cells results in NK-cell activation.",Non-OADS,/arxiv_data1/oa_pdf/2d/1b/onci-2-e22653.PMC3583932.pdf
"www.landesbioscience.com OncoImmunology e22664-1OncoImmunology 2:1, e22664; January 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: George Coukos; Email: gcks@mail.med.upenn.edu Submitted: 09/14/12; Revised: 10/25/12; Accepted: 10/25/12http://dx.doi.org/10.4161/onci.22664.Citation: Kandalaft LE, Powell Jr DJ, Chiang CL, Tanyi J, Kim S, Bosch M, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Semin Immunol 1998; 10:443- 8; PMID:9826577; http://dx.doi.org/10.1006/ smim.1998.0147.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Curr Opin Immunol 1998; 10:444-9;  PMID:9722921; http://dx.doi.org/10.1016/S0952- 7915(98)80119-2.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Nat Med 2004; 10:942-9;  PMID:15322536; http://dx.doi.org/10.1038/nm1093.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Nat Med 2008; 14:28-36;  PMID:18157142; http://dx.doi.org/10.1038/nm1699.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Clin Cancer Res 2009; 15:4521-8;  PMID:19567593; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0543.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Clin Cancer Res 2007; 13:3951-9;  PMID:17606729; http://dx.doi.org/10.1158/1078-0432.CCR-07-0374.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Expert  Opin Biol Ther 2005; 5:1193-210; PMID:16120050;  http://dx.doi.org/10.1517/14712598.5.9.1193.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460; http://dx.doi.org/10.1056/NEJMoa020177.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Proc Natl Acad Sci U S A 2005; 102:18538-43; PMID:16344461; http://dx.doi.org/10.1073/ pnas.0509182102.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Cancer Epidemiol  Biomarkers Prev 2006; 15:1014-20; PMID:16702385;  http://dx.doi.org/10.1158/1055-9965.EPI-05-0334.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Proc Natl Acad Sci U S A 2007;  104:12837-42; PMID:17652518; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Clin Immunol 2004; 112:45-53; PMID:15207781;  http://dx.doi.org/10.1016/j.clim.2004.04.002.,OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Semin Immunol 2008; 20:286- 95; PMID:18951039; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Supplemental Materials Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/22664/ 20.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Clin Exp Immunol  2007; 150:523-30; PMID:17956583; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Cancer Res 2010; 70:6171-80; PMID:20631075;  http://dx.doi.org/10.1158/0008-5472.CAN-10-0153.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
J Immunol 2011; 187:6130-42; PMID:22048768;  http://dx.doi.org/10.4049/jimmunol.1102209.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
J Immunother  2010; 33:211-8; PMID:20139774; http://dx.doi.org/10.1097/CJI.0b013e3181bb499f.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Cancer Immunol Immunother  2007; 56:641-8; PMID:16960692; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
J Clin Oncol 2009; 27:5911-8; PMID:19805669; http://dx.doi.org/10.1200/JCO.2009.23.3494.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Cancer Immunol Immunother 2012; 61:629-41;  PMID:22021066; http://dx.doi.org/10.1007/s00262- 011-1081-8.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
Clin Cancer Res 2005; 11:5515-25; PMID:16061868;  http://dx.doi.org/10.1158/1078-0432.CCR-05-0464.,Non-OADS,/arxiv_data1/oa_pdf/dd/77/onci-2-e22664.PMC3583933.pdf
"www.landesbioscience.com OncoImmunology e22789-1OncoImmunology 2:1, e22789; January 2013; © 2013 Landes BioscienceREVIEW  REVIEW *Correspondence to: Guido Kroemer and Lorenzo Galluzzi;  Email: kroemer@orange.fr and deadoc@vodafone.itSubmitted: 11/05/12; Accepted: 11/05/12http://dx.doi.org/10.4161/onci.22789Citation: Vacchelli E, Eggermont A, Galon J, Sautés-Fridman C, Zitvogel L, Kroemer G, et al.",Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nature  1975; 256:495-7; PMID:1172191; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Science 1993; 262:1271- 4; PMID:8235658; http://dx.doi.org/10.1126/sci- ence.8235658.4.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 1985; 313:337-42; PMID:2861567;  http://dx.doi.org/10.1056/NEJM198508083130601.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Immunol 2010; 10:317-27; PMID:20414205;  http://dx.doi.org/10.1038/nri2744.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938.7.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:306-15; PMID:22737606; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
OncoImmunology 2012; 1:1111-34; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:172-80; PMID:22178121; http://dx.doi.org/10.1016/ S1470-2045(11)70303-5.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med  2011; 365:2473-83; PMID:22204724; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2011; 365:2484- 96; PMID:22204725; http://dx.doi.org/10.1056/ NEJMoa1103799.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:608- 15; PMID:22253466; http://dx.doi.org/10.1200/ JCO.2011.38.9650.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl  J Med 2012; 366:299-309; PMID:22276820; http://dx.doi.org/10.1056/NEJMoa1111065.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2012; 366:310-20; PMID:22276821; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol  2012; 13:375-84; PMID:22377126; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:1476-83; PMID:22430271; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:1534- 40; PMID:22454414; http://dx.doi.org/10.1200/ JCO.2011.39.4767.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin  Oncol 2012; 30:2039-45; PMID:22529265; http://dx.doi.org/10.1200/JCO.2012.42.0505.25.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Cancer 2011; 2:309-16; PMID:21716847;  http://dx.doi.org/10.7150/jca.2.309.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2002; 20:2453- 63; PMID:12011122; http://dx.doi.org/10.1200/ JCO.2002.11.076.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Cancer 2007; 7:95-106;  PMID:17251916; http://dx.doi.org/10.1038/nrc2051.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat  Rev Drug Discov 2012; 11:215-33; PMID:22301798;  http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:346- 50; PMID:22737611; http://dx.doi.org/10.4161/ onci.18800.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:544-6; PMID:22754781;  http://dx.doi.org/10.4161/onci.19442.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Drug Discov 2012; 11:19-20;  PMID:22212672; http://dx.doi.org/10.1038/nrd3629.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Biotechnol 2012; 30:631-7; PMID:22781692;  http://dx.doi.org/10.1038/nbt.2289.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Clin Oncol  2011; 9:76-8; PMID:22182971; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:3968- 76; PMID:21844504; http://dx.doi.org/10.1200/ JCO.2011.36.2236.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:4436-41; PMID:21969504;  http://dx.doi.org/10.1200/JCO.2011.35.6923.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:4286- 93; PMID:21990397; http://dx.doi.org/10.1200/ JCO.2010.34.1255.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2011; 29:4662-8; PMID:22067389; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:699-716; PMID:22934262; http://dx.doi.org/10.4161/ onci.20696.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
OncoImmunology 2012; 1:894-907; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
OncoImmunology 2012; 1:  In press; http://dx.doi.org/10.4161/onci.22428.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
OncoImmunology 2012; 1: In press;  http://dx.doi.org/10.4161/onci.22009.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res  2008; 14:502-8; PMID:18223225; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Drug  Discov 2004; 3:391-400; PMID:15136787; http://dx.doi.org/10.1038/nrd1381.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Immunity  2006; 24:19-28; PMID:16413920; http://dx.doi.org/10.1016/j.immuni.2005.11.010.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:103-5; PMID:22720225; http://dx.doi.org/10.4161/ onci.1.1.17963.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Front Biosci 2011; 16:277-306;  PMID:21196171; http://dx.doi.org/10.2741/3688.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cell Res 2010; 20:34-50; PMID:20010915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med  2002; 346:235-42; PMID:11807147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:75- 7; PMID:22720216; http://dx.doi.org/10.4161/ onci.1.1.17825.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med  2012; 367:520-31; PMID:22873532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:3037-43; PMID:21709185; http://dx.doi.org/10.1200/JCO.2010.33.8038.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2011; 29:3419-26; PMID:21810686; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:33-42; PMID:22056021;  http://dx.doi.org/10.1016/S1470-2045(11)70318-7.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:1505-12; PMID:22412142; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:1755- 62; PMID:22473155; http://dx.doi.org/10.1200/ JCO.2011.38.0915.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:1620-7; PMID:22473163; http://dx.doi.org/10.1200/ JCO.2011.39.6036.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:2615-23; PMID:22665533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:509-17; PMID:22326922; http://dx.doi.org/10.1016/S1470- 2045(12)70007-4.60.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:2585- 92; PMID:22689807; http://dx.doi.org/10.1200/ JCO.2011.35.6725.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2011; 12:773-84;  PMID:21724462; http://dx.doi.org/10.1016/S1470- 2045(11)70150-4.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:3396- 401; PMID:21810681; http://dx.doi.org/10.1200/JCO.2010.33.6594.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:3559- 66; PMID:21844497; http://dx.doi.org/10.1200/ JCO.2010.33.8061.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:3990-8; PMID:21931035;  http://dx.doi.org/10.1200/JCO.2011.34.8508.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol  2011; 12:1013-22; PMID:21940214; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:830- 6; PMID:22312100; http://dx.doi.org/10.1200/JCO.2011.37.0296.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:716-23;  PMID:22677155; http://dx.doi.org/10.1016/S1470- 2045(12)70200-0.50.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:2509-15; PMID:22665541; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2011; 29:3366-73; PMID:21768458; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:3351- 7; PMID:21788566; http://dx.doi.org/10.1200/ JCO.2010.31.4930.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2011; 365:1273- 83; PMID:21991949; http://dx.doi.org/10.1056/ NEJMoa0910383.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:4491-7;  PMID:22042958; http://dx.doi.org/10.1200/JCO.2011.36.7045.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:25-32;  PMID:22153890; http://dx.doi.org/10.1016/S1470- 2045(11)70336-9.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:135- 44; PMID:22257523; http://dx.doi.org/10.1016/ S1470-2045(11)70397-7.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet 2012; 379:633-40;  PMID:22257673; http://dx.doi.org/10.1016/S0140- 6736(11)61847-3.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:2545-51; PMID:22665540; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Int J Radiat Oncol Biol Phys  2002; 54:1479-84; PMID:12459374; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res  2011; 17:6888-96; PMID:21989064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Blood  2009; 113:5905-10; PMID:19332764; http://dx.doi.org/10.1182/blood-2009-02-205476.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Exp Cell Res 2011; 317:1255- 60; PMID:21419116; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:2493-8; PMID:21576633; http://dx.doi.org/10.1200/JCO.2010.32.7270.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Blood 2012; In press; PMID:23024237;  http://dx.doi.org/10.1182/blood-2012-07-441030.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:477-86; PMID:22754766;  http://dx.doi.org/10.4161/onci.19864.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Eur J Cancer 1995; 31A:261-7; PMID:7718335; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Immunother Emphasis T umor Immunol  1996; 19:206-17; PMID:8811495; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:256-62; PMID:22184397; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2012; 366:109-19; PMID:22149875;  http://dx.doi.org/10.1056/NEJMoa1113216.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:1594-600; PMID:22393084; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:1960-5; PMID:22291084; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:1953-9; PMID:22547589; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nature 2012; 483:100- 3; PMID:22281684; http://dx.doi.org/10.1038/ nature10868.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res  2005; 11:1551-62; PMID:15746060; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cell Death Differ 2012; 19:107-20; PMID:21760595; http://dx.doi.org/10.1038/cdd.2011.96.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cell Death Differ  2009; 16:3-11; PMID:18846107; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Mol Cell Biol 2011; 12:385- 92; PMID:21527953; http://dx.doi.org/10.1038/ nrm3115.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:501-8;  PMID:22326924; http://dx.doi.org/10.1016/S1470- 2045(12)70006-2.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:459-65;  PMID:22456429; http://dx.doi.org/10.1016/S1470-2045(12)70090-6.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:2046-54; PMID:22547592;  http://dx.doi.org/10.1200/JCO.2011.38.4032.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol  2011; 12:1204-13; PMID:21992852; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2012; 30:1647-55; PMID:22493413; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet 2012; 379:39-46;  PMID:22093187; http://dx.doi.org/10.1016/S0140- 6736(11)61226-9.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lancet Oncol 2012; 13:403-11;  PMID:22357140; http://dx.doi.org/10.1016/S1470- 2045(11)70386-2.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2012; 30:2776-82; PMID:22753910; http://dx.doi.org/10.1200/ JCO.2011.39.4403.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol 2011; 29:4534-40; PMID:22025154;  http://dx.doi.org/10.1200/JCO.2010.33.0670.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Lung Cancer 2011; 71:55-9; PMID:20451284;  http://dx.doi.org/10.1016/j.lungcan.2010.04.010.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res 2010; 16:1915-23; PMID:20197484;  http://dx.doi.org/10.1158/1078-0432.CCR-09-2425.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Biol Ther  2012; 13:600-5; PMID:22555809; http://dx.doi.org/10.4161/cbt.19849.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Invest New Drugs 2012; 30:1138-43;  PMID:21170759; http://dx.doi.org/10.1007/s10637- 010-9619-8.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Invest New Drugs 2011; 29:996-1003; PMID:20454832;  http://dx.doi.org/10.1007/s10637-010-9444-0.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Invest New Drugs 2012; 30:1585-90;  PMID:21901403; http://dx.doi.org/10.1007/s10637- 011-9735-0.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res 2012;  18:3414-27; PMID:22510349; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Natl Cancer Inst 2012; 104:975-81; PMID:22761272; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Discov 2012; 2:OF4; PMID:23071056; http://dx.doi.org/10.1158/2159-8290.CD-NB2012-100.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:86-8; PMID:22318430;  http://dx.doi.org/10.4161/onci.1.1.17824.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:735-8; PMID:22934265;  http://dx.doi.org/10.4161/onci.20823.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Res 2007; 67:6253-62;  PMID:17616683; http://dx.doi.org/10.1158/0008- 5472.CAN-07-0538.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2004; 350:2129- 39; PMID:15118073; http://dx.doi.org/10.1056/ NEJMoa040938.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Rev Drug Discov 2005; (Suppl): S10-1; PMID:15962524; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat  Rev Drug Discov 2006; 5:987-8; PMID:17201026; http://dx.doi.org/10.1038/nrd2204.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:71-4; PMID:22720215; http://dx.doi.org/10.4161/ onci.1.1.18073.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Chemother Pharmacol 2011; 67:837-45;  PMID:20563810; http://dx.doi.org/10.1007/s00280- 010-1379-9.117.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
BMC Cancer 2011; 11:21; PMID:21244693;  http://dx.doi.org/10.1186/1471-2407-11-21.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
N Engl J Med 2003; 349:2184- 6; PMID:14657423; http://dx.doi.org/10.1056/ NEJMp038156.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res 2011; 17:6304-12;  PMID:21810918; http://dx.doi.org/10.1158/1078-0432.CCR-10-3336.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res 2011; 17:6052-60; PMID:21750201;  http://dx.doi.org/10.1158/1078-0432.CCR-10-2979.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Clin Cancer Res  2012; 18:2625-31; PMID:22465830; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Clin Oncol  2011; 29:e638-40; PMID:21606420; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J Thorac Oncol 2012; 7:419-26; PMID:22237261;  http://dx.doi.org/10.1097/JTO.0b013e31823c5b11.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Ann Oncol 2012; 23:2834-42;  PMID:22700995; http://dx.doi.org/10.1093/annonc/ mds142.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Chemother Pharmacol 2012; 70:407-14;  PMID:22810805; http://dx.doi.org/10.1007/s00280- 012-1924-9.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Nat Clin Pract  Oncol 2007; 4:136-7; PMID:17327854; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Oncoimmunology 2012; 1:326-33; PMID:22737608;  http://dx.doi.org/10.4161/onci.18852.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Immunol Immunother 2012; 61:1137-47; PMID:22210552; http://dx.doi.org/10.1007/s00262- 011-1193-1.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Cancer Metastasis Rev 2011; 30:111-24; PMID:21267767; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Invest New Drugs  2012; PMID:22828917; http://dx.doi.org/10.1007/ s10637-012-9857-z.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Prostate 2011; 71:1455-65; PMID:21321981; http://dx.doi.org/10.1002/pros.21362.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Curr  Opin Pharmacol 2008; 8:433-9; PMID:18625341; http://dx.doi.org/10.1016/j.coph.2008.06.011.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
BioDrugs  2009; 23:289-304; PMID:19754219; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
J  Clin Oncol 2010; 28:780-7; PMID:20048182; http://dx.doi.org/10.1200/JCO.2009.23.7537.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
Br J Haematol 1998; 102:783-90; PMID:9722307; http://dx.doi.org/10.1046/j.1365- 2141.1998.00835.x.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/onci-2-e22789.PMC3583934.pdf
"*Correspondence to: Adam J. Adler; Email: aadler@up.uchc.edu Submitted: 10/31/12; Revised: 11/06/12; Accepted: 11/09/12http://dx.doi.org/10.4161/onci.22837Citation: Adler AJ, Vella AT.",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
N Engl J Med 2006; 355:2408-17; PMID:17151364; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
N Engl J Med  2010; 363:809-19; PMID:20818844; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 1998; 396:643-9;  PMID:9872311; http://dx.doi.org/10.1038/25292.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cell 2011; 144:27-40; PMID:21215367;  http://dx.doi.org/10.1016/j.cell.2010.11.055.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
PLoS One 2009; 4:e6094; PMID:19593447;  http://dx.doi.org/10.1371/journal.pone.0006094.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev Immunol 2004; 4:595-602; PMID:15286726;  http://dx.doi.org/10.1038/nri1413.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol 2008; 26:741-66;  PMID:18173374; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Mucosal Immunol  2009; 2:403-11; PMID:19587639; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol  2010; 28:445-89; PMID:20192806; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Immunol 2003; 4:330-6;  PMID:12612578; http://dx.doi.org/10.1038/ni904.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cell 2000; 101:455-8;  PMID:10850488; http://dx.doi.org/10.1016/S0092- 8674(00)80856-9.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2001; 193:F41-6;  PMID:11390442; http://dx.doi.org/10.1084/ jem.193.11.F41.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 2004; 10:942-9;  PMID:15322536; http://dx.doi.org/10.1038/nm1093.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2005; 201:779-91;  PMID:15753211; http://dx.doi.org/10.1084/ jem.20041684.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunity 2007; 27:635-46;  PMID:17919943; http://dx.doi.org/10.1016/j.immu- ni.2007.08.014.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Curr Opin  Immunol 2010; 22:231-7; PMID:20144856; http://dx.doi.org/10.1016/j.coi.2010.01.009.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cell 1987; 49:273- 80; PMID:3494522; http://dx.doi.org/10.1016/0092-8674(87)90568-X.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev  Immunol 2005; 5:772-82; PMID:16200080; http://dx.doi.org/10.1038/nri1707.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunol Rev 2003; 193:58-69; PMID:12752671; http://dx.doi.org/10.1034/j.1600-065X.2003.00047.x.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol  2003; 21:305-34; PMID:12471050; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cell 1990; 63:1249-56; PMID:2148123;  http://dx.doi.org/10.1016/0092-8674(90)90420-J.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Science 1991; 251:1225-8;  PMID:1900951; http://dx.doi.org/10.1126/sci- ence.1900951.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 1998; 392:245-52;  PMID:9521319; http://dx.doi.org/10.1038/32588.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol  2001; 19:23-45; PMID:11244029; http://dx.doi.org/10.1146/annurev.immunol.19.1.23.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol 2002; 20:197-216;  PMID:11861602; http://dx.doi.org/10.1146/annurev.immunol.20.083001.084359.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 1992; 356:607-9; PMID:1313950;  http://dx.doi.org/10.1038/356607a0.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 2001; 411:1058-64; PMID:11429607;  http://dx.doi.org/10.1038/35082583.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunity 2002; 17:737-47; PMID:12479820;  http://dx.doi.org/10.1016/S1074-7613(02)00480-6.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Int Immunol 2000; 12:1539-46; PMID:11058573;  http://dx.doi.org/10.1093/intimm/12.11.1539.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 2003; 425:516-21; PMID:14520412;  http://dx.doi.org/10.1038/nature01991.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 2007; 13:1050-9;  PMID:17704786; http://dx.doi.org/10.1038/nm1622.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol 2003; 21:807-39;  PMID:12615893; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Immunol 2002; 3:991-8;  PMID:12407406; http://dx.doi.org/10.1038/ni1102- 991.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2004; 200:1581-92; PMID:15596524;  http://dx.doi.org/10.1084/jem.20041240.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 1996; 184:747-52; PMID:8760829; http://dx.doi.org/10.1084/ jem.184.2.747.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature  1998; 393:478-80; PMID:9624004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature  1998; 393:480-3; PMID:9624005; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 1998; 393:474-8;  PMID:9624003; http://dx.doi.org/10.1038/30989.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med  1999; 190:1717-22; PMID:10587362; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Proc Natl Acad Sci U S  A 1998; 95:1178-83; PMID:9448305; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunity  1999; 11:483-93; PMID:10549630; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Blood 2001; 98:1070- 7; PMID:11493453; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Prostate 2007; 67:536- 46; PMID:17221844; http://dx.doi.org/10.1002/ pros.20549.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2002;  195:423-35; PMID:11854356; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Annu Rev Immunol  2005; 23:23-68; PMID:15771565; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2001; 194:769-79; PMID:11560993;  http://dx.doi.org/10.1084/jem.194.6.769.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunity 2008; 28:521-32; PMID:18387832; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunol  Rev 1997; 157:217-22; PMID:9255632; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 1993; 178:489- 95; PMID:8340755; http://dx.doi.org/10.1084/ jem.178.2.489.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med  1996; 184:2207-16; PMID:8976176; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 1997; 185:453-9; PMID:9053445; http://dx.doi.org/10.1084/ jem.185.3.453.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Science 1994; 264:716-9; PMID:7513441;  http://dx.doi.org/10.1126/science.7513441.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med  1994; 179:1005-9; PMID:8113668; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Int Immunol  2002; 14:275-86; PMID:11867564; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
T rends Immunol 2002; 23:378-80; PMID:12133793;  http://dx.doi.org/10.1016/S1471-4906(02)02263-9.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
T rends Immunol 2005; 26:440- 6; PMID:15979409; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunol Rev 2011; 244:55-74;  PMID:22017431; http://dx.doi.org/10.1111/j.1600- 065X.2011.01055.x.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 1993; 178:669-74; PMID:7688031; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Blood 2007; 110:2501-10; PMID:17575071;  http://dx.doi.org/10.1182/blood-2007-01-070748.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat  Med 2006; 12:693-8; PMID:16680149; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunology 2004; 112:559-66;  PMID:15270726; http://dx.doi.org/10.1111/j.1365-2567.2004.01917.x.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Int J Cancer  2005; 116:934-43; PMID:15856473; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Eur J Immunol 2008; 38:2499- 511; PMID:18792403; http://dx.doi.org/10.1002/ eji.200838208.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 1997; 3:682-5;  PMID:9176498; http://dx.doi.org/10.1038/nm0697- 682.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J  Immunother 2010; 33:769-79; PMID:20842060; http://dx.doi.org/10.1097/CJI.0b013e3181ee238f.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cancer Res 2006; 66:4904-12;  PMID:16651447; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2813.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunol Rev 2011; 244:218-31;  PMID:22017441; http://dx.doi.org/10.1111/j.1600- 065X.2011.01069.x.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev Immunol  2003; 3:745-56; PMID:12949498; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunity  1999; 11:699-708; PMID:10626892; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 1997; 186:47- 55; PMID:9206996; http://dx.doi.org/10.1084/ jem.186.1.47.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Eur J Immunol 2004; 34:743-51; PMID:14991604;  http://dx.doi.org/10.1002/eji.200324278.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Blood  2012; 120:4772-82; PMID:22993390; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 1999; 5:780-7; PMID:10395323;  http://dx.doi.org/10.1038/10503.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 1999; 5:774-9;  PMID:10395322; http://dx.doi.org/10.1038/10495.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med  1998; 188:297-304; PMID:9670042; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Eur J Immunol 2006; 36:1093- 103; PMID:16541471; http://dx.doi.org/10.1002/eji.200535637.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Clin Cancer Res  2010; 16:2861-71; PMID:20460488; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
N Engl J Med 2006; 355:1018- 28; PMID:16908486; http://dx.doi.org/10.1056/NEJMoa063842.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Semin Oncol 2010; 37:508-16; PMID:21074066; http://dx.doi.org/10.1053/j.semi - noncol.2010.09.008.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Expert Opin Investig Drugs 2000; 9:103-11; PMID:11060664; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Eur J Immunol  2008; 38:2678-88; PMID:18825741; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Blood 2005; 106:2002- 10; PMID:15941918; http://dx.doi.org/10.1182/ blood-2004-04-1622.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Eur J Immunol  2008; 38:2678-88; PMID:18825741; http://dx.doi.org/10.1002/eji.200838250.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cold Spring Harb Symp Quant Biol 2005; 70:479-82; PMID:16869786; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature  2010; 468:973-7; PMID:21107323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Cancer Cell 2010; 18:683- 95; PMID:21156289; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nature 2010; 468:968-72; PMID:21107320;  http://dx.doi.org/10.1038/nature09627.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
N Engl J  Med 2012; 366:2455-65; PMID:22658128; http://dx.doi.org/10.1056/NEJMoa1200694.141.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Int J Cancer 1997; 71:142-7; PMID:9139833;  http://dx.doi.org/10.1002/(SICI)1097- 0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Blood 2001; 97:835-43; PMID:11159505; http://dx.doi.org/10.1182/blood.V97.4.835.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Proc Natl Acad Sci U S A 2002; 99:16168- 73; PMID:12427970; http://dx.doi.org/10.1073/ pnas.242600099.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunity 2009; 31:84-98; PMID:19559631; http://dx.doi.org/10.1016/j.immuni.2009.05.007.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Science  2012; 335:984-9; PMID:22323740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Immunother Emphasis  T umor Immunol 1996; 19:81-4; PMID:8859727;  http://dx.doi.org/10.1097/00002371-199601000- 00009.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2000;  192:1637-44; PMID:11104805; http://dx.doi.org/10.1084/jem.192.11.1637.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Clin Oncol  2006; 24:2283-9; PMID:16710025; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Proc Natl Acad Sci U S A 2008; 105:14987- 92; PMID:18818309; http://dx.doi.org/10.1073/ pnas.0806075105.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
N Engl J Med  2009; 361:211-2; PMID:19587352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Immunol 2011; 187:3555-64; PMID:21880986;  http://dx.doi.org/10.4049/jimmunol.1101244.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev Immunol 2002; 2:933-44;  PMID:12461566; http://dx.doi.org/10.1038/nri954.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev Immunol  2004; 4:900-11; PMID:15516969; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Int J Cancer  1984; 33:239-43; PMID:6319303; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Immunol Today  1995; 16:487-94; PMID:7576053; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2010; 207:637-50; PMID:20156971;  http://dx.doi.org/10.1084/jem.20091918.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Science 2003; 302:1041-3; PMID:14605368; http://dx.doi.org/10.1126/sci- ence.1090148.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Immunol 2005; 6:1236-44;  PMID:16273099; http://dx.doi.org/10.1038/ni1268.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Rev Cancer 2002; 2:389-96;  PMID:12044015; http://dx.doi.org/10.1038/nrc801.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
World J Urol 1996; 14:329- 37; PMID:8912473; http://dx.doi.org/10.1007/ BF00184606.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 2004; 10:33-9;  PMID:14702632; http://dx.doi.org/10.1038/nm972.,OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Androgen ablation mitigates  tolerance to a prostate/prostate cancer-restricted anti- gen. Cancer Cell 2005; 7:239-49; PMID:15766662;  http://dx.doi.org/10.1016/j.ccr.2005.01.027.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Nat Med 2001; 7:907-12; PMID:11479622;  http://dx.doi.org/10.1038/90942.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2005; 202:1691-701; PMID:16365148; http://dx.doi.org/10.1084/jem.20050915.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
J Exp Med 2009; 206:1103- 16; PMID:19414558; http://dx.doi.org/10.1084/ jem.20082205.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138.168.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
PLoS One 2011; 6:e19499; PMID:21559358; http://dx.doi.org/10.1371/journal.pone.0019499.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
Eur J Immunol 2011; 41:2217- 28; PMID:21538347; http://dx.doi.org/10.1002/ eji.201041235.,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/onci-2-e22837.PMC3583935.pdf
"In particu - lar, TYK2 is never solely responsible for cytokine signaling, but  *Correspondence to: Susetta Finotto; Email: susetta.finotto@uk-erlangen.de Submitted: 09/28/12; Accepted: 11/09/12http://dx.doi.org/10.4161/onci.22840Citation: Übel C, Mousset S, Trufa D, Sirbu H, Finotto S. Establishing the role of tyrosine kinase 2 in cancer.",Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Immunol Rev 2009; 228:273- 87; PMID:19290934; http://dx.doi.org/10.1111/ j.1600-065X.2008.00754.x.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Front Biosci 2011; 16:3214-32; PMID:21622231;  http://dx.doi.org/10.2741/3908.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Mol Biol  2010; 400:413-33; PMID:20478313; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Immunity  2000; 13:549-60; PMID:11070173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Immunity 2000; 13:561-71;  PMID:11070174; http://dx.doi.org/10.1016/S1074-7613(00)00055-8.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Immunity 2006; 25:695-7; PMID:17098200; http://dx.doi.org/10.1016/j.immuni.2006.10.007.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Biochem  Pharmacol 2006; 72:1538-46; PMID:16750817;  http://dx.doi.org/10.1016/j.bcp.2006.04.013.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cytokine  2009; 47:149-56; PMID:19648026; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Nat Rev Mol Cell Biol  2002; 3:651-62; PMID:12209125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cell 1992; 70:313-22; PMID:1386289;  http://dx.doi.org/10.1016/0092-8674(92)90105-L. 12.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Pediatr 2012; 160:1055-7; PMID:22402565; http://dx.doi.org/10.1016/j.jpeds.2012.01.056.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Immunol 2011; 187:181-9;  PMID:21606247; http://dx.doi.org/10.4049/jimmu-nol.1003244.15.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Immunol 2009; 183:7539-46; PMID:19917699;  http://dx.doi.org/10.4049/jimmunol.0902740.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Immunol 2009; 182:7776-83; PMID:19494301; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Clin Immunol  2009; 29:815-25; PMID:19653082; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Nat Immunol 2003; 4:471- 7; PMID:12679810; http://dx.doi.org/10.1038/ni910.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Eur J  Immunol 2004; 34:519-29; PMID:14768057; http://dx.doi.org/10.1002/eji.200324465.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Nat Med 2012; 18:693-704; PMID:22561833; http://dx.doi.org/10.1038/nm.2755.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cancer Immunol Immunother  2012; 61:1355-7; PMID:22911119; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cancer Immunol Immunother 2012; 61:1521-5;  PMID:22042251; http://dx.doi.org/10.1007/s00262-011-1127-y.29.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cancer Immunol Immunother 2012; 61:1547-64;  PMID:22139135; http://dx.doi.org/10.1007/s00262- 011-1162-8.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Eur J Cancer 2006; 42:3028-33; PMID:16945522; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Oncogene 2000; 19:5662-79; PMID:11114747; http://dx.doi.org/10.1038/ sj.onc.1203925.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Biochem Biophys  Res Commun 2008; 369:292-6; PMID:17920038;  http://dx.doi.org/10.1016/j.bbrc.2007.08.160.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Mol Cell Proteomics 2008; 7:163-9; PMID:17934210;  http://dx.doi.org/10.1074/mcp.M700115-MCP200.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Gynecol Oncol  2009; 112:248-56; PMID:19007971; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cancer Res 2009; 69:203-11;  PMID:19118004; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1705.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Int Immunol  2006; 18:425-34; PMID:16415100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Breast Cancer  Res 2007; 9:R32; PMID:17531096; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
N Engl J Med 2008; 359:1367-80; PMID:18815398;  http://dx.doi.org/10.1056/NEJMra0802714.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Surg Oncol Clin N  Am 2011; 20:701-20; PMID:21986267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Lancet 2009; 374:379-86;  PMID:19632716; http://dx.doi.org/10.1016/S0140- 6736(09)60737-6.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Ann Oncol 2005; 16(Suppl  1):i28-9; PMID:15888743; http://dx.doi.org/10.1093/annonc/mdi821.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Lung Cancer 2010; 67:257-74; PMID:19914732; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Pneumologie  2007; 61:162-70; PMID:17342577; http://dx.doi.org/10.1055/s-2007-959159.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Thorac Oncol  2012; 7:1417-22; PMID:22895139; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Clin Oncol  2005; 23:8081-92; PMID:16204011; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Clin Invest 2007; 117:3846-56; PMID:18060032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Nature 2012; 489:155-9; PMID:22820254;  http://dx.doi.org/10.1038/nature11303.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Proc Natl Acad Sci U S A 2009; 106:8368- 73; PMID:19416831; http://dx.doi.org/10.1073/ pnas.0903392106.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Arthritis Rheum 2009; 60:2558-64; PMID:19714582;  http://dx.doi.org/10.1002/art.24748.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Arthritis Res  Ther 2009; 11:R69; PMID:19442287; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Immunol 2011; 187:4611-20; PMID:21957150;  http://dx.doi.org/10.4049/jimmunol.1100649.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Med Chem 2011; 54:284- 8; PMID:21155605; http://dx.doi.org/10.1021/ jm101157q.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cancer Res 2006; 66:9714-21;  PMID:17018630; http://dx.doi.org/10.1158/0008- 5472.CAN-05-4280.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Mammary Gland Biol Neoplasia 2009; 14:121-9;  PMID:19424782; http://dx.doi.org/10.1007/s10911- 009-9124-x.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Oncogene  2012; PMID:22824799; http://dx.doi.org/10.1038/onc.2012.205.42.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Clin Exp Metastasis  2012; 29:143-53; PMID:22116632; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Interferon Cytokine  Res 2011; 31:671-7; PMID:21864028; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Cancer Res 2007; 67:465-73; PMID:17234753;  http://dx.doi.org/10.1158/0008-5472.CAN-06-1736.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Blood 2008; 111:4797-808; PMID:18270328; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
J Biol Chem 2006; 281:16238- 44; PMID:16601124; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Mol Cell Biol  2006; 26:8562-71; PMID:16982690; http://dx.doi.org/10.1128/MCB.00497-06.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
PLoS One 2011; 6:e19861;  PMID:21625473; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Science 2002; 296:1653- 5; PMID:12040185; http://dx.doi.org/10.1126/sci- ence.1071545.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
Blood  2008; 111:5663-71; PMID:17984313; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/2b/onci-2-e22840.PMC3583936.pdf
"*Correspondence to: Fathia Mami-Chouaib; Email: cfathia@igr.fr Submitted: 09/29/12; Accepted: 11/09/12http://dx.doi.org/10.4161/onci.22841Citation: Tabbekh M, Mokrani-Hammani M, Bismuth G, Mami-Chouaib F. T-cell modulatory properties of CD5 and its role in antitumor immune responses.",Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Nat Immunol 2004; 5:1143-8; PMID:15475958;  http://dx.doi.org/10.1038/ni1129.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med 1997; 186:65-70; PMID:9206998;  http://dx.doi.org/10.1084/jem.186.1.65.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med  2007; 204:345-56; PMID:17261634; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Oncogene 2010; 29:1093- 102; PMID:19946335; http://dx.doi.org/10.1038/onc.2009.416.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Immunol Rev 2006; 213:131-45; PMID:16972901; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Immunol 2010; 185:7133-40; PMID:21127315; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med 2010; 207:2187- 94; PMID:20819927; http://dx.doi.org/10.1084/ jem.20100643.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Immunother 2010; 33:225- 35; PMID:20445343; http://dx.doi.org/10.1097/ CJI.0b013e3181c01fcb.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Cancer Res 2011; 71:3540-51;  PMID:21430066; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0096.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med 2010; 207:2175-86; PMID:20819923;  http://dx.doi.org/10.1084/jem.20100637.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Eur J Immunol 1997; 27:679-86; PMID:9079809; http://dx.doi.org/10.1002/ eji.1830270316.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Biol Chem  2011; 286:30324-36; PMID:21757751; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med 1985; 162:802- 22; PMID:2863322; http://dx.doi.org/10.1084/ jem.162.3.802.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med 2001; 194:1253- 61; PMID:11696591; http://dx.doi.org/10.1084/ jem.194.9.1253.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med  2001; 193:1179-87; PMID:11369789; http://dx.doi.org/10.1084/jem.193.10.1179.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Immunity 1999; 11:173-81;  PMID:10485652; http://dx.doi.org/10.1016/S1074- 7613(00)80092-8.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med  2003; 197:1007-16; PMID:12707300; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Immunity 2004; 20:695-705; PMID:15189735;  http://dx.doi.org/10.1016/j.immuni.2004.05.002.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Immunol Cell Biol 2010; 88:451-60; PMID:20065997;  http://dx.doi.org/10.1038/icb.2009.109.32.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Clin Invest 1990;  85:130-4; PMID:1688565; http://dx.doi.org/10.1172/ JCI114402.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Eur J Immunol 1994; 24:1678- 84; PMID:7517879; http://dx.doi.org/10.1002/ eji.1830240733.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Immunol Lett 2008; 119:103-13; PMID:18573278;  http://dx.doi.org/10.1016/j.imlet.2008.05.008.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Eur J Immunol 2009; 39:2233-47; PMID:19609976; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Blood  2011; 118:6107-14; PMID:21926348; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
"Blood 2012; 119:4810-2, author reply 4812-3;  PMID:22596172; http://dx.doi.org/10.1182/blood-2012-02-409722.",Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Immunol Res  2002; 26:255-63; PMID:12403363; http://dx.doi.org/10.1385/IR:26:1-3:255.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Biol Chem 2003; 278:8564- 71; PMID:12473675; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Eur J Immunol 2002;  32:1811-7; PMID:12115665; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Nat Immunol 2002; 3:611-8;  PMID:12087419; http://dx.doi.org/10.1038/ni0702- 611.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Nature 1986; 323:346-9;  PMID:3093892; http://dx.doi.org/10.1038/323346a0.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Proc Natl Acad Sci U S A 1987;  84:204-8; PMID:3025855; http://dx.doi.org/10.1073/ pnas.84.1.204.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Eur J Immunol 1992; 22:2995-3000; PMID:1385158;  http://dx.doi.org/10.1002/eji.1830221135.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Exp Med 1996; 184:811-9; PMID:9064341; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Int Immunol 1998; 10:1185- 96; PMID:9723705; http://dx.doi.org/10.1093/ intimm/10.8.1185.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Nature 1991; 351:662-5;  PMID:1711157; http://dx.doi.org/10.1038/351662a0.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Tissue Antigens  1999; 54:16-26; PMID:10458319; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Immunol 2010; 185:6068-74; PMID:20952682;  http://dx.doi.org/10.4049/jimmunol.0903823.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Immunotoxicol 2012; 9:241-7; PMID:22524673;  http://dx.doi.org/10.3109/1547691X.2012.678021.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Nat Rev Cancer  2008; 8:299-308; PMID:18354418; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
J Immunol 2011; 187:102-9;  PMID:21622855; http://dx.doi.org/10.4049/jimmu- nol.1004145.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.61.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Clin Immunol Immunopathol  1995; 77:253-61; PMID:7586735; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
Hum Immunol 2000; 61:65-73;  PMID:10658979; http://dx.doi.org/10.1016/S0198- 8859(99)00156-1.,OADS,/arxiv_data1/oa_pdf/2d/eb/onci-2-e22841.PMC3583937.pdf
"Pollack; Email: bppolla@emory.edu Submitted: 10/23/12; Revised: 11/13/12; Accepted: 11/14/12http://dx.doi.org/10.4161/onci.22890Citation: Sapkota B, Hill CE, Pollack BP.",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
"Consistent with what  we observed with PLX4720, vemurafenib enhanced the induc - tion of MHC Class I molecules and β 2-microglobulin (B2M) and clinical trials to test such combinations are underway (http://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
www.landesbioscience.com OncoImmunology e22890-5Trust Sanger Institute database (http://www.sanger.ac.uk).,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
"31 We used BEZ235 a dual PI3K/mammalian target  of rapamycin (mTOR) inhibitor, as it is currently being tested in clinical trials (http://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J Am AcadDermatol2011; 65(Suppl  1):S78.e1-S78.e10; PMID:22018071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
N Engl J Med 2005; 353:2135- 47; PMID:16291983; http://dx.doi.org/10.1056/ NEJMoa050092.,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
N Engl J Med 2011;  364:2507-16; PMID:21639808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Nature 2011; 480:387-90;  PMID:22113612; http://dx.doi.org/10.1038/ nature10662.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J Cell Biochem 2012; 113:725-34; PMID:22006439; http://dx.doi.org/10.1002/ jcb.23402.7.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466.,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393;  http://dx.doi.org/10.1158/1078-0432.CCR-11-0116.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
N Engl J Med 2011; 364:2119- 27; PMID:21631324; http://dx.doi.org/10.1056/ NEJMoa1012863.,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Curr Opin Immunol  2011; 23:293-8; PMID:21295956; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Nat Rev Cancer  2008; 8:299-308; PMID:18354418; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J  ClinOncol 2009; 27:6199-206; PMID:19917835;  http://dx.doi.org/10.1200/JCO.2009.23.4799.13.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Cancer ImmunolImmunother  2011; 60:1359-71; PMID:21847631; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J Immunol  2012; 188:2630-42; PMID:22312128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Clin Cancer Res 2011; 17:6118-24; PMID:21705455; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0482.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Cancer Res 2010; 70:5213-9; PMID:20551059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
OncoImmunology 2012; 1:0-7; PMID:22720206;  http://dx.doi.org/10.4161/onci.21940.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Clin  Cancer Res 2012; 18:5329-40; PMID:22850568;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1632.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Oncoimmunology 2012;  1:71-4; PMID:22720215; http://dx.doi.org/10.4161/ onci.1.1.18073.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J T ransl Med 2010; 8:67; PMID:20630094; http://dx.doi.org/10.1186/1479- 5876-8-67.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Cancer Res  2006; 66:6405-11; PMID:16778219; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Photochem Photobiol  2009; 85:652-62; PMID:19076306; http://dx.doi.org/10.1111/j.1751-1097.2008.00485.x.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Mol Cancer Ther 2007; 6:2220- 9; PMID:17699719; http://dx.doi.org/10.1158/1535- 7163.MCT-06-0728.29.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
N Engl J Med  2010; 363:809-19; PMID:20818844; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Clin Cancer Res  2010; 16:6040-8; PMID:21169256; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Pigment Cell & Melanoma Research 2009; 22:400-19;  PMID:19493313; http://dx.doi.org/10.1111/j.1755-148X.2009.00585.x.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Immunity 1994; 1:447-56; PMID:7895156;  http://dx.doi.org/10.1016/1074-7613(94)90087-6.,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Immunogenetics 2008; 60:439-47; PMID:18545995;  http://dx.doi.org/10.1007/s00251-008-0303-5.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Int J Cancer 2012; 131:387- 95; PMID:21964766; http://dx.doi.org/10.1002/ ijc.26471.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Carcinogenesis 2012; 33:687-93;  PMID:22219178; http://dx.doi.org/10.1093/carcin/ bgr318.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Clin Cancer Res 2012; 18:1386-94;  PMID:22156613; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2479.19.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Mol Cancer  Res 2006; 4:779-92; PMID:17050671; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Cancer Res 2012; 72:3928-37;  PMID:22693252; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2837.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Int J Cancer 1998; 75:590-5; PMID:9466661;  http://dx.doi.org/10.1002/(SICI)1097- 0215(19980209)75:4<590::AID-IJC16> 3.0.CO;2-D. 22.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J Invest Dermatol 2004; 122:414- 22; PMID:15009724; http://dx.doi.org/10.1046/ j.0022-202X.2004.22237.x.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Immunity  1997; 6:591-600; PMID:9175837; http://dx.doi.org/10.1016/S1074-7613(00)80347-7.,OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Nat Immunol 2001; 2:652-7; PMID:11429551; http://dx.doi.org/10.1038/89810.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Clin Cancer Res 2011; 17:4400-13; PMID:21586626; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
J Invest Dermatol  2012; 132:154-62; PMID:21833020; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
Mol Cancer Res 2008; 6:751-9;  PMID:18458053; http://dx.doi.org/10.1158/1541- 7786.MCR-07-2001.,Non-OADS,/arxiv_data1/oa_pdf/1b/2f/onci-2-e22890.PMC3583938.pdf
"www.landesbioscience.com OncoImmunology e22892-1OncoImmunology 2:1, e22892; January 2013; © 2013 Landes Bioscience POInt-Of-VIew POInt-Of-VIew Keywords:  γδ T cell, NK cell, NKG2D,  NK receptor, T-cell receptor Abbreviations:  NK, natural killer; IFN γ,  interferon γ; IL, interleukin Submitted: 11/12/12Accepted: 11/14/12http://dx.doi.org/10.4161/onci.22892Citation: Correia DV, Lopes A, Silva- Santos B. Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs.  NK-cell receptors.",Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Immunity 2009; 31:184- 96; PMID:19699170; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
EMBO Rep 2007; 8:1024-30; http://dx.doi.org/10.1038/ sj.embor.7401090; PMID:17972902.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Nat Immunol 2008;  9:495-502; http://dx.doi.org/10.1038/ni1581;  PMID:18425106.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Eur J Immunol 2012; 42:228-40; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Nat Immunol 2008; 9:146-54;  PMID:18176566; http://dx.doi.org/10.1038/ni1556.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Science 2001; 294:605-9; PMID:11567106; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Immunity 2008; 28(5):571-80;  PMID:18394936; http://dx.doi.org/10.1016/j.immuni.2008.02.016.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Nat Immunol  2005; 6:928-37; PMID:16116470; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
J Immunol  2010; 185:55-63; http://dx.doi.org/10.4049/jimmu - nol.1000373; PMID:20511557.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Blood 2005; 105:251-8; http://dx.doi.org/10.1182/ blood-2004-04-1422; PMID:15328155.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
J Clin Invest 2009; 119:1251-63; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Immunol Rev 2007; 215:123-35; PMID:17291284; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Eur J Immunol 1997; 27:2812-21; http://dx.doi.org/10.1002/eji.1830271111; PMID:9394804.16.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
J Exp Med 2003; 197:163- 8; PMID:12538656; http://dx.doi.org/10.1084/ jem.20021500.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Immunity 2005; 22:71-80; PMID:15664160; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
J Immunol 2010; 184:6920-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Blood  2012; 120:2269-79; http://dx.doi.org/10.1182/blood-2012-05-430470; PMID:22767497.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Nat Immunol 2012; 13:872-9; http://dx.doi.org/10.1038/ni.2394; PMID:22885985.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Proc Natl Acad Sci U  S A 2011; 108:2414-9; http://dx.doi.org/10.1073/ pnas.1015433108; PMID:21262824.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Blood 2010; 115:2407-11; http://dx.doi.org/10.1182/blood-2009-08-237123;  PMID:20101024.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Nat Rev Immunol 2009; 9:568-80; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Immunity 2001; 15:83- 93; PMID:11485740; http://dx.doi.org/10.1016/S1074-7613(01)00168-6.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Semin Immunol 2010; 22:199-206; PMID:20447835; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Eur J Immunol  2009; 39:1361-8; http://dx.doi.org/10.1002/ eji.200838409; PMID:19404979.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Blood 2011; 118:992-1001; http://dx.doi.org/10.1182/blood-2011-02-339135;  PMID:21633088.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
J Exp Med  1997; 186:1769-74; PMID:9362537; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
J Exp Med 1990; 171:1567- 79; PMID:2185329; http://dx.doi.org/10.1084/jem.171.5.1567.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Immunol Rev 2007; 215:59-76; PMID:17291279; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Trends Immunol 2012; 33:199-206; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Haematologica  2010; 95:1397-404; http://dx.doi.org/10.3324/hae - matol.2009.020602; PMID:20220060.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Nat Rev Immunol 2010; 10:467-78; http://dx.doi.org/10.1038/nri2781;  PMID:20539306.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
Scand J Immunol 2007; 66:320-8;  PMID:17635809; http://dx.doi.org/10.1111/j.1365-3083.2007.01963.x.,Non-OADS,/arxiv_data1/oa_pdf/9c/5a/onci-2-e22892.PMC3583939.pdf
"www.landesbioscience.com OncoImmunology e22944-1OncoImmunology 2:1, e22944; January 2013; © 2013 Landes Bioscience BrIef repOrt BrIef repOrt *Correspondence to: Denise Nardelli-Haefliger; Email: dnardell@hospvd.ch Submitted: 09/26/12; Revised: 11/16/12; Accepted: 11/17/12http://dx.doi.org/10.4161/onci.22944Citation: Decrausaz L, Pythoud C, Domingos-Pereira S, Derré L, Jichlinski P , Nardelli-Haefliger D. Intravaginal live attenuated Salmonella  increase local antitumor  vaccine-specific CD8 + T cells.",Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Immunol Lett  2006; 102:191-201; PMID:16242781; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Semin Immunol  2010; 22:183-9; PMID:20299242; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Science 1997; 276:250-3; PMID:9092473;  http://dx.doi.org/10.1126/science.276.5310.250.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
J Leukoc Biol 2005; 78:909- 20; PMID:16033811; http://dx.doi.org/10.1189/ jlb.1204721.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/onci.20696.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
J Mol Med (Berl) 2010; 88:763-73;  PMID:20526574; http://dx.doi.org/10.1007/s00109-010-0636-z.11.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Clin Infect  Dis 2004; 38:771-9; PMID:14999618; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Clin Vaccine Immunol 2007; 14:1285- 95; PMID:17687110; http://dx.doi.org/10.1128/ CVI.00164-07.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Proc Natl Acad Sci U S A  1989; 86:5054-8; PMID:2544889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
J Infect  Dis 1999; 179(Suppl 2):S326-30; PMID:10081503;  http://dx.doi.org/10.1086/513850.,OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Nature 1981; 291:238-9;  PMID:7015147; http://dx.doi.org/10.1038/291238a0.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Cell 1991; 67:547-56; PMID:1657399; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
J Clin Pathol 2002; 55:244- 65; PMID:11919208; http://dx.doi.org/10.1136/ jcp.55.4.244.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Arch Med Res 2009; 40:493-8; PMID:19853190;  http://dx.doi.org/10.1016/j.arcmed.2009.07.003.,OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Mucosal Immunol 2012; In  press; PMID:22968420; http://dx.doi.org/10.1038/mi.2012.83.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
N  Engl J Med 2006; 354:610-21; PMID:16467548;  http://dx.doi.org/10.1056/NEJMra052723.,OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Infect Immun  2003; 71:4873-82; PMID:12933828; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
Infect Immun 2008; 5:1940- 51; PMID:18332214; http://dx.doi.org/10.1128/ IAI.01484-07.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
J Infect  Dis 1975; 131:553-8; PMID:1092768; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/6c/onci-2-e22944.PMC3583940.pdf
"www.landesbioscience.com OncoImmunology e22978-1OncoImmunology 2:1, e22978; January 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Kenneth Beaman; Email: kenneth.beaman@rosalindfranklin.edu Submitted: 07/04/12; Revised: 11/19/12; Accepted: 11/20/12http://dx.doi.org/10.4161/onci.22978Citation: Kwong C, Gilman-Sachs A, Beaman K. An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase.",Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Cell Biochem Biophys 2004; 40:185-206; PMID:15054222; http://dx.doi.org/10.1385/ CBB:40:2:185.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Biochem Biophys Res Commun  2000; 278:390-4; PMID:11097847; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Cancer Res 2006; 66:6699-707; PMID:16818644;  http://dx.doi.org/10.1158/0008-5472.CAN-06-0983.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Am J Physiol Cell Physiol 2004; 286:C1443-52;  PMID:14761893; http://dx.doi.org/10.1152/ajp- cell.00407.2003.6.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
T rends Immunol 2002; 23:549-55;  PMID:12401408; http://dx.doi.org/10.1016/S1471-4906(02)02302-5.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
J Exp Med 1992; 176:287- 92; PMID:1613462; http://dx.doi.org/10.1084/ jem.176.1.287.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Cancer Res 2004; 64:7022-9;  PMID:15466195; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1449.11.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Cancer Res 2005; 65:10637-41; PMID:16322203;  http://dx.doi.org/10.1158/0008-5472.CAN-05-3473.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Nat Rev Immunol 2004; 4:583-94; PMID:15286725; http://dx.doi.org/10.1038/nri1412.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Blood 2010; 116:e74-80;  PMID:20628149; http://dx.doi.org/10.1182/blood- 2010-02-258558.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Clin Immunol 2001; 100:325- 38; PMID:11513546; http://dx.doi.org/10.1006/ clim.2001.5072.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
J Leukoc Biol 2007; 81:584-92; PMID:17135573;  http://dx.doi.org/10.1189/jlb.0806510.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
T rends Immunol 2007; 28:519-24; PMID:17981504;  http://dx.doi.org/10.1016/j.it.2007.09.004.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Clin Exp Immunol  2010; 161:471-9; PMID:20636398; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
J Biol Chem 2008; 283:11752-62; PMID:18292083; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Dev Cell 2006; 10:839-50;  PMID:16740485; http://dx.doi.org/10.1016/j.dev- cel.2006.04.002.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Science  2007; 316:612-6; PMID:17463291; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Respir Res 2008; 9:59;  PMID:18687123; http://dx.doi.org/10.1186/1465- 9921-9-59.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Acta Biochim Biophys Sin (Shanghai)  2009; 41:773-80; PMID:19727526; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Protein Sci 2010; 19:1850-62; PMID:20669186;  http://dx.doi.org/10.1002/pro.470.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
J Supramol Struct 1980; 13:67-81; PMID:6255257;  http://dx.doi.org/10.1002/jss.400130107.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Eur J  Biochem 1995; 230:408-15; PMID:7607209; http://dx.doi.org/10.1111/j.1432-1033.1995.0408h.x.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Curr Opin Hematol 1997; 4:41-7; PMID:9050378;  http://dx.doi.org/10.1097/00062752-199704010-00007.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Annu Rev Immunol 2009; 27:669-92; PMID:19132917; http://dx.doi.org/10.1146/ annurev.immunol.021908.132557.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Immunol Today 1996; 17:424-8; PMID:8854561;  http://dx.doi.org/10.1016/0167-5699(96)10029-3.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
J Immunol  2011; 186:1781-9; PMID:21178005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Am J Reprod Immunol 2007; 57:201-9;  PMID:17295899; http://dx.doi.org/10.1111/j.1600-0897.2006.00463.x.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Hum Immunol  2007; 68:469-77; PMID:17509446; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Blood 2011; 118:e16- 31; PMID:21653326; http://dx.doi.org/10.1182/ blood-2010-12-326355.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Annu Rev Biochem 2009; 78:857-902;  PMID:19317650; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
J Cell Biol  1996; 135:1249-60; PMID:8947549; http://dx.doi.org/10.1083/jcb.135.5.1249.,Non-OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
Cell  Microbiol 2009; 11:1160-9; PMID:19388903; http://dx.doi.org/10.1111/j.1462-5822.2009.01326.x.,OADS,/arxiv_data1/oa_pdf/10/34/onci-2-e22978.PMC3583941.pdf
"www.landesbioscience.com OncoImmunology e23033-1OncoImmunology 2:1, e23033; January 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Robert H. Vonderheide; Email: rhv@exchange.upenn.edu Submitted: 09/13/12; Revised: 11/25/12; Accepted: 11/28/12http://dx.doi.org/10.4161/onci.23033Citation: Vonderheide RH, Burg JM, Mick R, Trosko JA, Li D, Shaik MN, et al.",Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
"In ongo - ing studies, therefore, we are dosing CP-870,893 (combined with  other agents) no more frequently than every three weeks (http://www.clinicaltrials.gov; NCT01103635 and NCT01456585).",Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Pfizer was the IND spon - sor of the trial (http://www.clinicaltrials.gov; NCT00607048).,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Clin Cancer Res 2007;  13:1083-8; PMID:17317815; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Mol Immunol 2000; 37:515-26; PMID:11163401;  http://dx.doi.org/10.1016/S0161-5890(00)00079-1.,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Science 2011; 331:1612- 6; PMID:21436454; http://dx.doi.org/10.1126/sci- ence.1198443.,OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Cancer Immunol Immunother 2011; 60:1009-17;  PMID:21479995; http://dx.doi.org/10.1007/s00262- 011-1014-6.6.,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
J Clin Oncol 2007; 25:876-83; PMID:17327609;  http://dx.doi.org/10.1200/JCO.2006.08.3311.,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
PLoS One  2011; 6:e16882; PMID:21359173; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
J Clin Oncol 2009; 27:2823- 30; PMID:19349552; http://dx.doi.org/10.1200/ JCO.2007.15.7636.,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Am J Clin Oncol  2002; 25:283-6; PMID:12040289; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
Cancer Res 2007; 67:10546-55;  PMID:17974999; http://dx.doi.org/10.1158/0008-5472.CAN-07-2765.,Non-OADS,/arxiv_data1/oa_pdf/02/8d/onci-2-e23033.PMC3583942.pdf
"7 Second, NSCLC may represent a class  of tumors that is particularly resistant to Victories and deceptions in tumor immunology Stimuvax® Guido Kroemer,1,2,3,4,5,* Laurence Zitvogel6,7, 8,9 and Lorenzo Galluzzi1,2,6,* 1Université Paris d escartes/Paris V; s orbonne Paris c ité; Paris, France; 2Equipe 11 labellisée par la Ligue n ationale contre le c ancer; c entre de r echerche des c ordeliers; Paris, France;   3InsErM, U848; Villejuif, France; 4Metabolomics Platform, Institut Gustave r oussy; Villejuif, France; 5Pôle de Biologie, Hôpital Européen Georges Pompidou, a P-HP; Paris, France;  6Institut Gustave r oussy; Villejuif, France; 7InsErM, U1015; Villejuif, France; 8center of c linical Investigations, c IcBt507; Institut Gustave r oussy; Villejuif, France;   9Université Paris- sud/Paris XI; Le Kremlin-Bicêtre, France Keywords:  CTLA4, ipilimumab, L-BLP25, mucin 1, non-small cell lung carcinoma, PD1 Abbreviations:  MUC1, mucin 1; NSCLC, non-small cell lung carcinoma; TAA, tumor-associated antigen *Correspondence to: Guido Kroemer or Lorenzo Galluzzi; Email: kroemer@orange.fr or deadoc@vodafone.it Submitted: 01/14/2013; Accepted: 01/14/2013http://dx.doi.org/10.4161/onci.23687Citation: Kromer G, Zitvogel L, Galluzzi L. Victories and deceptions in tumor immunology: Stimuvax®.",Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Ann Oncol 2012; 23:1387- 93; PMID:22156658; http://dx.doi.org/10.1093/ annonc/mdr564.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncoimmunology  2012; 1:1557-76; PMID:23264902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
OncoImmunology 2013;  2: In press; http://dx.doi.org/10.4161/onci.22789.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Nat Rev Drug Discov 2012; 11:215- 33; PMID:22301798; http://dx.doi.org/10.1038/ nrd3626.6.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Nat Rev Immunol 2006; 6:715-27;  PMID:16977338; http://dx.doi.org/10.1038/nri1936.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Nat Rev Cancer 2012; 12:298-306;  PMID:22419253; http://dx.doi.org/10.1038/nrc3245.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Science  2006; 313:1960-4; PMID:17008531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncoimmunology 2012; 1:1323- 43; PMID:23243596; http://dx.doi.org/10.4161/onci.22009.11.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncogene 2012; 31:1869-83; PMID:21892204;  http://dx.doi.org/10.1038/onc.2011.384.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/ onci.20696.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
Oncoimmunology 2012; 1:894-907; PMID:23162757;  http://dx.doi.org/10.4161/onci.20931.,Non-OADS,/arxiv_data1/oa_pdf/76/45/onci-2-e23687.PMC3583943.pdf
"Kaumaya; Email: kaumaya.1@osu.edu Submitted: 01/15/2013; Accepted: 01/15/2013http://dx.doi.org/10.4161/onci.23914Citation: Foy KC, Miller MJ, Moldovan N, Carson WE, Kaumaya PPT.",Non-OADS,/arxiv_data1/oa_pdf/bc/99/onci-2-e23914.PMC3583944.pdf
"However, although RPN13 has been shown to be an integral proteasomesubunit in mammals and yeast, 7,8its presence in affinity-purified Arabidopsis proteasomes was not detected.9The association of RPN13 with proteasome in Arabidopsis likely is transient andmediated by RPN2 as its interaction with RPN13 was observed *Correspondence to: Hongyong Fu; Email: hongyong@gate.sinica.edu.tw Submitted: 03/20/12; Revised: 04/12/12; Accepted: 04/12/12 http://dx.doi.org/10.4161/psb.20360Plant Signaling & Behavior 7:7, 722– 727; July 2012; G2012 Landes Bioscience 722 Plant Signaling & Behavior Volume 7 Issue 7",Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nat Rev Mol Cell Biol2009; 10:385-97; PMID:19424292; http://dx.doi.org/10.1038/nrm2688 3.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Annu Rev Plant Biol 2011; 62:299-334;PMID:21370976; http://dx.doi.org/10.1146/annurev-arplant-042809-112256 4.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Trends Plant Sci 2010; 15:375-86; PMID:20399133; http://dx.doi.org/ 10.1016/j.tplants.2010.03.004 6.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Annu Rev Biochem 2009; 78:477-513; PMID:19489727; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nature 2008; 453:481-8; PMID:18497817; http://dx.doi.org/10.1038/nature06926 8.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nature 2008; 453:548-52; PMID:18497827; http://dx.doi.org/10.1038/nature06924 9.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
J Biol Chem 2010; 285:25554- 69; PMID:20516081; http://dx.doi.org/10.1074/jbc.M110.136622 10.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nat Cell Biol 2002; 4:725-30; PMID:12198498; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Biochemistry 2003; 42:13529-35; PMID: 14621999; http://dx.doi.org/10.1021/bi035391j 13.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Plant Cell 2011; 23:2754-73; PMID: 21764993; http://dx.doi.org/10.1105/tpc.111.086702 14.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Semin CellDev Biol 2007; 18:780-91; PMID:17942349; http://dx.doi.org/10.1016/j.semcdb.2007.09.008 15.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nat Rev Mol Cell Biol 2005; 6:610-21;PMID:16064137; http://dx.doi.org/10.1038/nrm1701 16.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
FEBS J 2010; 277:796-816; PMID:20059542; http://dx.doi.org/10.1111/j.1742-4658.2009.07531.x 17.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
"Curr Opin Struct Biol 2011; 21:792-801; PMID:22036065; http://dx.doi.org/10.1016/j.sbi.2011.09.009 18. van Nocker S, Sadis S, Rubin DM, Glickman M, Fu H, Coux O, et al.",OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
EMBO J 2001; 20:7096-107; PMID:11742986;http://dx.doi.org/10.1093/emboj/20.24.7096 22.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Mol Cell Biol 2007; 27:6629-38; PMID: 17646385; http://dx.doi.org/10.1128/MCB.00509-07 23.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Mol Biol Cell 2006; 17:5356-71; PMID:17050737;http://dx.doi.org/10.1091/mbc.E06-05-0437 24.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
J Cell Sci 2003; 116:1023-33; PMID: 12584246; http://dx.doi.org/10.1242/jcs.00332 25.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Plant Cell 2003; 15:965-80; PMID:12671091; http://dx.doi.org/10.1105/tpc.009217 27.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Biochem Biophys Res Commun 2010; 396:1048-53; PMID:20471955;http://dx.doi.org/10.1016/j.bbrc.2010.05.061 29.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Cell 2009; 137:914-25; PMID:19490896; http://dx.doi.org/10.1016/j.cell.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nature 2009; 459:866-70; PMID:19412160; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Nature 2009; 459: 861-5; PMID:19412159; http://dx.doi.org/10.1038/ nature08063 33.,Non-OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Cell 2009; 137:900-13; PMID:19446323; http://dx.doi.org/10.1016/j.cell.2009.05.00534.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Mol Cell 2010; 38:404-15; PMID:20471946; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/63/76/psb-7-722.PMC3583950.pdf
Published online at http://www.nature.com/doifinder/10.1038/nmeth.2340.,Non-OADS,/arxiv_data1/oa_pdf/e2/bc/41592_2013_Article_BFnmeth2340.PMC3584181.pdf
reprints and permissions information is available online at http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/e2/bc/41592_2013_Article_BFnmeth2340.PMC3584181.pdf
"To view  a copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/3.0/ 1.",Non-OADS,/arxiv_data1/oa_pdf/e2/bc/41592_2013_Article_BFnmeth2340.PMC3584181.pdf
"2003;302(5646):822-6, http://dx.doi.org/10.1126/ science.1092132.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2006;63(2):168-74, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"1997;55(1):1- 7, http://dx.doi.org/10.1590/S0004-282X1997000100001.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2009;41(10):1088- 93, http://dx.doi.org/10.1038/ng.440.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2009;41(10):1094-9, http://dx.doi.org/10.1038/ng.439.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2007;18(17):1761-4, http://dx.doi.org/10.1097/ WNR.0b013e3282f13e7a.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2008;455(7215):890-3, http://dx.doi.org/10.1038/nature07454.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2008;29(5):769-70, http://dx.doi.org/10.1002/humu.20725.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2009;66(10):1260-6, http://dx.doi.org/10.1001/ archneurol.2009.101.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2007;39(2):168-77, http://dx.doi.org/10.1038/ng1943.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2012;61(7):973-5, http://dx.doi.org/10.1016/j.neuint.2012.07.014.",OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2007;54(5):713-20, http://dx.doi.org/10.1016/j.neuron.2007.05.",OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2009;30(2):E338-44, http://dx.doi.org/10.1002/humu.20909.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2008;30(1):103-6, http://dx.doi.org/ 10.1016/j.nbd.2007.12.006.",OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2010;31(3):277-81, http://dx.doi.org/10.1007/s10072-009-0178-8.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2011;412(5-6):446-9, http://dx.doi.org/10.1016/j.cca.",OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2008;64(4):446-54, http://dx.doi.org/10.1002/ana.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"1984;34(7):939-44, http://dx.doi.org/10.1212/WNL.34.7.939.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2010;32(3):216-22, http://dx.doi.org/10.1590/S1516-44462010005000002.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"1993;43(8):1467-72, http://dx.doi.org/10.1212/WNL.43.8.1467.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2005;58(6):829-39, http://dx.doi.org/10.1002/ana.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2002;2(2):151-65, http://dx.doi.org/10.1385/NMM:2:2:151.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2002;973:323-33, http://dx.doi.org/10.1111/j.1749-6632.2002.tb04660.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2007;282(18):13833-44, http://dx.doi.org/10.1074/jbc.M610146200.",Non-OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"2010;223(2):322-5, http://dx.doi.org/10.1016/j.expneurol.2009.",OADS,/arxiv_data1/oa_pdf/1f/2c/cln-68-02-277.PMC3584260.pdf
"1999;281(6):537-44, http://dx.doi.org/ 10.1001/jama.281.6.537.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2009;16(6):1139-48, http://dx.doi.org/10.1097/gme.0b013e3181a4e317.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2001;27(5):395-403, http://dx.doi.org/10.1080/713846827.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2010;45(7- 8):1060-76, http://dx.doi.org/10.3109/10826080903565271.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2008;29:131-49, http://dx.doi.org/10.1159/000126628.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2012;6(1):57- 67, http://dx.doi.org/10.1097/ADM.0b013e318233d603.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2011;33(1):68-71, http://dx.doi.org/10.1590/S1516- 44462010005000020.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2007;32(2):189-98, http://dx.doi.org/10.1016/j.jsat.2006.08.",OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2012;109(6):888-96, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2011;52(5):486-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2011;11:29, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2007;87(2-3):194-201, http://dx.doi.org/10.1016/j.drugalcdep.",OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2011;106(6):1191-2, http://dx.doi.org/10.1111/j.1360-0443.2011.03427.x.CLINICS 2013;68(2):205-211 Substance-related female sexual dysfunction Diehl A et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/aa/cln-68-02-205.PMC3584261.pdf
"2006;64(2B):538-42, http://dx.doi.org/10.1590/ S0004-282X2006000300037.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2008;12(4):540-6, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2003;16(2):165-70, http://dx.doi.org/10.1097/00019052-200304000-00008.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"1993;34(3):453-68, http://dx.doi.org/10.1111/j.1528-1157.1993.tb02586.x.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2002;43(11):1402-9, http://dx.doi.org/ 10.1046/j.1528-1157.2002.t01-1-26901.x.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2005;4(1):21-31, http://dx.doi.org/ 10.1016/S1474-4422(04)00963-9.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2010;19(10):630-6, http://dx.doi.org/10.1016/j.seizure.2010.10.017.",OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2006;367(9516):1087-100, http://dx.doi.org/10.1016/S0140-6736(06) 68477-8.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"1996;37(11):1121-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"1996;37(11):1128-37, http://dx.doi.org/10.1111/j.1528-1157.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"2012;10:1-14, http://dx.doi.org/10.1017/S0022149X12000600.",Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
http://www.who.int/mental_health/ management/globalepilepsycampaign/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/26/cln-68-02-127.PMC3584262.pdf
"1990;33(2):160-72, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"1990;33(3):381-7, http://dx.doi.org/10.1002/ art.1780330311.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"1995;38(1):19-28, http://dx.doi.org/10.1002/art.1780380104.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"Curr Pain Headache Rep. 2011;15(5):347-57, http://dx.doi.org/10.1007/ s11916-011-0213-3.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2011;17:468-76, http://dx.doi.org/10.1590/S1980-65742011000300010.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2001;44(1):222-30, http://dx.doi.org/10.1002/1529-0131(200101)44:1 ,222::AID-ANR29 .3.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2006;7(3):293-6, http://dx.doi.org/10.1016/j.sleep.2005.09.002 14.",OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2004;292(19):2388-95, http://dx.doi.org/10.1001/ jama.292.19.2388.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2011;6(4):e18440, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2009;48(9):1155-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2002;22(2):56-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"1990;27(5):560-6, http://dx.doi.org/10.1111/j.1469-8986.1990.tb01976.x.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2005;26(2):168-72, http://dx.doi.org/10.1007/s00296-005- 0623-9.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2007;8:27, http://dx.doi.org/10.1186/1471-2474-8-27.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2012;31(1):55-66, http://dx.doi.org/10.1007/s10067-011-1783-5.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"1999;40(3):226-8, http://dx.doi.org/10.1016/S0010-440X(99) 90008-1.",OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2002;28(2):353-65, http://dx.doi.org/10.1016/S0889- 857X(01)00012-6.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2005;22(2):207-25, http://dx.doi.org/10.1081/CBI-200053477.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"2004;8(2):81-93, http://dx.doi.org/10.1016/S1087-0792(03)00023-6.CLINICS 2013;68(2):135-139 Passive Body Heating, Sleep and Fibromyalgia Silva A et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/cln-68-02-135.PMC3584263.pdf
"(http://www.datasus.gov.br) The age range of 0-14 years was chosen based on the criteria used by SEER (Surveillance, Epidemiology and End results; www.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
http://seer.cancer.gov.),Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
and IARC (International Agency for Research in Cancer; http://www.iarc.fr) in their international monographs.,Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2010:116(21):5063-74, http://dx.doi.org/10.1002/cncr.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2007;110(8):1823-31, http://dx.doi.org/10.1002/cncr.22982.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2000;19(3):335-51, http://dx.doi.org/10.1002/ (SICI)1097-0258(2 0000215)19:3 ,335::AID-SIM336 .3.0.CO;2-Z.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2011;377(9779):1778-97, http://dx.doi.org/10.1016/S0140-6736(11)60054-8.Table 3 - Age-adjusted* and crude (0-14 years) mortality rates for all cancers and leukemia by age group in Brazil and its regions (2006-2008) per million children.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2011;377(9780):1863-76, http://dx.doi.org/10.1016/ S0140-6736(11)60138-4.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2009;42(2):121-5, http://dx.doi.org/10.1016/j.bcmd.2008.10.012.",OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2004;291(20):2471-5, http://dx.doi.org/10.1001/jama.291.20.2471.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"1983:1(1):49-55, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"1988;63(1):23-30, http://dx.doi.org/10.1136/adc.63.1.23.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2010;28(11):1911-8, http://dx.doi.org/10.1200/JCO.2009.25.6115.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2006;24(6):1161-8, http://dx.doi.org/10.1200/JCO.2005.03.5352.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2009;27(8):1297-303, http://dx.doi.org/10.1200/JCO.2008.16.4202.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"2010;56(3):309- 12, http://dx.doi.org/10.1590/S0104-42302010000300015.",Non-OADS,/arxiv_data1/oa_pdf/39/55/cln-68-02-219.PMC3584264.pdf
"1996;12(1):23-9, http://dx.doi.org/10.1016/0899-9007 (95)00015-1.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"1997;25(12):1962-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2001;22(1):149-63, http://dx.doi.org/10.1016/S0272-5231(05)70031-9.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2000;28(3):643-8, http://dx.doi.org/10.1097/00003246-200003000- 00007.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"1986;24(1):65-74, http://dx.doi.org/10.1097/00004311- 198602410-00007.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2012;38(3):384-94, http://dx.doi.org/10.1007/s00134-011-2459-y.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2008;12(4):R90, http://dx.doi.org/10.1186/cc6958.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"1997;13:870-7, http://dx.doi.org/10.1016/S0899-9007(97)00270-0.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"1995;19(6):453-60, http://dx.doi.org/10.1177/0148607195019006453.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"1996;223(6):629-35; discussion 635-8, http://dx.doi.org/10.1097/00000658-199606000-00001.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2003;22(4):415-21, http://dx.doi.org/10.1016/S0261-5614(03)00098-0.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2008;12(4):R90, http://dx.doi.org/10.1186/cc6958.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2012; Suppl 1:S9, http://dx.doi.org/10.1186/2110-5820-2-S1-S9.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2004;32(2):350-7, http://dx.doi.org/10.1097/01.CCM.0000089641.06306.68.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"Crit Care 2009;13(4):R132-130, http://dx.doi.org/10.1186/cc7993.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"2006;6:19, http://dx.doi.org/10.1186/1471-230X-6-19.CLINICS 2013;68(2):173-177 Enteral nutrition in critically ill patients Silva MA et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/dd/cln-68-02-173.PMC3584265.pdf
"1982;80(5):769-84, http://dx.doi.org/10.1085/jgp.80.5.769.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2010;277(1680):475-84, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2012;102(3):145a, http://dx.doi.org/10.1016/j.bpj.2011.11.796.",OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1971;233(5321):533-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2002;545(Pt 1):321-30, http://dx.doi.org/10.1113/ jphysiol.2002.018010.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2004;207(Pt 16):2787-91, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2004;37(9):1305- 12, http://dx.doi.org/10.1016/j.jbiomech.2003.12.033.",OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2010;299(6):C1398-401, http://dx.doi.org/10.1152/ajpcell.00222.2010.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2003;36(9):1309-16, http://dx.doi.org/10.1016/S0021-9290(03)00155-6.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2004;96(2):419-27, http://dx.doi.org/ 10.1152/japplphysiol.00653.2003.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2012;279(1739):2705-13, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1990;57(2):209-21, http://dx.doi.org/10.1016/ S0006-3495(90)82524-8.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1953;141(902):104-17, http://dx.doi.org/10.1098/rspb.1953.0027.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1996;17(2):261-8, http://dx.doi.org/10.1007/BF00124247.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2003;270(1525):1735-40, http://dx.doi.org/10.1098/rspb.2003.2418.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2000;33(5):531-42, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1993;14(5):498- 510, http://dx.doi.org/10.1007/BF00297212.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2009;297(5):C1211-9, http://dx.doi.org/10.1152/ajpcell.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2006;573(Pt 1):173-85, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2006;90(2):514-30, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2011;7:e1002156, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2003;206(Pt 20):3635-43, http://dx.doi.org/10.1242/ jeb.00645.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2005;38(3):409-15, http://dx.doi.org/10.1016/j.jbiomech.2004.05.001.",OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2008;294(1):C74-8, http://dx.doi.org/10.1152/ajpcell.00218.2007.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2010;299(1):C14-20, http://dx.doi.org/10.1152/ajpcell.00049.2010.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2001;89(10):874- 81, http://dx.doi.org/10.1161/hh2201.099453.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2005;1(3):342-5, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2002;82(6):3118-27, http://dx.doi.org/10.1016/S0006-3495(02)75653-1.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2010;299(1):C11-3, http://dx.doi.org/10.1152/ajpcell.00147.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1996;221(3):491-7, http://dx.doi.org/10.1006/bbrc.1996.0624.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2000;526(Pt 3):589-96, http://dx.doi.org/10.1111/j.1469-7793.2000.00589.x.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1996;71(2):898-907, http://dx.doi.org/10.1016/ S0006-3495(96)79293-7.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2010;299(5):C1127-35, http://dx.doi.org/10.1152/ajpcell.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2004;97(4):1395-400, http://dx.doi.org/10.1152/japplphysiol.00377.2004.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2003;5(11):980-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2005;7(9):861-9, http://dx.doi.org/10.1038/ncb1287.",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"1994;368(6467):113-9, http://dx.doi.org/10.1038/368113a0.Force enhancement Minozzo FC and Lira CACLINICS 2013;68(2):269-274 274",Non-OADS,/arxiv_data1/oa_pdf/15/89/cln-68-02-269.PMC3584266.pdf
"2010;117(4):757-65, http://dx.doi.org/10.1016/j.ophtha.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2002;16(3):242-60, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2010;376(9735):124-36, http://dx.doi.org/10.1016/S0140-6736(09)62124- 3.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"1999;222(3):205-13, http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2005;29(1):146-50, http://dx.doi.org/10.1038/sj.ijo.0802839.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2008;372(9647):1394-1402, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2008;372(9647):1385-93, http://dx.doi.org/10.1016/S0140-6736 (08)61411-7.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"1976;72:248-54, http://dx.doi.org/10.1016/0003- 2697(76)90527-3.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2005;46(11):4295-301, http://dx.doi.org/10.1167/iovs.04-1057.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2006;74(3):249-56, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"1998;111(3):604-10, http://dx.doi.org/10.1046/j.1365-2249.1998.00519.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"1999;42(2):222-32, http://dx.doi.org/10.1007/s001250051142.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2011;31(9):1951-57, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2007;48:4342-50, http://dx.doi.org/ 10.1167/iovs.06-1473.23.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2005;46(9):1069-77, http://dx.doi.org/10.1167/iovs.04-0885.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2010;29(4):284-311, http://dx.doi.org/10.1016/j.preteyeres.2010.03.003.",OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2008;17(7):983-96, http://dx.doi.org/10.1517/13543784.17.7.983.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2012;96(2):289-92, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2005;19(5):1304-17, http://dx.doi.org/10.1210/me.2004-0239.CLINICS 2013;68(2):185-191 Attenuation of NF- kB & MCP-1 in retinopathy Ng ZX et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/cln-68-02-185.PMC3584267.pdf
"2001;6(6):461-75, http://dx.doi.org/10.1053/siny.2001.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2005;25(1):59-62, http://dx.doi.org/10.1097/00006982-200501000-00008.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2004;24(2):242-5, http://dx.doi.org/10.1097/00006982-200404000-00009.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"1996;80(5):425-8, http://dx.doi.org/10.1136/bjo.80.5.425.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2010;99(4):488-9, http://dx.doi.org/10.1111/j.1651-2227.2009.01672.x.7.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2009;9(3):99-110, http://dx.doi.org/10.1097/ANC.0b013e3181a68b48.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2010;99(3):329-34, http://dx.doi.org/ 10.1111/j.1651-2227.2009.01612.x.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2010;95(6):F419-22, http://dx.doi.org/10.1136/adc.2009.180943.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2012;39(1):239-54, http://dx.doi.org/10.1016/j.clp.2011.12.013.",OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"1997;86(2):217-20, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2007;70(5):875-83, http://dx.doi.org/10.1590/S0004-27492007000500028.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2006;89(3):197, http://dx.doi.org/10.1159/000089754.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2005;25(1):59-62, http://dx.doi.org/10.1097/00006982-200501000-00008.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2005;39(5):829-33, http://dx.doi.org/10.1345/aph.1E476.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2010;30(11):731-5, http://dx.doi.org/10.1038/jp.2010.36.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2005;39(6):1029-33, http://dx.doi.org/10.1345/aph.1E477.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2005;25(1):33-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2011;20(7- 8):1054-9, http://dx.doi.org/10.1111/j.1365-2702.2010.03529.x.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2005;115(4):1004-7, http://dx.doi.org/10.1542/peds.2004-1189.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2010;376(9748):1225-32, http://dx.doi.org/10.1016/S0140-6736(10)61303-7.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"1999;117(2):72-80, http://dx.doi.org/10.1590/S1516-31801999000200005.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"2008;8(3):285-90, http://dx.doi.org/10.1590/S1519- 38292008000300007.CLINICS 2013;68(2):199-203 Pain relief and ROP: A masked clinical trial Costa MC et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/77/cln-68-02-199.PMC3584268.pdf
"An online collection of statistical programs was used for statistical analysis, and the tools that we used are available at http://www.stattools.",OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"1997;49(2):452-6, http://dx.doi.org/10.1212/WNL.49.2.452.2.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2005;366(9486):643-8, http://dx.doi.org/10.1016/S0140-6736(05)66954-1.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"1983;59(1):111-8, http://dx.doi.org/10.3171/jns.1983.59.1.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2009;34(22 Suppl):S101-7, http://dx.doi.org/10.1097/BRS.0b013e3181bac4b2.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2006;31(24):2849-56, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2010;35(22):E1221-9, http://dx.doi.org/10.1097/BRS.0b013e3181e16ae2.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2011;29(22):3072-7, http://dx.doi.org/10.1200/JCO.2010.34.3897.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"1977;33(1):159-74, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2006;66(4):1212-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
"2011;9(1):4-10, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e7/0f/cln-68-02-213.PMC3584270.pdf
The present study compared sex hormone levels between Chinese and Malay men in Malaysia because these groups represent the two major ethnicities in Malaysia (92% of the total population; http://www.statistics.gov.,Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2007;67(2):295-303, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2008;93(6):2135-41, http://dx.doi.org/10.1210/jc.2007-1469.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"1998;83(7):2266-74, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2009;94(9):3337-46, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2009;70(1):26-34, http://dx.doi.org/10.1111/j.1365-2265.2008.03300.x.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2008;93(5):1834-40, http://dx.doi.org/10.1210/jc.2007-2177.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2007;10(4):300-5, http://dx.doi.org/10.1111/j.1479-8077.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"J Clin Endocrinol Metab 2006;91(11):4326-34, http://dx.doi.org/10.1210/jc.2006-0037.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2007;92(7):2519-25, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2001;50(10):1242-7, http://dx.doi.org/10.1053/meta.2001.26714.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2010;95(10):E151-60, http://dx.doi.org/10.1210/jc.2009-2435.18.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2002;23(3):279-302, http://dx.doi.org/10.1210/er.23.3.279.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"1997;82(8):2386-90, http://dx.doi.org/10.1210/jc.82.8.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"1982;16(6):801- 10, http://dx.doi.org/10.1016/0022-4731(82)90038-3.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2004;27(4):861-8, http://dx.doi.org/10.2337/diacare.27.4.861.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2008;168(1):47-54, http://dx.doi.org/10.1001/archinternmed.2007.2.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2002;87(2):589-98, http://dx.doi.org/10.1210/jc.87.2.589.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2005;26(6):833-876, http://dx.doi.org/10.1210/er.2004-0013.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"1996;44(6):659-64, http://dx.doi.org/10.1046/j.1365-2265.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"1996;81(7):2534-40, http://dx.doi.org/10.1210/jc.81.7.2534.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2004;89(12):6039-47, http://dx.doi.org/10.1210/jc.2004-0735.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"J Clin Endocrinol Metab 2006;91(4):1336-44, http://dx.doi.org/10.1210/jc.2005-1830.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2011;108(9):1480-4, http://dx.doi.org/10.1111/j.1464-410X.2010.10030.x.CLINICS 2013;68(2):159-165 Sex hormones in Malay and Chinese men Chin KY et al.",Non-OADS,/arxiv_data1/oa_pdf/24/d2/cln-68-02-159.PMC3584271.pdf
"2011;107(3):353-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2005;100(5):404-12, http://dx.doi.org/10.1007/s00395-005-0539-2.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2007;93(6):749-52, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2007;116(12):1386-95, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2002;106(23):2881-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2006;105(3):550-6, http://dx.doi.org/10.1097/00000542- 200609000-00019.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"1988;22(9):656-65, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2012;97(8):908-17, http://dx.doi.org/10.1113/expphysiol.2012.064923.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2009; 374(9700):1557-65, http://dx.doi.org/10.1016/S0140-6736(09)61421-5.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2004;25(6):1006-10, http://dx.doi.org/10.1016/j.ejcts.2004.02.003.",OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2004;279(20):21233-8, http://dx.doi.org/10.1074/jbc.M400695200.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2010;87(3):406-23, http://dx.doi.org/10.1093/cvr/ cvq129.",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"2012;33(1):13-5, http://dx.doi.org/ 10.1093/eurheartj/ehr341.Cardioprotective comparison of three remote conditionings Z h uS Be ta l .CLINICS 2013;68(2):263-268 268",Non-OADS,/arxiv_data1/oa_pdf/9c/1c/cln-68-02-263.PMC3584272.pdf
"Epub 2000/06/17, http://dx.doi.org/10.1210/er.21.3.245.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2010/11/06, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2010/ 09/09, http://dx.doi.org/10.1210/jc.2009-2631.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2007/ 02/15, http://dx.doi.org/10.1210/jc.2006-2109.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2009/06/09, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2009/06/23, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2004/03/06, http://dx.doi.org/10.1016/S1084- 2756(03)00042-3.",OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 1983/05/01, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 1998/12/16, http://dx.doi.org/10.1210/jc.83.12.4416.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2002/03/08, http://dx.doi.org/10.1136/fn.86.2.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2006/02/02, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2010/ 06/19, http://dx.doi.org/10.1373/clinchem.2010.146035.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2011/06/11, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2009/05/30, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2004/11/24, http://dx.doi.org/10.1007/s00431- 004-1572-0.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2002/06/01, http://dx.doi.org/10.1530/eje.0.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"Epub 2007/02/15, http://dx.doi.org/10.1017/S0007114507280572.CLINICS 2013;68(2):147-151 Mineralocorticoid replacement in CAH Gomes LG et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/63/cln-68-02-147.PMC3584273.pdf
"1998;14(6):256-62, http://dx.doi.org/10.1007/ s003810050221.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2007;114(2):97-109, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2008;20(6):668-75, http://dx.doi.org/10.1097/CCO.0b013e32831369f4.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2008;3(8):e3088, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2011;29(11):1408-14, http://dx.doi.org/ 10.1200/JCO.2009.27.4324.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2011;29(11):1424-30, http://dx.doi.org/10.1200/JCO.2010.28.5148.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2012;123(4):473-84, http://dx.doi.org/10.1007/s00401- 012-0958-8.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2012;123(4):465-72, http://dx.doi.org/10.1007/s00401- 011-0922-z.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2006;5(22):2666-70, http://dx.doi.org/10.4161/cc.5.22.3446.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1998;14:59-88, http://dx.doi.org/10.1146/ annurev.cellbio.14.1.59.",OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2003;94(3):225-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1999;21(12):1021- 30, http://dx.doi.org/10.1002/(SICI)1521-1878(199912)22:1 ,1021::AID- BIES6 .3.0.CO;2-P. 15.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2001;92(1):136-45, http://dx.doi.org/ 10.1002/1097-0142(20010701)92:1 ,136::AID-CNCR1301 .3.0.CO;2-R. 16.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2003;18(3):280-7, http://dx.doi.org/10.1046/j.1440-1746.2003.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1997;275(5307):1787-90, http://dx.doi.org/ 10.1126/science.275.5307.1787.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1997;275(5307):1752-3, http://dx.doi.org/10.1126/science.275.5307.1752.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1995;2:60- 4, http://dx.doi.org/10.1097/00125480-199501000-00044.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1981;29(4):577-80, http://dx.doi.org/10.1177/29.4.6166661.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2001;25(4):402-8, http://dx.doi.org/10.1006/meth.2001.1262.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2005;11(1):17-22, http://dx.doi.org/10.1016/j.molmed.",OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"Nature 2005; 434:843-50, http://dx.doi.org/10.1038/nature03319.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2006;112(1):13-20, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2005;23(31):7951-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2011;29(11):1400-7, http://dx.doi.org/10.1200/JCO.2010.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2002;277(25):22692-8, http://dx.doi.org/10.1074/jbc.M201975200.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2001;276(43):40113-9, http://dx.doi.org/10.1074/jbc.M105317200.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"1999;4(12):757-67, http://dx.doi.org/10.1046/j.1365-2443.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2000;2(9):653-60, http://dx.doi.org/10.1038/35023605.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2009;100(8):1292-302, http://dx.doi.org/10.1038/sj.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2011;331(6016):435-9, http://dx.doi.org/10.1126/science.1198056.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2003;22(4):632-6, http://dx.doi.org/10.1038/sj.onc.1206156.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2007;31(1):33-44, http://dx.doi.org/10.1080/01913120 601169501.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2010;29 (20):3017-24, http://dx.doi.org/10.1038/onc.2010.32.",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2009;218(1):86-94, http://dx.doi.org/10.1002/path.2514.Molecular analysis of medulloblastomas Silva R et al.CLINICS 2013;68(2):167-172 172",Non-OADS,/arxiv_data1/oa_pdf/79/65/cln-68-02-167.PMC3584274.pdf
"2007;177(10):1193-9, http://dx.doi.org/10.1503/cmaj.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2008;54(9):1424-31, http://dx.doi.org/ 10.1373/clinchem.2008.105387.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2009;42(10-11):1012-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2008;117(10):1292-301, http://dx.doi.org/10.1161/CIRCU LATIONAHA.107.699173.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2011;412(11-12):993-98, http://dx.doi.org/10.1016/j.cca.2011.02.038.",OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2010;121(9):1124-33, http://dx.doi.or g/10.1161/CIRCULATIONAHA.109.882704.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2001;104(13):1533-7, http://dx.doi.org/10.1161/hc3801.095588.13.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2011;106(5):804-13, http://dx.doi.org/10.1160/TH11-09-0605.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"2012;110(6):857-69, http://dx.doi.org/10.1161/CIRCRESAHA.111.",Non-OADS,/arxiv_data1/oa_pdf/4d/99/cln-68-02-193.PMC3584275.pdf
"1973;177(5):513-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1998;70(1):121- 2, http://dx.doi.org/10.1006/gyno.1998.5045.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1999;402(6762):656-60, http://dx.doi.org/10.1038/45230.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2008;29(7):1231-40, http://dx.doi.org/10.1016/j.peptides.2008.02.012.",OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2005;68(8):318-26, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"http:// www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002026, http://dx.doi.org/10.1371/journal.pone.0002026.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1998;33(1):91-3, http://dx.doi.org/10.1016/S0022-3468(98)90369-4.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1981;112(1):70-5, http://dx.doi.org/10.1016/0003-2697(81)90261-X.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1973;177(2):222-7, http://dx.doi.org/10.1097/00000658-197302000-00017.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2002;87(6):2988, http://dx.doi.org/10.1210/jc.87.6.2988.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2005;3(1-3):45-62, http://dx.doi.org/10.1163/156856005774423971.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2007;12(7-8):276-88, http://dx.doi.org/10.1016/j.drudis.2007.02.009.",OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2006;130(1): 1-7, http://dx.doi.org/10.1016/j.jss.2005.08.003.",OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2000;275(2):477-80, http://dx.doi.org/10.1006/bbrc.2000.3342.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"2000;85(12):4908-11, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1993;192(3):1011-15, http://dx.doi.org/10.1006/bbrc.1993.1517.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1989;243(4889):393-6, http://dx.doi.org/10.1126/science.2783498.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1986;232(4755):1250-3, http://dx.doi.org/10.1126/science.2422 759.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1992;216(2):184-91, http://dx.doi.org/10.1097/00000658-199208000- 00009.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1995;38(11):1200-5, http://dx.doi.org/10.1007/BF02048337.",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"1984;27(2):99-104, http://dx.doi.org/ 10.1007/BF02553985.Ghrelin improves colonic anastomosis healing in rats Ceran C et al.CLINICS 2013;68(2):239-244 244",Non-OADS,/arxiv_data1/oa_pdf/23/9d/cln-68-02-239.PMC3584276.pdf
"85-23, revised 1996) and the Comite de Etica em Experimentac ¸a˜o Animal/ Universidade Federal de Minas Gerais (CETEA/UFMG; http://www.ufmg.br/bioetica/cetea/).",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1996;7:127-44, http://dx.doi.org/10.1016/ S0079-6123(08)61862-2.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1989;81:105-16, http://dx.doi.org/10.1016/S0079- 6123(08)62002-6.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"2000;51(2):119-28, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"2005;14(8):1019-31, http://dx.doi.org/10.1517/13543784.14.8.1019.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"2006;326(2):599-616, http://dx.doi.org/10.1007/ s00441-006-0190-8.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"2008;86(6):715-22, http://dx.doi.org/10.1007/s00109-008-0331-5.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1997;18(4):383-439, http://dx.doi.org/10.1006/frne.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"2007;293(3):H1416-24, http://dx.doi.org/10.1152/ajpheart.00141.2007.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1997;750(1- 2):305-10, http://dx.doi.org/10.1016/S0006-8993(96)01476-X.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1994;35(4):293-8, http://dx.doi.org/10.1016/0361-9230(94)90104-X.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1982;257(3):275-325, http://dx.doi.org/10.1016/ 0165-0173(82)90010-8.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1994;665(2):245-52, http://dx.doi.org/10.1016/0006-8993(94)91344-7.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1993;609(1- 2):81-92, http://dx.doi.org/10.1016/0006-8993(93)90858-K. 26.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1994;23(6 Pt 2):962-6, http://dx.doi.org/10.1161/01.HYP.23.6.962.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1993;37(7):633-42, http://dx.doi.org/10.1111/j.1399-6576.1993.tb03780.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1986;42(3):292-7, http://dx.doi.org/10.1007/ BF01942510.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"1998;72(1):46-54, http://dx.doi.org/10.1016/S0165-1838(98)000 84-8.Peripheral mechanisms of Ang-(1-7) at the RVLM Oliveira RC et al.CLINICS 2013;68(2):245-252 252",OADS,/arxiv_data1/oa_pdf/c6/d0/cln-68-02-245.PMC3584277.pdf
"Using a variety of analytical methods, differentially co-expressed genes (DCGs) in cells from herniated discs and from discs exhibiting signs of degen- erative disc disease were analyzed using the DCGL package (11,12) in R. &MATERIALS AND METHODS Microarray analysis The transcription profile of GSE23130 was obtained from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
The PATHWAY database records networks of molecular interactions in the cells and variants that are specific to particular organisms(http://www.genome.jp/kegg/).,OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"1999;354(9178):581-5, http://dx.doi.org/10.1016/S0140-6736(99) 01312-4.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2006;5(5):512-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"1994;19(7):801-6, http://dx.doi.org/10.1097/00007632- 199404000-00013.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2006;31(18):2151-61, http://dx.doi.org/10.1097/ 01.brs.0000231761.73859.2c.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2003;5(3):120-30, http://dx.doi.org/10.1186/ar629.6.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2008;40(5):837-42, http://dx.doi.org/10.1016/j.biocel.2007.12.011.",OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2008;33(25):2801-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2004;14(6):1085-94, http://dx.doi.org/10.1101/gr.1910904.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2003;302(5643):249- 55, http://dx.doi.org/10.1126/science.1087447.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2011;12:315, http://dx.doi.org/10.1186/1471-2105- 12-315.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2002;18(12):1585-92, http://dx.doi.org/10.1093/bioinformatics/ 18.12.1585.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2003;4(2):249-64, http://dx.doi.org/10.1093/biostatistics/4.2.249.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2002;247:91- 101; discussion -3, 19-28, 244-52, http://dx.doi.org/10.1002/0470857897.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2001;26(6):618-21, http://dx.doi.org/10.1097/00007632-200103150-00011.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2002;27(12):1291-6, http://dx.doi.org/10.1097/00007632-200206150-00009.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2008;43(2):215-9, http://dx.doi.org/10.1016/j.cyto.",OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2000;18:621-63, http://dx.doi.org/10.1146/annurev.immunol.18.1.621.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2011;13(4):R140, http://dx.doi.org/10.1186/ar3454.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"1995;206(1):89-96, http://dx.doi.org/10.1006/bbrc.1995.1013.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"2007;8(2):315-23, http://dx.doi.org/10.2174/138945007779940188.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"1999;14(10):1654-63, http://dx.doi.org/10.1359/jbmr.1999.14.10.1654.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"1996;273(5279):1236-8, http://dx.doi.org/10.1126/science.273.5279.1236.",Non-OADS,/arxiv_data1/oa_pdf/cd/e3/cln-68-02-225.PMC3584278.pdf
"1998;26(11):1842-9, http://dx.doi.org/10.1097/00003246-199811000-00026.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2008;14(5):483-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1999;5:180, http://dx.doi.org/10.1097/00075198-199906000-00005.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2000;19(4):453-73, http://dx.doi.org/10.1002/(SICI) 1097-0258(20000229)19:4 ,453::AID-SIM350 .3.0.CO;2-5.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1985;13(10):818- 29, http://dx.doi.org/10.1097/00003246-198510000-00009.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1991;100(6):1619-36, http://dx.doi.org/10.1378/chest.100.6.1619.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2005;31(10):1336-44, http://dx.doi.org/10.1007/s00134-005-2762-6.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2005;31(10):1345-55, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2006; 34(5):1297-310, http://dx.doi.org/10.1097/01.CCM.0000215112.84523.F0.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1994;271(2):140-3, http://dx.doi.org/10.1001/jama.1994.03510260072031.CLINICS 2013;68(2):153-158 SAPS 3 or APACHE II to predict mortality Oliveira VM et al.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1997;3(5):532-7, http://dx.doi.org/ 10.1002/lt.500030509.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2006;32:1839-44, http://dx.doi.org/10.1007/s00134-006-0374-4.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2010;36:1188-95, http://dx.doi.org/10.1007/s00134- 010-1807-7.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1988;16(1):34-42, http://dx.doi .org/10.1097/00003246-198801000-00007.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2010;60(1):20-31, http://dx.doi.org/10.1590/S0034-70942010000100003.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2008;14(5):485-90, http://dx.doi.org/10.1097/MCC.0b013e32830864d7.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1995;23(3):466-73, http://dx.doi.org/10.1097/00003246-199503000-00009.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1995;21(1):32-7, http://dx.doi.org/10.1007/BF02425151.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2000;28(1):150-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2002;6(3):245-50, http://dx.doi.org/10.1186/cc1497.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2002;6(3):188-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2009;9:11, http://dx.doi.org/10.1186/1471-2482-9-11.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2003;3(5):626- 30, http://dx.doi.org/10.1034/j.1600-6143.2003.00092.x.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2004;10(7):903-7, http://dx.doi.org/ 10.1002/lt.20169.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"Liver Transplant 2003;9(7):737-40, http://dx.doi.org/10.1053/jlts.2003.50122.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2004;77(1):99-106, http://dx.doi.org/10.1097/01.TP.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2010;16(2):138-46, http://dx.doi.org/10.1002/lt.21969.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"1995;107(5):1402-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2009;88(6):1757-64, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2011;30(1):14-21, http://dx.doi.org/10.1016/j.healun.2010.",OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2010;31(2):108-14, http://dx.doi.org/10.1055/s- 0030-1249107.",Non-OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2007; 26(2):188-93, http://dx.doi.org/10.1016/j.healun.2006.11.006.SAPS 3 or APACHE II to predict mortality Oliveira VM et al.CLINICS 2013;68(2):153-158 158",OADS,/arxiv_data1/oa_pdf/35/40/cln-68-02-153.PMC3584279.pdf
"2009;47(7):2149-55, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"2004;42(7):3000-11, http://dx.doi.org/10.1128/JCM.42.7.3000-3011.2004.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"2001;39(9):3222-7, http://dx.doi.org/10.1128/JCM.39.9.3222- 3227.2001.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"2009;45(1):19-26, http://dx.doi.org/10.4068/ cmj.2009.45.1.19.Table 3 - Distribution of mycobacterial species identified by PRA-PCR in the routine setting.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"2009;42(6):716-22, http://dx.doi.org/10.1590/S0037-86822009000600020.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"2006;19(4):658-85, http://dx.doi.org/10.1128/CMR.00061-05.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"2003;98(5):655-8, http://dx.doi.org/10.1590/ S0074-02762003000500012.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/cln-68-02-179.PMC3584283.pdf
"1999;50(4):560-3, http://dx.doi.org/10.1016/ S0016-5107(99)70084-2.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2007;66(5):966-73, http://dx.doi.org/10.1016/j.gie.2007.02.053.",OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"1998;59(5):502-8, http://dx.doi.org/10.1159/ 000007527.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2006;63(6):776-82, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2010;24(2):343-52, http://dx.doi.org/ 10.1007/s00464-009-0562-8.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2001;54(1):62-6, http://dx.doi.org/10.1067/mge.2001.115729.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2006;9(4):262-70, http://dx.doi.org/10.1007/s10120-006- 0389-0.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2001;33(8):682-6, http://dx.doi.org/10.1055/s-2001-16213.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"1998;48(5):550-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2000;3(4):219-25, http://dx.doi.org/10.1007/PL00011720.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"1993;25(7):455-61, http://dx.doi.org/ 10.1055/s-2007-1010367.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2003;43(5):413-26, http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2000;355(9211):1211-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2001;33(4):306-10, http://dx.doi.org/10.1055/s-2001-13700.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2003;57(1):48-53, http://dx.doi.org/10.1067/mge.2003.31.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"1996;44(1):8-14, http://dx.doi.org/10.1016/S0016- 5107(96)70222-5.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2004;36(12):1089-93, http://dx.doi.org/10.1055/s- 2004-826039.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"1999;42(12):1602-8, http://dx.doi.org/10.1007/BF02236215.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2007;39(5):418-22, http://dx.doi.org/10.1055/s- 2007-966427.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2007;66(1):100-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2007;5(6):678-83, http://dx.doi.org/10.1016/j.cgh.2007.01.006.",OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2007;10(1):1-11, http://dx.doi.org/10.1007/s10120-006-0408-1.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2007;65(3):537-42, http://dx.doi.org/10.1016/j.gie.2006.11.002.CLINICS 2013;68(2):141-145 Submucosal dissection Meirelles-Santos JO et al.",Non-OADS,/arxiv_data1/oa_pdf/28/d5/cln-68-02-141.PMC3584284.pdf
"2012;67(9):1063-9, http://dx.doi.org/ 10.6061/clinics/2012(09)14.",Non-OADS,/arxiv_data1/oa_pdf/3d/55/cln-68-02-275.PMC3584285.pdf
"1990;24(7):521- 7, http://dx.doi.org/10.1093/cvr/24.7.521.",Non-OADS,/arxiv_data1/oa_pdf/3d/55/cln-68-02-275.PMC3584285.pdf
"1995;86(3):202-6, http://dx.doi.org/10.1159/000176874.",Non-OADS,/arxiv_data1/oa_pdf/3d/55/cln-68-02-275.PMC3584285.pdf
"2007;153(4):544.e1-8, http://dx.doi.org/10.1016/j.ahj.2006.12.017.",OADS,/arxiv_data1/oa_pdf/3d/55/cln-68-02-275.PMC3584285.pdf
"2010;3:82-8, http://dx.doi.org/10.1161/CIRCHEARTFAILURE.",Non-OADS,/arxiv_data1/oa_pdf/3d/55/cln-68-02-275.PMC3584285.pdf
"2007;18(12):1236-40, http://dx.doi.org/10.1111/j.1540-8167.",Non-OADS,/arxiv_data1/oa_pdf/3d/55/cln-68-02-275.PMC3584285.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/78/b7/srep01359.PMC3584311.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Pezo, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/78/b7/srep01359.PMC3584311.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a1/92/srep01354.PMC3584312.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Biron, K.E., Dickstein, D.L., Gopaul, R., Fenninger, F. & Jefferies, W.A.",Non-OADS,/arxiv_data1/oa_pdf/a1/92/srep01354.PMC3584312.pdf
"Chand, M. Ph.D. Thesis , Tata Institute of Fundamental Research, Mumbai, India (available at http://www.tifr.res.in/ ,superconductivity/pdfs/madhavi.pdf).",OADS,/arxiv_data1/oa_pdf/e6/12/srep01357.PMC3584313.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/12/srep01357.PMC3584313.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Mondal, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/12/srep01357.PMC3584313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/5e/srep01358.PMC3584314.pdf
"Water-Repelling Metals, http://www.technologyreview.com/energy/21530/ page1/, Date accessed: May 5, 2012.",Non-OADS,/arxiv_data1/oa_pdf/65/37/srep01078.PMC3584315.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/37/srep01078.PMC3584315.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Radha, B., Lim, S.H., Saifullah, M.S.M.",Non-OADS,/arxiv_data1/oa_pdf/65/37/srep01078.PMC3584315.pdf
Available  from: http://www.iom.edu/Reports/2010/The-  Future-of-Nursing-Leading-Change-Advanc - ing-Health.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ed/08/yjbm_86_1_1.PMC3584486.pdf
Available from:  https://www.ninr.nih.gov/sites/www.ninr.nih  .gov/files/ninr-strategic-plan-2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/08/yjbm_86_1_1.PMC3584486.pdf
Available from: http://www.cdc.gov/chron - icdisease/index.htm.,OADS,/arxiv_data1/oa_pdf/8d/ee/yjbm_86_1_15.PMC3584492.pdf
Available from: http://www.cdc.gov/chron - icdisease/resources/publications/AAG/dhdsp.,OADS,/arxiv_data1/oa_pdf/8d/ee/yjbm_86_1_15.PMC3584492.pdf
Available from: https://www.quotation - spage.com/quote/27655.html.,Non-OADS,/arxiv_data1/oa_pdf/8d/ee/yjbm_86_1_15.PMC3584492.pdf
Available from :  http://www.integration.samhsa.gov/inte - grated-care-models/behavioral-health-in-pri - mary-care.,Non-OADS,/arxiv_data1/oa_pdf/8d/ee/yjbm_86_1_15.PMC3584492.pdf
Available from:  http://www.apna.org/i4a/pages/index.cfm?pa  geid=3292.,OADS,/arxiv_data1/oa_pdf/8d/ee/yjbm_86_1_15.PMC3584492.pdf
Available from  http://thinkexist.com/quotation/it_is_much_m  ore_important_to_know_what_sort_of_a/331  707.html.,Non-OADS,/arxiv_data1/oa_pdf/8d/ee/yjbm_86_1_15.PMC3584492.pdf
Available from: http://www.cdc.gov/obe - sity/defining.html.,OADS,/arxiv_data1/oa_pdf/00/7a/yjbm_86_1_29.PMC3584493.pdf
Avail - able from: http://www.cdc.gov/mmwr/pre - view/mmwrhtml/mm59e0803a1.htm.,OADS,/arxiv_data1/oa_pdf/00/7a/yjbm_86_1_29.PMC3584493.pdf
Available from:  http://www.cdc.gov/obesity/causes/health.ht  ml.,Non-OADS,/arxiv_data1/oa_pdf/00/7a/yjbm_86_1_29.PMC3584493.pdf
Available from:  http://www.nhlbi.nih.gov/health/public/heart/  obesity/lose_wt/risk.htm.,Non-OADS,/arxiv_data1/oa_pdf/00/7a/yjbm_86_1_29.PMC3584493.pdf
Available from:  http://thenationshealth.aphapublications.org/  content/39/7/6.1.extract.,Non-OADS,/arxiv_data1/oa_pdf/00/7a/yjbm_86_1_29.PMC3584493.pdf
Avail - able from: http://www.cdc.gov/cdctv/Obesi - tyEpidemic/.,Non-OADS,/arxiv_data1/oa_pdf/00/7a/yjbm_86_1_29.PMC3584493.pdf
Available from  http://www.cdc.gov/Features/OlderAmeri - cansMonth/.,OADS,/arxiv_data1/oa_pdf/36/7b/yjbm_86_1_41.PMC3584494.pdf
Available from http://www.kff.org/medic - aid/upload/8081.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/7b/yjbm_86_1_41.PMC3584494.pdf
A vailable from  https://www.cms.gov/TheChartSeries/Down - loads/ChartbookFinal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/7b/yjbm_86_1_41.PMC3584494.pdf
[cited 2011 Nov 10] Available from:  http://www.kff.org/entmedia/upload/genera - tion-m-media-in-the-lives-of-8-18-year-olds-  report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/c4/yjbm_86_1_49.PMC3584495.pdf
Available from:  http://www.pewinternet.org/Reports/2008/Writ - ing-Technology-and-Teens/04-The-Lives-of-  T eens-and-Their-T echnology/02-Nearly-all-teens-  use-the-internet.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1c/c4/yjbm_86_1_49.PMC3584495.pdf
Available  from: http://www.cdc.gov/nchs/data/hestat/obe - sity_child_07_08/obesity_child_07_08.htm.,Non-OADS,/arxiv_data1/oa_pdf/1c/c4/yjbm_86_1_49.PMC3584495.pdf
Avail - able from: http://www.americanheart.org/down - loadable/heart/1265665152970DS-3241%20He  artStrokeUpdate_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/yjbm_86_1_5.PMC3584496.pdf
Available from: http://www.nursecreden - tialing.org/Magnet/FindaMagnetFacility.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1e/3d/yjbm_86_1_63.PMC3584497.pdf
Available  from: http://www.acestar.uthscsa.edu/acestar-  model.asp.,Non-OADS,/arxiv_data1/oa_pdf/1e/3d/yjbm_86_1_63.PMC3584497.pdf
Available from:  http://ohsr.od.nih.gov/guidelines/belmont.ht  ml.,Non-OADS,/arxiv_data1/oa_pdf/f2/63/yjbm_86_1_89.PMC3584499.pdf
Tremor Other Hyperkinet Mov 2011;1: http://tremorjournal.org/article/view/55 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Also absent from most datasets are theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Deep Brain Stimulation for Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Deep Brain Stimulation for Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Expert Rev Med Devices 2004;1:33–41, http://dx.doi.org/10.1586/ 17434440.1.1.33.",Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Brain 2008;131:1895–1902, http://dx.doi.org/10.1093/brain/awn120.",Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Neurotherapeutics 2008;5:320–330, http://dx.doi.org/10.1016/j.nurt.2008.01.002.",OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Deep Brain Stimulation for Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Neuroscience 2008;152:558– 571, http://dx.doi.org/10.1016/j.neuroscience.2008.01.001.",OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Neurosurgery 2004;55:1361–1368; discussion 68–70, http://dx.doi.org/10.1227/ 01.NEU.0000143331.86101.5E.",Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Mov Disord 2002;17:138–144, http://dx.doi.org/10.1002/mds.1250.8.Vasques X, Cif L, Gonzalez V, et al.",OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Mov Disord 2009;24:846–853, http://dx.doi.org/10.1002/mds.22433.",OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Acta Neurochir (Wien) 2009;151:473– 478; discussion 78, http://dx.doi.org/10.1007/s00701-009-0281-x.",Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Mov Disord 2003;18:303–312, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/96/4e/tre-02-55-272-1.PMC3584502.pdf
"Thesis of Master of Arts, Texas A & M University, 2011 (accessedonline on the 14 thof January 2013, at http://repository.tamu.edu/bitstream/ handle/1969.1/ETD-TAMU-2011-08-10126/BROWN-THESIS.pdf).",Non-OADS,/arxiv_data1/oa_pdf/b5/66/srep01296.PMC3584573.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Charlier, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/66/srep01296.PMC3584573.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ba/92/srep01319.PMC3584574.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Pais-Vieira, M., Lebedev, M., Kunicki, C., Wang, J.",Non-OADS,/arxiv_data1/oa_pdf/ba/92/srep01319.PMC3584574.pdf
http://info.can- cerresearchuk.org/cancerstats/keyfacts/.,Non-OADS,/arxiv_data1/oa_pdf/d4/b8/ORT-84-40.PMC3584601.pdf
Available from http://www.stat.fi/til/ksyyt/2003/ksyyt_2003_2005-05-31_tau_001_en.html.,OADS,/arxiv_data1/oa_pdf/5e/40/ORT-84-44.PMC3584602.pdf
"http://www.terveys2000.fi/julkaisut/baseline.pdf Aronson D D, Singer R M, Higgins R F. Skeletal traction for fractures of the  femoral shaft in children.",Non-OADS,/arxiv_data1/oa_pdf/77/13/ORT-84-71.PMC3584607.pdf
"Publications of the National Public Health Institute, B 25 / 2007. http://www.ktl.fi/portal/2920 Kellgren J H, Lawrence J S. Radiological assessment of osteo-arthrosis.",Non-OADS,/arxiv_data1/oa_pdf/77/13/ORT-84-71.PMC3584607.pdf
"In contrast, the American Academy of Orthopedic Surgeons, in a recently posted information statement, favored the administration of antibiotic prophylaxis prior to GI endoscopic procedures in patients with joint arthroplasties(http://www.aaos.org/about/papers/advistmt/1033.asp).",Non-OADS,/arxiv_data1/oa_pdf/4b/5b/ORT-84-82.PMC3584609.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Electromagnetic ﬁeld for osteogenesis KS Kang et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/cb/61/emm201311a.PMC3584658.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Anticancer effect by restoring miR-636 expression J-Y Jang et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/e7/4b/emm20131a.PMC3584659.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Potential use of MSCs in HSCT E-J Kim et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/0e/1b/emm20132a.PMC3584660.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Experimental & Molecular Medicine website (http://www.nature.com/emm)DC vaccination using RG-II retards the tumor growth SN Park et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/85/0c/emm201314a.PMC3584663.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/APC differentially regulates BP effects on osteoblasts Y-J Lee et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d8/69/emm201316a.PMC3584664.pdf
GTG-banding (G-banding by trypsin and Giemsa stain) with 450 bands of resolution wasconducted in a clinical Cytogenetics Laboratory at Ajou UniversityHospital (http://www.ajoumc.or.kr).,OADS,/arxiv_data1/oa_pdf/26/33/emm201321a.PMC3584665.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Retroviral transduction of MSC JS Park et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/26/33/emm201321a.PMC3584665.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Negative modulation of TLR signaling MA Anwar et al 14 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/ad/d4/emm201328a.PMC3584666.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Identiﬁcation of genetic locus for type 2 diabetes M-H Park et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/5f/76/emm20135a.PMC3584667.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Screening for mutations in multiple myeloma E Leich et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/9b/19/bcj201247a.PMC3584721.pdf
"4      http://www.jcancer .org 170  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 170-171. doi: 10.7150/ jca.5882  Editorial   Special Issue on Precision Risk Stratification -Based  Screening in Colorectal Cancer   Alexander Stojadinovic1, Itzhak Avital2, Scott Steele3  1.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jcav04p0170.PMC3584830.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jcav04p0170.PMC3584830.pdf
"During the past year we have witnessed not only  a multi -faceted national effort to improve quality and  value of cancer c are aligned with the Institute for  Healthcare Improvement’s “triple aim” Initiative [improving the individual patient care experience, the  health of populations, and thereby the efficiency and cost of care], but also realized several major clinical  advance s in cancer treatment [http://www.ihi.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jcav04p0170.PMC3584830.pdf
"4    http://www.jcancer .org 171  patient -specific tumor biology, genetic make -up and  epigenetic regulation.",Non-OADS,/arxiv_data1/oa_pdf/bc/6e/jcav04p0170.PMC3584830.pdf
"4      http://www.jcancer .org 172  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 172-192. doi: 10.7150/ jca.5834  Review  Evidence -Based Guidelines for Precision  Risk Stratific a- tion-Based Screening (PRSBS)  for Colorectal Cancer :  Lessons Learned from the US Armed Forces: Consensus  and Future Directions   Itzhak Avital1,2,3,4, Russell C. Langan5, Thomas A. Summers3,6, Scott R .",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
This is an open -access article distributed under the terms of the Crea tive Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 173  risk stratif ication of  patients with CRC and identify those who may benefit from preventive  measures, early aggressive treatment, alternative treatment strategies, and/or frequent survei l- lance for the early detectio n of disease recurrence.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 174  fact, in and of itself, represents a significant oppo r- tunity to transform cancer screening a nd care through  population- based initiatives of outreach, education  and stimulus aimed at improving compliance with  recommended CRC screening, and reducing ca n- cer-specific mortality.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 175  routine screening for CRC in adults 76 to 85 years of  age; however, it  deemed that  certain unique consi d- erations for patient s on a case -by-case basis may  support its use [11] .",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 176  The American College of Gastroenterology  supported the division of screening tests into cancer  prevention and cancer detection modalities and r e- leased formal screening guidelines in 2008 [13].,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 177  administered in addition to CT barium su lfate along  with diatr izoate meglumine and diatrizoate sulfate for  stool tagging [6].,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 178  Study: First  Author, Year  (Reference  No.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 179  Hassan, 2007 (44)  10 years, all findings  Sn: 95  Sp: 86 97 FSIG, COL  CS Dominant vs. FSIG,  ICER COL vs. CTC:  14,600   Ladabaum, 2004 (53)  10 years, all findings  Sn: 95  Sp: 85 1,037  COL  36,300  Dominated by  COL   Pickhardt, 2007 (19)  10 years, findings 6+ mm  Sn: 95  Sp: 86 555 FSIG, COL  5,100  Dominant vs. FSIG,  ICER COL vs. CTC:  74,200   Sonnenberg, 2000 (54)  10 years, all findings  Sn: 80  Sp: 95 741 COL  17,800  Dominated by COL   Vijan, 2007 (23)  5 years, all findings  Sn: 91  Sp: 91 707 gFOBT, COL, FSIG,  FSIG + gFOBT  10,300 –21,800  197,200   Zauber, 2009 (MISCAN)  (22)  5 years, findings 6+ mm  Sn: 84–92  Sp: 80–88 522 gFOBT, SENSA,  COL, FSIG, FIT, FSIG  + gFOBT  9,500 –10,200  Dominated by COL,  FSIG + gFOBT   Zauber, 2009 (SimCRC)  (22)  5 years, findings 6+ mm  Sn: 84–92  Sp: 80–88 522 gFOBT, SENSA,  COL, FSIG, FIT, FSIG  + gFOBT  3,600 –4,200  Dominated by COL,  FSIG + gFOBT   Zauber, 2009  (CRC -SPIN) (22)  5 years, findings 6+ mm  Sn: 84–92  Sp: 80–88 522 gFOBT , SENSA,  COL, FSIG, FIT, FSIG  + gFOBT  1,900 –2,100  Dominated by COL,  FSIG + gFOBT   Abbreviations: CER, cost -effectiveness ratio compared with no screening; COL, colonoscopy; CS, cost -saving; CTC, computed tomographic colonography; FIT,  fecal immunochemical test; FSIG, flexible sigmoidoscopy; gFOBT, guaiac fecal occult blood test with Hemoccult II (Beckman Coulter, Inc., Brea, Cal ifornia);  ICER, incremental cost -effectiveness ratio; SENSA, guaiac fecal occult blood test with Hemoccult SENSA (Beckman Coulter).",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 180  27].,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 181  Table 5 : Advantages and limitations of current screening methods   Methods   Efficiency   Insufficiency or drawbacks  Reference   FOBT or   FIT Easiest , least expensive m ethod for screening   Reduce s cancer mortality 15% to 33%   Specificity ranging from 88% to 98%  Detects only 30 –40% of CRC   Detects 10% of late stage adenomas  18-24  sDNA  Sensitivity ranging from 52% to 91%   Specificity ranging from 93% to 97%  Detects only late stage lesions  25-29  FSIG Directly inspect s the mucosal surface   Ability to r esect identified  abnormalities   Reduce s CRC mortality  Fails to detect polyps in the proximal colon, where  40% of all cancers occur, Fails to detect  10–15%  sigmoid colon cancers   30-40  COL Directly inspect s the mucosal surface   Ability to r esect identified  abnormalities   Reduce s CRC mortality    Ability to p erform interventions for other diseases   Current gold standard for detection and   treatment  Invasive and time consuming   Requires bowel preparation   Costly   Carries risk of perforation  or death   May miss up to 10 –20% of polyps < 1 cm  41-53  DCB E Sensitivity for detecting polyps and  cancer are about 7 0%  and 85%, respectively   Less invasive  procedure  Doesn’t permit removal of  identified  abnormal i- ties  Less specific  screening test  54-56  CTC  Sensitivity for detecting adenoma s ≥5 mm ranging from   65-72%  Sensitivity for detecting large r adenoma s ranging from  80-85%  Less invasive than C OL Delivers a significant ly higher  amount of radi a- tion exposure ( 2-4 rad) than routine chest radi o- graph (0.5 rad)  57-62    Table 6 : Comparison of the estimated costs of USPSTF recommended screening methods   N0 Screening method  Frequency  Cost/screening ($)  10-year cost ($)   1 FOBT or FIT  Annually   5-10  50-100  2 FSIG  Every 5 -years   70-600  140-1,200   3 DCBE  Every 5 -years   600-1000   1,200 -2,000   4 COL Every 10 -years   250-5000   250-5,000       Together, these technical limitations and the  preparation necessary for the screening examination appear to not only negatively impact the efficiency of  CRC screening, but also represent major factor s con- tributing  to a low compliance rate amongst the  screen -eligible population .",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 182  up-regulated in the early phases of tumorigensis such  as adenomatous polyps and colonic epithelium  proximal to tumor [31] .,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 183  of both CRC and critical precursor lesions”  throug h- out the colon and rectum [39].,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 184  DNA methylation biomarkers in colorectal cancer: Potential  for screening and early detection .,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 185  magnification endoscopy, confocal microscopy, opt i- cal coherence tomography, and narrow -band ima g- ing.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 186  develop systemic metastasis or recurrent lesions,  while none of the current approaches can reliably  identify th is at -risk subset of  patients for early inte r- ventions.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 187  D. Chronic ulcerative colitis, Crohn ’s colitis, familial juvenile polyposis , and others, 1%   E. The risk in a 40 -year -old person with a family hi story of colorectal carcinoma is comparable to that in an average -risk  50-year -old person.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 188  eligible population at large.,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 189  in training for screening guidelines in high -risk CRC  populations.,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4    http://www.jcancer .org 190  CTC: computed tomographic colonography   DCBE: double -contrast barium enema   FIT: fecal immunochemical tests   FOBT: fecal occult blood testing   GUCY2C: guanylyl cyclase C   H&E: hematoxylin and eosin   IHC: immunohistochemisty MHS: Military Health System   mlBBN: Machine learned Bayesian Belief Net- work   PRSBS: Precision risk stratification based  screening   RDA: Representational difference analysis   ROC: receiver operating characteristic s curve   RT-PCR: reverse transcriptase polymerase chain  reaction   sDNA: stool DNA test      Sn: sensitivity   Sp: specificity                                                                                  TNM: Tumor -Node -Metastasis   U.S.: United States   USMCI: United States Military Cancer Institute   USPSTF: United States Preventive Services Task  Force   VC: virtual colonoscopy (also CT colonography)   Acknowledgement   The authors are grateful to Tiffany Felix for her  editorial assistance with this collaborative effor t.   Funding : This work is supported by the Tele- medicine and Advanced Technology Research Center, the Henry M. Jackson Foundation for the Advanc e- ment of Military Medicine, the California Oncology  Research Institute, INCORE, International Consort i- um of Resea rch Excellence of the The- odor -Billroth -Academy [TBA ®], and the United  States Military Cancer Institute.",Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 191  16.,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
4    http://www.jcancer .org 192  71.,Non-OADS,/arxiv_data1/oa_pdf/77/0e/jcav04p0172.PMC3584831.pdf
"4      http://www.jcancer .org 193  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 193-199. doi: 10.7150/ jca.5830  Review  Molecular Staging of Node Negative Patients with  Colorectal Cancer   Terry Hyslop and Scott A. Waldman   Department  of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA     Corresponding author : Scott A. Waldman, MD, PhD , 132 South 10th Street, 1170 Main , Philadelphia, PA 19107 , USA.",Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
4    http://www.jcancer .org 194  predictive value of lymph node metastases is re- stricted [1 -5].,Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
"4    http://www.jcancer .org 195  being administered to patients who derive no benefit,  and may suffer adverse reactions.",Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
4    http://www.jcancer .org 196  clinical trial.,Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
"4    http://www.jcancer .org 197  Occult tumor burden was an independent marker of  prognosis and patients with MolInt and MolHigh  disease exhibited a graded risk of earlier time to re- currence (MolInt, adjusted hazard ratio 25.52  [11.08- 143.18]; P<0.001; MolHigh, 65.38 [39.01 -676.94];  P<0.001) and lower disease -free survival (MolInt, 9.77  [6.26 -87.26];  p<0.001; MolHigh, 22.97 [21.59- 316.16];  P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
4    http://www.jcancer .org 198  information from tumors to enhance staging alg o- rithms to improve outcomes.,Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
4    http://www.jcancer .org 199  19.,Non-OADS,/arxiv_data1/oa_pdf/87/b3/jcav04p0193.PMC3584832.pdf
"4      http://www.jcancer .org 200  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 200-209. doi: 10.7150/ jca.5858  Review  Advances in CT Colonography for Colorectal Cancer  Screening and D iagnosis   Judy Yee, Stefanie Weinstein, Tara Morgan, Patrick Alore, Rizwan Aslam   Dept.",Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
"4    http://www.jcancer .org 201  imbursement for diagnostic CTC is available, alt- hough screening CTC is still not reimbursable by the  Centers for Medicare and Medicaid Services (CMS).",Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 202  and the patient is instructed to ingest 10 ounces in the  late afternoon or early evening on the day prior to the  CT scan.,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
"4    http://www.jcancer .org 203  compliance due to abdominal discomfort, nausea, and  bloating.",Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 204  the CO2.,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 205  Results showed that the benefit to risk ratio was very  high ranging from 24:1 to 35:1 and that the benefits of  CTC screening clearly outweigh the risks.,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 206     Figure 2  - Pedunculated Polyp – Axial view (A) shows a large pedunculated polyp with a short stalk in the sigmoid colon.,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 207  sity polyps are removed along with tagged material  causing incorrect sizing or false negatives.,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 208  oscopy among the study group[51 ].,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
2009  http://www.acr.org/SecondaryMainMenuCategories/quali ty_safety/guidelines/d x/gastro/ct_colonography.aspx .,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
4    http://www.jcancer .org 209  47.,Non-OADS,/arxiv_data1/oa_pdf/6d/2b/jcav04p0200.PMC3584833.pdf
"4      http://www.jcancer .org 210  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 210-216. doi: 10.7150/ jca.5839  Review  Serum -Based DNA Methylation Biomarkers in Colo- rectal Cancer: Potential for Screening and Early Dete c- tion  Thomas Summers1, Russell C. Langan2, Aviram Nissan3,4,5, Björn L.D.M Brücher4, 5, 12 , Anton J. Bilchik4, 5,  6,7, Mladjan Protic4,5,8,9, Martin Daumer5,10, Itzhak Avital4,5,11,12 , Alexander Stojadinovic1,4,5,12   1.",Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
"4    http://www.jcancer .org 211  Advances are urgently needed from the key  stakeholders in translational cance r research, which  will impact cancer -related mortality in the near- term.",Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
"4    http://www.jcancer .org 212  throughput research tools are becoming less expen- sive, robust, and more efficient.",Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
4    http://www.jcancer .org 213  Potential for Development of DNA  Methylation- based Biomarker Tests for  CRC Screening    Analysis of DNA methylation using cfcDNA  can  facilitate the development of very accurate b i- omarkers for screening and early detection if re- searched and developed appropriately.,Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
"4    http://www.jcancer .org 214  The advantages of utilizing DNA methyla- tion- based tests in screening and early CRC detection  also include the ability to compare test results to a b- solute reference points (c ompletely methylated or  completely unmethylated DNA), which simplifies the  design of internal references for methylation assays.12  Additionally, methylation assays for individual  markers tend to be universal, just like gene- expression  markers.",Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
4    http://www.jcancer .org 215  Table 2 .,Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
4    http://www.jcancer .org 216  National Institutes of Health workshop.,Non-OADS,/arxiv_data1/oa_pdf/d2/49/jcav04p0210.PMC3584834.pdf
4      http://www.jcancer .org 217  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 217-226. doi: 10.7150/ jca.5829  Review  Colonoscopy for Colorectal Cancer Screening   Patrick E. Young1 and  Craig M. Womeldorph2  1.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org /  licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 218  Several studies have shown that colonoscopy with  polypectomy is effective at decreasing CRC (see se c- tion II).,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 219  studies represent the best available science on which  clinicians must base patient care decisions.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 220  3.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 221  herence to an accepted group of quality indicators.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
"4    http://www.jcancer .org 222  histology , number removed, location in the right  hemi -colon, and current anti -coagulation use.",Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 223  be seen if these results are replicable in a community  setting.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 224  educate the public about the importance of colorectal  screening are needed.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 225  34.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
4    http://www.jcancer .org 226  87.,Non-OADS,/arxiv_data1/oa_pdf/ab/b7/jcav04p0217.PMC3584835.pdf
"4      http://www.jcancer .org 227  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 227-240. doi: 10.7150/ jca.5835  Review  Significance of Infectious Agents in Colorectal Cancer  Development   Vlado  Antonic1,2,3, Alexander Stojadinovic1,3,4,5,6 , Kent E. Kester1,6,7, Peter J Weina6,7, Björn LDM Brücher8,9,  Mladjan Protic5,10,11, 12, Itzhak  Avital6,8, Mina Izadjoo1,2,3,6  1.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"4    http://www.jcancer .org 228  cases of CRC is estimated for the U.S. in 2012 with  disease -specific mortality of up to 60,000 reported in  2011.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"4    http://www.jcancer .org 229  lished opinion amongst biologists and medical scie n- tists, that this bacterial “burden” is not harmful, on  the contrary, very beneficial.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"4    http://www.jcancer .org 230  Since the mid -70’s, several clinical studies eva l- uated the association of S.bovis/galloliticus  with CRC  and demonstrated different, if not contradictory r e- sults.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 231  which is one of its proposed mechanisms for the d e- velopment of neoplastic changes.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 232  more reports showing that K. pneumoniae is the most  common cause of PLA within western countries as  well (60).,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 233  double stranded linear DNA viruses.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"4    http://www.jcancer .org 234  for HPV 16, 18 or both (79).",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"4    http://www.jcancer .org 235  evidence to support a correlation between CRC and  the presence of HPV, and t hey recommended conti n- uing research in this regard.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 236  when coupled with clinical data provide a better u n- derstanding of so- called “good” and “bad” bacteria.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"However, according to 2009  Humana Military’s Clinical Quality Report Card  (http://www.humana -military.com/library/pdf/qm -report -card -2009.pdf) screening rates remain low,  less than 60%.",Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 237  needed and warranted in order to better understand  the association between infectious agents and human  cancer development.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 238  cancer at an early stage of tumorigenesis.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 239  56.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
4    http://www.jcancer .org 240  96.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
Cancer prevention & early detection  facts & figures 2008. http://www.cancer.org/research/   cancerfactsfigures/cancer -prevention- early -detection- facts -figures -2008.,Non-OADS,/arxiv_data1/oa_pdf/28/cf/jcav04p0227.PMC3584836.pdf
"4      http://www.jcancer .org 241  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 241-250. doi: 10.7150/ jca.5832  Review  Colorectal Cancer Biomarkers and the Potential Role of  Cancer Stem Cells   Russell C. Langan1, John E. Mullinax2, Manish T. Raiji1, Trevor Upham1, Thomas Summers3, Alexander  Stojadinovic4,5, Itzhak Avital6   1.",Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4    http://www.jcancer .org 242  ogy is to identify those patients who would most  benefit from adjuvant trea tments and intensive  post -treatment surveillance protocols.,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4    http://www.jcancer .org 243  detectable K -ras mutations in the serum27.,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4    http://www.jcancer .org 244  response  rates similar to patients with BRAF(V600E)  melanoma when given vemurafenib.,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
"4    http://www.jcancer .org 245  Properties that define pot ential CSC’s are: [1]  self-renewal; [2] the capacity for differentiation (a l- lowing for recapitulation of all cell types of the origi- nal tumor); [3] tumor initiating capacity; and, [4]  asymmetric cell division via non -random chromos o- mal co -segregation49,58.",Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
"4    http://www.jcancer .org 246  There are various methods of CSC identification  in vitro; however, there i s currently no consensus on a  universally acceptable method48-51, 56,59.",Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
"4    http://www.jcancer .org 247  of protein expression 66,67,68,59.",Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4    http://www.jcancer .org 248  lon progenitor cells found exclusive expression of  leucine -rich-repeat -containing G- protein- coupled r e- ceptor 5 (Lgr5) in the crypt cells of the colon.,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4    http://www.jcancer .org 249  IFITM3 as a biomarker of early colon carcinogenesis.,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4    http://www.jcancer .org 250  57.,Non-OADS,/arxiv_data1/oa_pdf/43/f2/jcav04p0241.PMC3584837.pdf
4      http://www.jcancer .org 251  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 251-261. doi: 10.7150/ jca.5838  Review  Advances in Biophotonics Detection of Field Carcin o- genesis for Colon Cancer Risk Stratification   Vadim Backman1 and Hemant K. Roy2   1.,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
"4    http://www.jcancer .org 252  form, throughout the colon.",Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
"4    http://www.jcancer .org 253  ways may be manifested as common microarchite c- tural/ microvasclar consequences, making them r e- markably sensitive to the field effect.",Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
4    http://www.jcancer .org 254  cells may still appear to be histologically normal.,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
4    http://www.jcancer .org 255    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
"4    http://www.jcancer .org 256  dubbed an early increase in microvascular bl ood  supply (EIBS)[35, 46] .",Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
4    http://www.jcancer .org 257  structural alterations in both colonocytes and ECM  lead to similar optical changes makes it convenient to  assess bo th simultaneously by means of a single LEBS  reading with a penetration depth ~100 µm.,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
"4    http://www.jcancer .org 258  foci (ACF) time point, as early as 2-5 weeks after AOM  administration.",Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
"4    http://www.jcancer .org 259  to-oncogene but also the LEBS -detectable alterations  and Ld increase were mitigated by treatment with a  cytoskeletal inhibitor colchicine and by  EB1-knockdown, thus indicating cytoskeletal abno r- malities in the histologically normal cells in early ca r- cinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
4    http://www.jcancer .org 260  sive.,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
4    http://www.jcancer .org 261  normal colonic mucosa: Biomarker for neoplasia risk.,Non-OADS,/arxiv_data1/oa_pdf/ba/70/jcav04p0251.PMC3584838.pdf
"4      http://www.jcancer .org 262  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 262-269. doi: 10.7150/ jca.5831  Review  Patients  at Risk for  Peritoneal Surface Malign ancy of  Colorectal Cancer Origin: The Role of Second  Look  Laparotomy   Björn LDM Brücher1,7,8, Alexa nder Stojadinovic2,8, Anton J. Bilchik3,8, Mladjan Protic4,8, Martin Daumer5,8,  Aviram Nissan6,8, Itzhak Avital7,8  1.",Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
4    http://www.jcancer .org 263  (QOL) and limited survival.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
"4    http://www.jcancer .org 264  centers of excellence investigating second laparotomy  accumulates important insights will be gained, pa r- ticularly defining an optimal time point following  operation f or the primary CRC when a second lap a- rotomy should be performed.",Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
4    http://www.jcancer .org 265  most clinically relevant in selected at -risk patients at a  time when peritoneal tumor burden is low.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
4    http://www.jcancer .org 266  aroscopic second look operation is  unclear.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
4    http://www.jcancer .org 267  may risk stratify patients and individualize applic a- tion of second look laparotomy and CRS + HIPEC  as  well as yield agent specific predictions of targeted  systemic therapy response.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
4    http://www.jcancer .org 268    Figure 2 : Resected CRC  / Considered for 2nd Look in High Risk for PSM     Abbreviations   PSM: Per itoneal Surface Malignancy   CEA: carcinoembryonic antigen   CRC: Colorectal Cancer   CRS: Cytoreductive  Surgery   5-FU: 5 -Flourouracil   FOLFOX: 5 -FU + Leucovorin + Oxaliplatin   HA-CMC: Hyaluronate -carboxymethylcellulose   HIPEC: Heated intra -peritoneal chemotherapy   IFL: Irinotecan + 5 -FU/Leucovorin   IROX: Irinotecan + Oxaliplatin   NCCTG: North Central Cancer Treatment Group   PCI: Peritoneal Cancer Index   QOL: Quality of Life   RCT: Randomized Controlled Trial   VEGF: Vascular Endothelial Growth Factor   Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
4    http://www.jcancer .org 269  developing colorectal peritoneal carcinomatosis.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/jcav04p0262.PMC3584839.pdf
"4      http://www.jcancer .org 270  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 270-280. doi: 10.7150/ jca.5833  Review  Colorectal Cancer Screening in an Equal Access  Healthcare System   Mia DeBarros , Scott R. Steele  Department of Surgery, Madigan Healthcare System, Tacoma, Washington , USA.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
"4    http://www.jcancer .org 271  ing only $71 and $1,397 per person  for fecal occult  blood testing (FOBT) and colonoscopy, respectively6.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 272  version of Hemoccult II was abandoned in the 1980s  by most investigators because a standard rehydration  technique had not been established17.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 273  Current Colorectal Screening Guidelines  and Future Directions   Several different national and international or- ganizations ranging from the National Cancer Coal i- tion Network (NCCN) to professional societies such  as the American College of Gastroenterology (ACG)  and American Society of Colon & Rectal Surgeons  (ASCRS) provide clinical practice guidelines (CPGs)  for the care and prevention of colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
"4    http://www.jcancer .org 274  screening and; c) are the newly developed screening  tests (i.e., FIT, sDNA, CTC and capsule endoscopy)  cost-effective compared with the established CRC  screening modalities.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 275  a modality for this screening.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 276  role in the attitudes and actions of individual p a- tients —these are magnified when any large group of  people are “clumped” together —especially in regards  to race.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 277  barrier in a 2011 study and conducted a RCT in which  patients were mailed FIT and FOBT cards after being  contacted via phone or mail in the intervention  groups or continued with usual  care in the control  group.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 278  emphasizes the need for both in- reach and out -reach  programs to increase the CRC screening rate.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
http://www.cdc.gov/uscs.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
3 [Internet] http://seer.cancer.gov/csr/1975_2009_pops09/   results_single/sect_01_table.01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
"Rockville, MD: Agency for Healthcare Research and Quality;  2008.  http://www.uspreventiveservicestaskforce.org/uspstf/   uspscolo.htm.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
Healthy peo- ple 2020.  http://www.healthypeople.gov/2020/topicsobjectives2020/   default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 279  29.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
"http://seer.cancer.gov/csr/1975 -2000, 2003   75.",Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
http://www.census.gov/   newsroom/releases/archives/population/cb08 -67.html   80.,OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
4    http://www.jcancer .org 280  83.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
[Internet]  http://www.health.mil/About_MHS/FAQs.aspx    101.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
http://health.mil/About_MHS/StakeholdersReport.aspx   102.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
[Internet]  http://www.va.gov/health/aboutVHA.asp .,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Pu blicationsPolicyAndGuidance/DH_132961   109.,Non-OADS,/arxiv_data1/oa_pdf/2c/41/jcav04p0270.PMC3584840.pdf
"4      http://www.jcancer .org 281  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(3): 281-295. doi: 10.7150/ jca.5836  Review  The Diagnostic and Prognostic Role of microRNA in  Colorectal Cancer –  a Comprehensive review   Haggi  Mazeh1, Ido  Mizr ahi1, Nadia  Ilyayev1, David  Halle1, Björn LDM Brücher1,2,3,4, Anton  Bilchik2,3,4,5,  Mladjan  Protic2,3,4,6, Martin  Dau mer2,3,7, Alexander  Stojadinovic2,3,4, 8, Itzhak  Avital7,8, Aviram  Nissan2,3,4,9  1.",Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 282  cancer mortality.1  The lifetime incidence of CRC in the average- risk  population living in North America and Western E u- rope is  5%.,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"4    http://www.jcancer .org 283  However, procedural competence varies among e x- aminers and the cecum is reached in 80 –98% of pr o- cedures, with the depth of penetration depending  mainly on the experience of the endoscopist and the  adequacy of bowel preparation.",Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"4    http://www.jcancer .org 284  repair, manifested by microsatellite instability (M SI).24  Other molecular pathways leading to CRC are  the CpG islands promoter hypermethylation (CIMP)  including several different molecular pathways cha r- acterized by CIMP.25-30 Colorectal cancer may also be  detectable through the use of DNA markers assoc i- ated with disordered apoptosis.31 Several studies u s- ing fecal- based DNA testing have reported a sensiti v- ity of 62 -91% for cancer and 27- 82% for advanced  adenomas, with a specificity of 93 -96% in persons  with normal findings on colonoscopy.32-36 However,  those  studies were conducted in patients with a d- vanced, symptomatic lesions.",Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"Since the first miR  discovery in the Caenorhabditis Elegans  worm in 1993,  numerous different miRs were identif ied in plants,  animals, and humans.44 At present, 2042 mature h u- man miRs are listed in the updated database  (http://www.mirbase.org).",OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 285  protein -coding genes are controlle d by miRs49.,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 286  miR-221 also correlated with prognosis as well as with  p53 expression.,OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"4    http://www.jcancer .org 287  regulation of miR -320, miR -420, miR -498, and  miR-526c) correl ated with recurrence- free survival in  AJCC- stage II CRC patients by a multivariate analy- sis.88 Kaplan -Meier survival curves showed that p a- tients diagnosed with AJCC -stage II CRC bearing  tumors with high expression of miR -320 or miR -498  showed a significant  difference in progression -free  survival compared to patients bearing tumors with  low expression.88 Yantiss et al demonstrated that CRC  patients younger than 40 years of age had more a g- gressive tumors and upregulation of miR -20a, miR -21,  miR-145, miR -181b,  and miR -203.123 Wang et al ide n- tified positive correlation between miR -31 and ad- vanced AJCC- TNM stage.82 Schetter et al identified  that miR -21 expression was associated with infla m- matory cytokines expression (IL -6, IL -8, IL -10, IL -12a,  and NOS2a) as well as cancer -specific mortality.124 Pu  et al showed that circulating plasma levels of miR -221  are associated with poor overall survival in CRC p a- tients.112 Chiang et al identified that low expression of  miR-203 was correlated with tumor size and pT  stage.71 Nielsen et al using a multivariate analysis,  showed that upregulation of stromal miR -21 signif i- cantly correlates with shorter disease -free survival in  AJCC- stage II colon (but not rectal) cancer patients.125  Feng et al confirmed that upregulation of miR -21 was  associated with advanced tumor stage.126 Wang et al  showed that downregulation of miR -195 was an i n- dependent predictor of overall survival and it was  upregulated  more often in CRC patients with lymph  node metastasis and advanced tumor stage, compared to patients with early, node -negative disease.",Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 288  ring in various regions of the human genome were  shown to have significant value in both risk for d e- veloping cancer in a given population and as predi c- tive markers.,OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"4    http://www.jcancer .org 289    Table 2. miR dysregualtion in serum or fecal samples   Source  Dysregulation  Number of studies   miRs and references   Serum  Upregulated  3 miR-221110,112,115   2 miR-2176,113; miR-92a96,115; miR -222110,111   1 miR-Let-7e115; miR -17-3p111; miR -19a115;   miR-22*115; miR -23a110; miR -24115; miR -29a96;   miR-92111; miR -95111; miR -125-5p115; miR -134110;  miR-135b111; miR -141114; miR -146110; miR -210115;  miR-376a115  Downregulated  1 miR-10a115; miR -141115; miR -150115; miR -188-3p115;   miR-192115; miR -224*115; miR -425*115; miR -495115;  miR-572115; miR -601115; miR -720115; miR -760115;   Let-7a115  Feces  Upregulated  4 miR-2172,116 -118  1 miR-17118; miR -18a118; miR -19a118;   miR-19b-1118; miR -20a116; miR -92116; miR -92a72;  miR-96116; miR -106a116; miR -106b117; miR -135118;  miR-144120; miR -203116; miR -326116  Downregulated  2 miR-143116,121 ; miR -145116,121   1 miR-16116; miR -125b116; miR -126116; miR -320116;  miR-484-5p116    Table 3.",Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 290  miR-21 and miR -155 expression levels in CRC tissue were independent progno s- tic factors for OS and DFS.,OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 291  Nishida131 2012  miR-10b 88  miR-10b over expression was associated with high incidence of lymphatic inv a- sion (P  = 0.0257) and poor prognosis (P  = 0.0057).,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"4    http://www.jcancer .org 292  others used serum, the timing between blood sa m- pling and separation of the serum/plasma is critical,  and so is the methods in which the samples were  stored.",Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 293  38.,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 294  91.,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
4    http://www.jcancer .org 295  141.,Non-OADS,/arxiv_data1/oa_pdf/e8/0c/jcav04p0281.PMC3584841.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Schwarz, J.P., Gao, R.S., Perring, A.E., Spackman, J.R. & Fahey, D.W. Black carbon aerosol size in snow.",Non-OADS,/arxiv_data1/oa_pdf/0e/d0/srep01356.PMC3584901.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ta, V.D., Chen, R. & Sun, H.D.",Non-OADS,/arxiv_data1/oa_pdf/34/f0/srep01362.PMC3584906.pdf
"9      http://www.biolsci.org  190  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2013; 9(2):190-199.  doi: 10.7150/ ijbs.5844  Research Paper   Temporal Profile of Astrocyte s and Changes of Ol i- godendrocyte -Based  Myelin Following Middle Cerebral  Artery Occlusion  in Diabetic and Non -diabetic Rats   Li Jing1, 2, Qingping He1, Jian -Zhong Zhang2, P. Andy Li1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  191  from oxidative stress  [8].,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  192  were exposed.,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  193  considered as statistically significant.,OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  194    Fig.,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
"9    http://www.biolsci.org  195  less in hyperglycemic animals than in normoglycemic  animals subjected to ischemia and reperfusion at 7, 14,  an 28 days.",Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  196    Fig.,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9      http://www.biolsci.org  197  Discussion   Diabetes aggravates  cerebral ischemic da m- age  We have previously shown that diabetes acce l- erates and enlarges ischemic brain damage in early  reperfusion phase [7].,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  198  ty.,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
9    http://www.biolsci.org  199  Brain Damage Under Hyperglycemic Conditions by Altering  Autophagy.,Non-OADS,/arxiv_data1/oa_pdf/0b/de/ijbsv09p0190.PMC3584915.pdf
"9      http://www.biolsci.org  200  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2013; 9(2):200-208. doi: 10.7150/ ijbs.5613   Review  Interferon Induced IFIT Family Genes in Host Antiviral  Defense   Xiang Zhou1,2, Jennifer J. Michal1, Lifan Zhang1, Bo Ding1, Joan K. Lunney3, Bang Liu2 and Zhihua Jiang1  1.",Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
"9    http://www.biolsci.org  201  thus improving therapy of infectious diseases in h u- man, as well as in animals.",Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
9    http://www.biolsci.org  202    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
"9    http://www.biolsci.org  203  pathogens, particularly viruses, induce IFIT  family  gene expression.",Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
"9    http://www.biolsci.org  204  IFN-β-promoter stimulator 1 (IPS -1) located in mit o- chondria interacts with the caspase -recruitment do- main (CARDs) of RLRs a nd triggers signaling ca s- cades and enhances IFN expression, thus stimulating  IFIT family gene expression though JAK -STAT si g- naling as a result of TLRs signaling (Figure 3 ) [36] .",Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
9    http://www.biolsci.org  205    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
"9    http://www.biolsci.org  206  RNA is considered as an essential process for RNA  translation and stability [49] , therefore, 2’ -O methyl a- tion of the viral genome that imitates host mRNA  greatly benefits its life cycle and survival.",Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
9    http://www.biolsci.org  207  6.,Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
9    http://www.biolsci.org  208  54.,Non-OADS,/arxiv_data1/oa_pdf/cd/18/ijbsv09p0200.PMC3584916.pdf
"9      http://www.biolsci.org  209  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2013; 9(2):209-218. doi: 10.7150/ ijbs.5646   Research Paper   Effects of Hypothyroidism on Expression of CRMP2 B  and ARPC5  during Development of the Rat Frontal  Cortex    Chun -rong Liu, Jun Miao, Yong -liang Zhang, Ya- min Liu, Bao -guo Yu    Department of Pathology,  Affiliated Hospital of Logistics University of Chinese People’s Armed Police Force,  Tianjin  300162, China .",Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9    http://www.biolsci.org  210  been completely elucidated.,OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9    http://www.biolsci.org  211  with SynGene 3.07.03 analysis software.,OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9    http://www.biolsci.org  212    Fig.,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9      http://www.biolsci.org  213                Fig.,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9      http://www.biolsci.org  214  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9    http://www.biolsci.org  215    Fig.,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9    http://www.biolsci.org  216  was decreased with  the brain ischemic duration i n- creased.,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
"9    http://www.biolsci.org  217  cortex  of P15 rats with hypothyroid ism, suggest ing  that ARPC5  may be a target gene of thyroid hor- mone s. The lower ARPC5 expression at P15 may co n- tribute to deformation of growth cone filopodia and  lamellipodia  by interfering  with actin activation  and  reorganization .",Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
9    http://www.biolsci.org  218  17.,Non-OADS,/arxiv_data1/oa_pdf/c6/b7/ijbsv09p0209.PMC3584917.pdf
"9      http://www.biolsci.org  219  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2013; 9(2):219-227. doi: 10.7150/ ijbs.5380   Research Paper   Analysis of Core Region f rom Egg White  Lysozyme  Forming Amyloid Fibrils    Yuhei Tokunaga1, Yukako Sakakibara1, Yoshiki Kamada1, Kei-ichi Watanabe1,2, Yasushi  Sugimoto1  1.",Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
This is an open -access article distributed under the terms of the Creative Comm ons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
9    http://www.biolsci.org  220  accepted that the formation of amyloid fibrils is im- plicated in particular regions of protein as well as the  entire protein [17].,Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
"9      http://www.biolsci.org  221  Preparation of aggregates and fibrils    The solutions containing each of the K peptide  and ot her peptides prepared by dissolving with 100%  dimetylsulfoxide (DMSO) were diluted to the peptide  concentration of 2 mg/ml in different pH buffers, and incubated at 37°C for the indicated time periods.",Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
"9    http://www.biolsci.org  222  and more were formed, than those at pH 2.",Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
9      http://www.biolsci.org  223    Fig.,Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
9    http://www.biolsci.org  224      Fig.,Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
"9      http://www.biolsci.org  225  Significance of amino acid residue in the K  peptide     The K peptide , consist ing of nine amino acids,  is  abundant in the hydrophobic side chains.",Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
9    http://www.biolsci.org  226  cubation of the K peptide is interpreted by assuming  that the  tryptophan residue is in more internal and  has a  propensity to be non- polarized.,Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
9    http://www.biolsci.org  227  22.,Non-OADS,/arxiv_data1/oa_pdf/be/ee/ijbsv09p0219.PMC3584918.pdf
"Orfanidis, S. J. Electromagnetic Waves and Antennas , http://www.ece.rutgers.",Non-OADS,/arxiv_data1/oa_pdf/44/3b/srep01361.PMC3584925.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Feuillet-Palma, C., Todorov, Y., Vasanelli, A.",Non-OADS,/arxiv_data1/oa_pdf/44/3b/srep01361.PMC3584925.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/91/3b/srep01351.PMC3584926.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Carotenuto, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/91/3b/srep01351.PMC3584926.pdf
"All data analysis was done with R (http://www.r-project.org/, version 2.15.0).",OADS,/arxiv_data1/oa_pdf/12/ed/srep01360.PMC3584930.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Mavrodiev, P., Tessone, C.J.",Non-OADS,/arxiv_data1/oa_pdf/12/ed/srep01360.PMC3584930.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Early life growth trajectories and overweight JC Jones-Smith et al 7 &2013 Macmillan Publishers Limited Nutrition and Diabetes (2013), 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/78/df/nutd201232a.PMC3584986.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Nutrition and Diabetes website (http://www.nature.com/nutd)Circulating CD36 in type 2 diabetes MJ Alkhatatbeh et al 7 &2013 Macmillan Publishers Limited Nutrition and Diabetes (2013) 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/9d/56/nutd20131a.PMC3584987.pdf
"Keywords Reproductive health, maternity services, health financing, vouchersThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b7/71/czs030.PMC3584990.pdf
"Keywords Reproductive health, voucher programme, community-level impact, service utilization, KenyaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/cd/18/czs033.PMC3584991.pdf
"Keywords Health insurance, third-party payments, developing country, systematic review JEL codes I13, I38This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a3/cf/czs034.PMC3584992.pdf
"Keywords Willingness-to-pay, contingent valuation, drug shop, malaria, rapid diagnostic test, artemisinin-based combination therapy, Uganda JEL codes D12, I11This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/5d/czs048.PMC3584993.pdf
"Online at: http://www.theglobalfund.org/documents/amfm/AMFm_PriceTrackingByHAIAugust2011Survey_Report_en, accessed 26April 2012.",Non-OADS,/arxiv_data1/oa_pdf/82/5d/czs048.PMC3584993.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journa l, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/dd/f0/ehs330.PMC3584995.pdf
Multivariate linear regression analysis was performed using the lm function of software R 2.4.1 ( http://www.R-project.org ).,OADS,/arxiv_data1/oa_pdf/dd/f0/ehs330.PMC3584995.pdf
Cell Cycle 2012; 11:4378- 4384; http://www.landesbioscience.com/journals/cc/ article/22688/,OADS,/arxiv_data1/oa_pdf/42/d0/nucl-4-1.PMC3585020.pdf
Cell 2012; 150:122-35; PM iD:22770216; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
"org/10.1016/j .cell.2012.04.043Keywords:  nucleus, nuclear envelope, cell  cycle, LEM, barrier-to-autointegration  factor, kinase, phosphatase, phosphorylation, VRK, PP2A Submitted: 10/25/2012Revised: 11/15/2012Accepted: 11/19/2012http://dx.doi.org/10.4161/nucl.22961 Correspondence to: Mátyás Gorjánácz;   Email: gorjanac@embl.deThe transitions between the successive  cell cycle stages depend on revers - ible protein phosphorylation events.",OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Mol Biol Cell 2006; 17:2451-64; PMID:16495336; http://dx.doi.org/10.1091/mbc.E05-12-1179.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Biol Chem 2012; 287:5278-89; PMID:22194607; http://dx.doi.org/10.1074/jbc.M111.281709.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Mol Biol Cell 2006; 17:1154-63; PMID:16371512; http://dx.doi.org/10.1091/mbc.E05-04-0356.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Trends Cell Biol 2009; 19:531-41; PMID:19734049; http://dx.doi.org/10.1016/j.tcb.2009.06.005.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Biochem J 2001; 353:417-39; PMID:11171037; http://dx.doi.org/10.1042/0264-6021:3530417.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nat Cell Biol 2010; 12:886-93; PMID:20711181; http://dx.doi.org/10.1038/ncb2092.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Dev Cell 2011; 20:550-62; PMID:21497765; http://dx.doi.org/10.1016/j.dev - cel.2011.02.005.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Dev Cell 2011; 20:563-71; PMID:21497766; http://dx.doi.org/10.1016/j.devcel.2011.03.007.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Science 2010; 328:1043-6; PMID:20489023; http://dx.doi.org/10.1126/science.1176495.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Trends Cell Biol 1999; 9:216-21; PMID:10354567; http://dx.doi.org/10.1016/S0962-8924(99)01558-5.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Diabetes 2002; 51(Suppl 3):S385-8; PMID:12475780; http://dx.doi.org/10.2337/dia - betes.51.2007.S385.11.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nat Struct Mol Biol 2005; 12:935-6; PMID:16155580; http://dx.doi.org/10.1038/nsmb989.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Biol Chem 2007; 282:14525-35; PMID:17355960; http://dx.doi.org/10.1074/jbc.M700576200.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Biol 2006; 173:469-76; PMID:16717124; http://dx.doi.org/10.1083/jcb.200512078.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nat Rev Mol Cell Biol 2009; 10:178-91; PMID:19234477; http://dx.doi.org/10.1038/nrm2641.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nat Rev Mol Cell Biol 2011; 12:469-82; PMID:21750572; http://dx.doi.org/10.1038/nrm3149.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Sci 2009; 122:1963-9; PMID:19494125; http://dx.doi.org/10.1242/jcs.044750.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Biol 2012; 198:981-90; PMID:22986494; http://dx.doi.org/10.1083/jcb.201205103.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Biochem 2012; 113:2813-21; PMID:22566057; http://dx.doi.org/10.1002/jcb.24178.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Biol 2008; 182:911-24; PMID:18779370; http://dx.doi.org/10.1083/jcb.200805140.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Biol 2009; 186:183-91; PMID:19620630; http://dx.doi.org/10.1083/jcb.200901106.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
EMBO J 2007; 26:132-43; PMID:17170708; http://dx.doi.org/10.1038/sj.emboj.7601470.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
J Cell Sci 2008; 121:2540-54; PMID:18628300; http://dx.doi.org/10.1242/jcs.033597.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nat Cell Biol 2007; 9:1160-6; PMID:17828249; http://dx.doi.org/10.1038/ncb1636.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
"Cell 2012; 150:122-35; PMID:22770216; http://dx.doi.org/10.1016/j.cell.2012.04.043.and PP2A, as well as to understand,  how other proteins are dephosphorylated in order that they can play their part in rebuilding the interphase nuclear struc - tures such as nuclear pore complexes, lamin filaments or different nuclear bodies.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Annu Rev Cell Dev Biol 2005; 21:347-80; PMID:16212499; http://dx.doi.org/10.1146/annurev.cellbio.21.090704.151152.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Trends Cell Biol 2003; 13:584-92; PMID:14573352; http://dx.doi.org/10.1016/j.tcb.2003.09.009.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nat Rev Mol Cell Biol 2010; 11:317-28; PMID:20414256; http://dx.doi.org/10.1038/nrm2894.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Nucleus 2011; 2:339-49; PMID:21970986; http://dx.doi.org/10.4161/nucl.2.5.17846.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Genes Dev 2008; 22:832-53; PMID:18381888; http://dx.doi.org/10.1101/gad.1652708.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Annu Rev Cell Dev Biol 2010; 26:421-44; PMID:20507227; http://dx.doi.org/10.1146/annurev-cellbio-100109-104037.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
FEBS Lett 2007; 581:2794-801; PMID:17418822; http://dx.doi.org/10.1016/j.febs - let.2007.03.052.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Trends Cell Biol 2007; 17:202-8; PMID:17320395; http://dx.doi.org/10.1016/j.tcb.2007.02.004.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Biochem Soc Trans 2011; 39:1735-41; PMID:22103517; http://dx.doi.org/10.1042/BST20110724.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
Int Rev Cytol 2007; 261:1-46; PMID:17560279; http://dx.doi.org/10.1016/S0074-7696(07)61001-8.,OADS,/arxiv_data1/oa_pdf/52/3d/nucl-4-14.PMC3585021.pdf
"www.landesbioscience.com  Nucleus  29Nucleus 4:1, 29–36; January/February 2013; © 2013 Landes Bioscienc e Extra Vi Ew Extra Vi Ew Keywords:  LINC complex, SUN  domain, KASH domain, nuclear  envelope, mechanotransduction, nuclear membrane spacing, spermatogenesis, nuclear pore complex, spindle pole body, membrane fusion Abbreviations:  NE, nuclear envelope;  INM, inner nuclear membrane; ONM,  outer nuclear membrane; PNS, perinu - clear space; ER, endoplasmic reticulum; NPC, nuclear pore complex; LINC, link - er of nucleoskeleton and cytoskeleton; SUN, Sad1/UNC-84; KASH, Klarsicht/ANC-1/SYNE homology; TM, trans - membrane; SPB, spindle pole body Submitted: 11/08/12Revised: 12/12/12Accepted: 12/21/12http://dx.doi.org/10.4161/nucl.23387 *Correspondence to: Ulrike Kutay;   Email: ulrike.kutay@bc.biol.ethz.chLinker of nucleoskeleton and cyto - skeleton (LINC) complexes span the  double membrane of the nuclear enve - lope (NE) and physically connect nuclear  structures to cytoskeletal elements.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cell 2012 149:1035-47.;  PMiD:22632968; http://dx.doi.org/10.1016/j .,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Curr Opin Cell Biol 2012; 24:71-8; PMID:22192274; http://dx.doi.org/10.1016/j.ceb.2011.11.007.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Science 2007; 318:1408-12; PMID:18048680; http://dx.doi.org/10.1126/science.1142034.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000760; PMID:20182615; http://dx.doi.org/10.1101/cshperspect.a000760.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Annu Rev Biophys 2012; 41:557-84; PMID:22577827; http://dx.doi.org/10.1146/annurev-bio - phys-050511-102328.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Dev Cell 2009; 17:587-97; PMID:19922864; http://dx.doi.org/10.1016/j.dev - cel.2009.10.018.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cell Mol Life Sci 2009; 66:1518-33; PMID:19125221; http://dx.doi.org/10.1007/s00018-008-8713-y.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Annu Rev Cell Dev Biol 2010; 26:421-44; PMID:20507227; http://dx.doi.org/10.1146/annurev-cellbio-100109-104037.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cell 2012; 149:1035-47; PMID:22632968; http://dx.doi.org/10.1016/j.cell.2012.03.046.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Biol Chem 2012; 287:5317-26; PMID:22170055; http://dx.doi.org/10.1074/jbc.M111.304543.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2006; 172:41-53; PMID:16380439; http://dx.doi.org/10.1083/jcb.200509124.11.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Sci 2005; 118:3419-30; PMID:16079285; http://dx.doi.org/10.1242/jcs.02471.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cell Res 2012; 22:1440-52; PMID:22945352; http://dx.doi.org/10.1038/cr.2012.126.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Biol Chem 2004; 279:25805-12; PMID:15082709; http://dx.doi.org/10.1074/jbc.M313157200.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Science 2010; 329:956-9; PMID:20724637; http://dx.doi.org/10.1126/science.1189072.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Dev Cell 2007; 12:863-72; PMID:17543860; http://dx.doi.org/10.1016/j.devcel.2007.03.018.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2012; 198:165-72; PMID:22826121; http://dx.doi.org/10.1083/jcb.201204085.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
FEBS Lett 2002; 525:135-40; PMID:12163176; http://dx.doi.org/10.1016/S0014-5793(02)03105-8.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Exp Cell Res 2004; 295:330-9; PMID:15093733; http://dx.doi.org/10.1016/j.yexcr.2004.01.014.20.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Biol Chem 2010; 285:3487-98; PMID:19933576; http://dx.doi.org/10.1074/jbc.M109.071910.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Sci 2012; 125:3025-38; PMID:22797926; http://dx.doi.org/10.1242/jcs.095794.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Vis Exp 2011; 55:e3087;  PMID:21946671; http://dx.doi.org/10.3791/3087.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Biochem Biophys Res Commun 2012; 424:94-9; PMID:22728879; http://dx.doi.org/10.1016/j.bbrc.2012.06.073.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Biol Chem 2011; 286:26743-53; PMID:21652697; http://dx.doi.org/10.1074/jbc.M111.233700.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Nucleic Acids Res 2009; 37(Database issue):D315-22; PMID:18842638; http://dx.doi.org/10.1093/nar/gkn675.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Nat Rev Mol Cell Biol 2007; 8:258-64; PMID:17287811; http://dx.doi.org/10.1038/nrm2119.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
PLoS One 2010; 5:e12072; PMID:20711465; http://dx.doi.org/10.1371/journal.pone.0012072.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Curr Opin Struct Biol  2012; 22:187-96; PMID:22365575; http://dx.doi.org/10.1016/j.sbi.2012.01.007.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2007; 178:785-98; PMID:17724119; http://dx.doi.org/10.1083/jcb.200704108.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2011; 194:27-37; PMID:21727197; http://dx.doi.org/10.1083/jcb.201012154.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Nucleus 2012; 3:226-36; PMID:22572959; http://dx.doi.org/10.4161/nucl.20148.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Annu Rev Cell Dev Biol 2004; 20:1-28; PMID:15473833; http://dx.doi.org/10.1146/annurev.cellbio.20.022003.114106.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
PLoS Genet 2011; 7:e1002365; PMID:22125491; http://dx.doi.org/10.1371/journal.pgen.1002365.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 1991; 114:745-54; PMID:1869587; http://dx.doi.org/10.1083/jcb.114.4.745.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Nat Struct  Mol Biol 2008; 15:690-8; PMID:18596815; http://dx.doi.org/10.1038/nsmb.1456.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
BMC Plant Biol 2010; 10:269; PMID:21143845; http://dx.doi.org/10.1186/1471-2229-10-269.40.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2006; 174:665-75; PMID:16923827; http://dx.doi.org/10.1083/jcb.200601062.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 1995; 129:1033-47; PMID:7744953; http://dx.doi.org/10.1083/jcb.129.4.1033.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2002; 159:945-56; PMID:12486115; http://dx.doi.org/10.1083/jcb.200208169.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Biol 2007; 179:845-54; PMID:18039933; http://dx.doi.org/10.1083/jcb.200706040.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cell 2008; 134:427-38; PMID:18692466; http://dx.doi.org/10.1016/j.cell.2008.06.022.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
EMBO J 2011; 30:3799-811; PMID:21822217; http://dx.doi.org/10.1038/emboj.2011.267.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Methods Cell Biol 2008; 88:3-17; PMID:18617025; http://dx.doi.org/10.1016/S0091-679X(08)00401-9.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Methods Cell Biol 2007; 79:23-56; PMID:17327151; http://dx.doi.org/10.1016/S0091-679X(06)79002-1.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Nat Rev Mol Cell Biol 2009; 10:178-91; PMID:19234477; http://dx.doi.org/10.1038/nrm2641.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Chromosoma 2010; 119:469-77; PMID:20721671; http://dx.doi.org/10.1007/s00412-010-0289-2.30.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Cytogenet Cell Genet 1998; 81:65-7; PMID:9691178; http://dx.doi.org/10.1159/000014990.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Acta Biochim Biophys Sin (Shanghai) 2004; 36:351-9; PMID:15156277; http://dx.doi.org/10.1093/abbs/36.5.351.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Dev Biol 1999; 211:109-23; PMID:10373309; http://dx.doi.org/10.1006/dbio.1999.9297.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Cell Sci 2010; 123:2763-72; PMID:20647369; http://dx.doi.org/10.1242/jcs.066589.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Am J Anat 1991; 192:97-120; PMID:1759685; http://dx.doi.org/10.1002/aja.1001920202.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
J Ultrastruct Res 1974; 48:284-303; PMID:4210599; http://dx.doi.org/10.1016/S0022-5320(74)80083-3.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Mol Biol Cell 2011; 22:1739-52; PMID:21411627; http://dx.doi.org/10.1091/mbc.E10-08-0733.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
Mol Genet Genomics 2004; 270:449-61; PMID:14655046; http://dx.doi.org/10.1007/s00438-003-0938-8.,OADS,/arxiv_data1/oa_pdf/b9/2f/nucl-4-29.PMC3585024.pdf
C ell 2012; 150:317- 26; PM iD:22817894; http://dx.doi.org/10.1016/j .,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
"cell.2012.05.035Keywords:  CENP-A, nucleosome,  structure, oscillation, octamer, tetramer,  hemisome, cell-cycle, AFM, acetylation Submitted: 11/21/12Revised: 01/04/13Accepted: 01/13/13http://dx.doi.org/10.4161/nucl.23588 *Correspondence to: Yamini Dalal;   Email: dalaly@mail.nih.govThe structure of the centromere-spe - cific histone centromeric protein A  (CENP-A) nucleosome has been a hot  topic of debate for the past five years.",OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
J Cell Biol 1994; 127:581-92; PMID:7962047; http://dx.doi.org/10.1083/jcb.127.3.581.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
J Cell Biol 1987; 104:805-15; PMID:3558482; http://dx.doi.org/10.1083/jcb.104.4.805.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Science 1974; 184:865-8; PMID:4825888; http://dx.doi.org/10.1126/sci - ence.184.4139.865.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nature 2011; 476:232-5; PMID:21743476; http://dx.doi.org/10.1038/nature10258.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Mol Cell 2009; 35:794-805; PMID:19782029; http://dx.doi.org/10.1016/j.molcel.2009.07.022.6.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nature 2004; 430:578-82; PMID:15282608; http://dx.doi.org/10.1038/nature02766.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nature 2010; 467:347-51; PMID:20739937; http://dx.doi.org/10.1038/nature09323.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nat Commun 2011; 2:313; PMID:21587230; http://dx.doi.org/10.1038/ncomms1320.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Mol Cell 2012; 45:263-9; PMID:22209075; http://dx.doi.org/10.1016/j.mol - cel.2011.12.010.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2007; 129:1153-64; PMID:17574026; http://dx.doi.org/10.1016/j.cell.2007.04.026.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2009; 138:104-13; PMID:19596238; http://dx.doi.org/10.1016/j.cell.2009.04.049.12.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
PLoS Biol 2007; 5:e218; PMID:17676993; http://dx.doi.org/10.1371/journal.pbio.0050218.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nat Rev Genet 2008; 9:923-37; PMID:19002142; http://dx.doi.org/10.1038/nrg2466.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nat Rev Mol Cell Biol 2009; 10:192-206; PMID:19234478; http://dx.doi.org/10.1038/nrm2640.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Curr Opin Cell Biol 2010; 22:392-402; PMID:20303726; http://dx.doi.org/10.1016/j.ceb.2010.02.005.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nature 2010; 463:446-56; PMID:20110988; http://dx.doi.org/10.1038/nature08912.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
PLoS One 2008; 3:e2099; PMID:18461125; http://dx.doi.org/10.1371/journal.pone.0002099.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nucleus  2011; 2:146-57; PMID:21738837; http://dx.doi.org/10.4161/nucl.2.2.15211.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
J Cell Biol 2009; 185:397-407; PMID:19398759; http://dx.doi.org/10.1083/jcb.200903088.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Biochem Res Int 2011; 2011:195209; PMID:21152184; http://dx.doi.org/10.1155/2011/195209.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 1976; 9:409-17; PMID:991271; http://dx.doi.org/10.1016/0092-8674(76)90085-4.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Science 2010; 328:94-8; PMID:20360108; http://dx.doi.org/10.1126/science.1178994.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Centromere assembly requires the direct recognition of CENP-A nucleosomes by CENP-N. Nat Cell Biol 2009; 11:896-902; PMID:19543270; http://dx.doi.org/10.1038/ncb1899.,Non-OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2012; 150:245-7; PMID:22817887; http://dx.doi.org/10.1016/j.cell.2012.07.003.28.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Dev Cell 2012; 22:749-62; PMID:22406139; http://dx.doi.org/10.1016/j.devcel.2012.02.001.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Dev Cell 2012; 22:52-63; PMID:22169070; http://dx.doi.org/10.1016/j.devcel.2011.10.014.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Genes Cells 2006; 11:673-84; PMID:16716197; http://dx.doi.org/10.1111/j.1365-2443.2006.00969.x.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
J Biol Chem 2009; 284:23312-21; PMID:19520870; http://dx.doi.org/10.1074/jbc.M109.003202.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2010; 140:678-91; PMID:20211137; http://dx.doi.org/10.1016/j.cell.2010.01.003.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
J Cell Sci 2004; 117:3807-20; PMID:15252119; http://dx.doi.org/10.1242/jcs.01230.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Dev Cell 2010; 18:191-202; PMID:20159591; http://dx.doi.org/10.1016/j.devcel.2009.12.017.18.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2012; 150:317-26; PMID:22817894; http://dx.doi.org/10.1016/j.cell.2012.05.035.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2009; 137:485-97; PMID:19410545; http://dx.doi.org/10.1016/j.cell.2009.02.040.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2009; 137:472-84; PMID:19410544; http://dx.doi.org/10.1016/j.cell.2009.02.039.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Cell 2012; 150:304-16; PMID:22817893; http://dx.doi.org/10.1016/j.cell.2012.05.034.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
Nucleic Acids Res 2005; 33:934-45; PMID:15716311; http://dx.doi.org/10.1093/nar/gki224.,OADS,/arxiv_data1/oa_pdf/a8/e1/nucl-4-37.PMC3585026.pdf
